Gene to GO BP test for over-representation
| GOBPID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006950 | 0.00000 | 2.66571 | 149 | 283 | 4110 | response to stress |
| GO:0010033 | 0.00000 | 2.66599 | 120 | 239 | 3302 | response to organic substance |
| GO:0009605 | 0.00000 | 2.83867 | 91 | 200 | 2520 | response to external stimulus |
| GO:0050896 | 0.00000 | 2.47827 | 338 | 477 | 9324 | response to stimulus |
| GO:0034097 | 0.00000 | 3.41851 | 44 | 122 | 1211 | response to cytokine |
| GO:0006954 | 0.00000 | 3.95040 | 31 | 99 | 848 | inflammatory response |
| GO:0070887 | 0.00000 | 2.50814 | 119 | 229 | 3281 | cellular response to chemical stimulus |
| GO:0071310 | 0.00000 | 2.61527 | 98 | 201 | 2707 | cellular response to organic substance |
| GO:0032496 | 0.00000 | 6.25367 | 12 | 59 | 330 | response to lipopolysaccharide |
| GO:0048519 | 0.00000 | 2.22563 | 213 | 336 | 5869 | negative regulation of biological process |
| GO:0071345 | 0.00000 | 3.39291 | 40 | 113 | 1118 | cellular response to cytokine stimulus |
| GO:0002237 | 0.00000 | 5.96303 | 12 | 59 | 343 | response to molecule of bacterial origin |
| GO:0048523 | 0.00000 | 2.24924 | 178 | 295 | 4903 | negative regulation of cellular process |
| GO:0051707 | 0.00000 | 3.37467 | 37 | 103 | 1013 | response to other organism |
| GO:0009607 | 0.00000 | 3.32872 | 38 | 105 | 1047 | response to biotic stimulus |
| GO:0043207 | 0.00000 | 3.36687 | 37 | 103 | 1015 | response to external biotic stimulus |
| GO:0042221 | 0.00000 | 2.17798 | 174 | 285 | 4797 | response to chemical |
| GO:0009617 | 0.00000 | 3.88792 | 25 | 82 | 699 | response to bacterium |
| GO:0048518 | 0.00000 | 2.09259 | 226 | 342 | 6254 | positive regulation of biological process |
| GO:0071222 | 0.00000 | 7.24683 | 7 | 42 | 205 | cellular response to lipopolysaccharide |
| GO:0006952 | 0.00000 | 2.65049 | 65 | 143 | 1797 | defense response |
| GO:0009893 | 0.00000 | 2.21931 | 132 | 231 | 3642 | positive regulation of metabolic process |
| GO:0048522 | 0.00000 | 2.08223 | 199 | 309 | 5490 | positive regulation of cellular process |
| GO:0071219 | 0.00000 | 6.94570 | 8 | 42 | 212 | cellular response to molecule of bacterial origin |
| GO:0071216 | 0.00000 | 6.26544 | 9 | 43 | 236 | cellular response to biotic stimulus |
| GO:0051716 | 0.00000 | 1.99365 | 276 | 387 | 7617 | cellular response to stimulus |
| GO:0035556 | 0.00000 | 2.24054 | 107 | 195 | 2952 | intracellular signal transduction |
| GO:0010604 | 0.00000 | 2.14976 | 122 | 212 | 3366 | positive regulation of macromolecule metabolic process |
| GO:0002376 | 0.00000 | 2.16969 | 116 | 204 | 3193 | immune system process |
| GO:1901700 | 0.00000 | 2.57820 | 59 | 129 | 1637 | response to oxygen-containing compound |
| GO:0030155 | 0.00000 | 3.52051 | 25 | 75 | 691 | regulation of cell adhesion |
| GO:0048583 | 0.00000 | 2.04745 | 157 | 254 | 4342 | regulation of response to stimulus |
| GO:0001775 | 0.00000 | 2.66688 | 52 | 118 | 1440 | cell activation |
| GO:0007154 | 0.00000 | 1.94571 | 241 | 346 | 6647 | cell communication |
| GO:0048585 | 0.00000 | 2.52862 | 61 | 131 | 1693 | negative regulation of response to stimulus |
| GO:0019221 | 0.00000 | 3.28033 | 29 | 81 | 798 | cytokine-mediated signaling pathway |
| GO:0031325 | 0.00000 | 2.11716 | 121 | 208 | 3330 | positive regulation of cellular metabolic process |
| GO:0022407 | 0.00000 | 4.38934 | 15 | 54 | 403 | regulation of cell-cell adhesion |
| GO:0007166 | 0.00000 | 2.14792 | 111 | 195 | 3052 | cell surface receptor signaling pathway |
| GO:1902531 | 0.00000 | 2.38719 | 71 | 143 | 1961 | regulation of intracellular signal transduction |
| GO:0051239 | 0.00000 | 2.11265 | 118 | 204 | 3260 | regulation of multicellular organismal process |
| GO:0023052 | 0.00000 | 1.91090 | 240 | 342 | 6620 | signaling |
| GO:0045321 | 0.00000 | 2.68685 | 46 | 107 | 1284 | leukocyte activation |
| GO:0080134 | 0.00000 | 2.48471 | 60 | 126 | 1645 | regulation of response to stress |
| GO:0051240 | 0.00000 | 2.40554 | 66 | 134 | 1811 | positive regulation of multicellular organismal process |
| GO:0051173 | 0.00000 | 2.08429 | 116 | 199 | 3200 | positive regulation of nitrogen compound metabolic process |
| GO:0007165 | 0.00000 | 1.88471 | 223 | 321 | 6155 | signal transduction |
| GO:0042127 | 0.00000 | 2.41492 | 62 | 127 | 1700 | regulation of cell proliferation |
| GO:0009966 | 0.00000 | 2.06226 | 115 | 196 | 3170 | regulation of signal transduction |
| GO:0050865 | 0.00000 | 3.44453 | 22 | 66 | 614 | regulation of cell activation |
| GO:0051246 | 0.00000 | 2.08771 | 106 | 185 | 2936 | regulation of protein metabolic process |
| GO:0065007 | 0.00000 | 2.07961 | 463 | 551 | 12777 | biological regulation |
| GO:0033993 | 0.00000 | 2.90126 | 33 | 84 | 923 | response to lipid |
| GO:0010648 | 0.00000 | 2.50622 | 51 | 111 | 1419 | negative regulation of cell communication |
| GO:0001816 | 0.00000 | 3.06555 | 29 | 76 | 790 | cytokine production |
| GO:0023057 | 0.00000 | 2.49798 | 52 | 111 | 1423 | negative regulation of signaling |
| GO:0009968 | 0.00000 | 2.55525 | 48 | 105 | 1313 | negative regulation of signal transduction |
| GO:0007159 | 0.00000 | 4.44192 | 12 | 46 | 337 | leukocyte cell-cell adhesion |
| GO:0010646 | 0.00000 | 1.98299 | 128 | 210 | 3542 | regulation of cell communication |
| GO:0019220 | 0.00000 | 2.30300 | 66 | 130 | 1816 | regulation of phosphate metabolic process |
| GO:0051174 | 0.00000 | 2.29999 | 66 | 130 | 1818 | regulation of phosphorus metabolic process |
| GO:0065009 | 0.00000 | 2.04113 | 108 | 185 | 2989 | regulation of molecular function |
| GO:0065008 | 0.00000 | 1.92228 | 147 | 231 | 4057 | regulation of biological quality |
| GO:0008219 | 0.00000 | 2.16170 | 82 | 151 | 2264 | cell death |
| GO:0016477 | 0.00000 | 2.37007 | 58 | 118 | 1592 | cell migration |
| GO:1901701 | 0.00000 | 2.62759 | 41 | 94 | 1136 | cellular response to oxygen-containing compound |
| GO:0023051 | 0.00000 | 1.94772 | 130 | 210 | 3591 | regulation of signaling |
| GO:0006915 | 0.00000 | 2.21671 | 72 | 137 | 1988 | apoptotic process |
| GO:0001944 | 0.00000 | 2.95770 | 29 | 74 | 792 | vasculature development |
| GO:0032268 | 0.00000 | 2.05631 | 97 | 169 | 2679 | regulation of cellular protein metabolic process |
| GO:1903037 | 0.00000 | 4.48349 | 11 | 42 | 304 | regulation of leukocyte cell-cell adhesion |
| GO:0010941 | 0.00000 | 2.28289 | 63 | 124 | 1736 | regulation of cell death |
| GO:0072358 | 0.00000 | 2.91956 | 29 | 74 | 801 | cardiovascular system development |
| GO:0031324 | 0.00000 | 2.04957 | 96 | 167 | 2650 | negative regulation of cellular metabolic process |
| GO:0001932 | 0.00000 | 2.38652 | 53 | 110 | 1465 | regulation of protein phosphorylation |
| GO:0002694 | 0.00000 | 3.33246 | 21 | 60 | 571 | regulation of leukocyte activation |
| GO:0022610 | 0.00000 | 2.40379 | 52 | 108 | 1427 | biological adhesion |
| GO:0051172 | 0.00000 | 2.06856 | 90 | 159 | 2488 | negative regulation of nitrogen compound metabolic process |
| GO:0043067 | 0.00000 | 2.30820 | 58 | 117 | 1613 | regulation of programmed cell death |
| GO:0071396 | 0.00000 | 3.21469 | 22 | 62 | 610 | cellular response to lipid |
| GO:0006468 | 0.00000 | 2.18022 | 72 | 135 | 1983 | protein phosphorylation |
| GO:0007155 | 0.00000 | 2.38907 | 51 | 107 | 1420 | cell adhesion |
| GO:0012501 | 0.00000 | 2.13857 | 77 | 142 | 2132 | programmed cell death |
| GO:0048584 | 0.00000 | 2.05638 | 91 | 159 | 2500 | positive regulation of response to stimulus |
| GO:0042981 | 0.00000 | 2.30086 | 57 | 115 | 1587 | regulation of apoptotic process |
| GO:0001817 | 0.00000 | 2.97954 | 26 | 68 | 719 | regulation of cytokine production |
| GO:0035295 | 0.00000 | 2.55581 | 40 | 90 | 1110 | tube development |
| GO:0042325 | 0.00000 | 2.28106 | 58 | 116 | 1614 | regulation of phosphorylation |
| GO:0072359 | 0.00000 | 2.50814 | 42 | 93 | 1169 | circulatory system development |
| GO:0032101 | 0.00000 | 2.72273 | 33 | 79 | 913 | regulation of response to external stimulus |
| GO:1902533 | 0.00000 | 2.55958 | 39 | 88 | 1082 | positive regulation of intracellular signal transduction |
| GO:0051179 | 0.00000 | 1.75789 | 244 | 333 | 6735 | localization |
| GO:0001568 | 0.00000 | 2.89247 | 28 | 70 | 761 | blood vessel development |
| GO:0051247 | 0.00000 | 2.22209 | 62 | 120 | 1713 | positive regulation of protein metabolic process |
| GO:0008283 | 0.00000 | 2.12748 | 73 | 135 | 2024 | cell proliferation |
| GO:0050793 | 0.00000 | 1.98948 | 98 | 166 | 2696 | regulation of developmental process |
| GO:0048513 | 0.00000 | 1.88322 | 130 | 205 | 3583 | animal organ development |
| GO:0050789 | 0.00000 | 1.86538 | 438 | 521 | 12093 | regulation of biological process |
| GO:0008284 | 0.00000 | 2.63879 | 34 | 80 | 951 | positive regulation of cell proliferation |
| GO:0007275 | 0.00000 | 1.76790 | 199 | 283 | 5491 | multicellular organism development |
| GO:0048870 | 0.00000 | 2.18874 | 63 | 121 | 1751 | cell motility |
| GO:0051674 | 0.00000 | 2.18874 | 63 | 121 | 1751 | localization of cell |
| GO:1902532 | 0.00000 | 3.16324 | 20 | 57 | 566 | negative regulation of intracellular signal transduction |
| GO:0031399 | 0.00000 | 2.13866 | 68 | 126 | 1867 | regulation of protein modification process |
| GO:0050794 | 0.00000 | 1.78358 | 399 | 484 | 11022 | regulation of cellular process |
| GO:0031323 | 0.00000 | 1.72711 | 228 | 313 | 6305 | regulation of cellular metabolic process |
| GO:0048731 | 0.00000 | 1.76611 | 178 | 258 | 4918 | system development |
| GO:0035239 | 0.00000 | 2.61533 | 33 | 77 | 920 | tube morphogenesis |
| GO:0008285 | 0.00000 | 2.79638 | 28 | 68 | 760 | negative regulation of cell proliferation |
| GO:0009653 | 0.00000 | 1.93788 | 99 | 165 | 2735 | anatomical structure morphogenesis |
| GO:0040011 | 0.00000 | 2.08150 | 72 | 130 | 1977 | locomotion |
| GO:0051248 | 0.00000 | 2.36334 | 43 | 90 | 1188 | negative regulation of protein metabolic process |
| GO:0051704 | 0.00000 | 1.92749 | 95 | 159 | 2635 | multi-organism process |
| GO:0050790 | 0.00000 | 1.97779 | 84 | 145 | 2328 | regulation of catalytic activity |
| GO:0033554 | 0.00000 | 2.03160 | 75 | 133 | 2069 | cellular response to stress |
| GO:0048856 | 0.00000 | 1.70474 | 217 | 298 | 5988 | anatomical structure development |
| GO:0045785 | 0.00000 | 3.51318 | 15 | 45 | 403 | positive regulation of cell adhesion |
| GO:0048514 | 0.00000 | 2.83438 | 25 | 62 | 681 | blood vessel morphogenesis |
| GO:1901564 | 0.00000 | 1.68487 | 255 | 338 | 7040 | organonitrogen compound metabolic process |
| GO:0032502 | 0.00000 | 1.69255 | 232 | 314 | 6411 | developmental process |
| GO:0030334 | 0.00000 | 2.52103 | 34 | 77 | 950 | regulation of cell migration |
| GO:0043069 | 0.00000 | 2.53600 | 34 | 76 | 932 | negative regulation of programmed cell death |
| GO:0010647 | 0.00000 | 2.08093 | 67 | 122 | 1844 | positive regulation of cell communication |
| GO:0080090 | 0.00000 | 1.69428 | 226 | 307 | 6233 | regulation of primary metabolic process |
| GO:0009719 | 0.00000 | 2.13688 | 60 | 113 | 1658 | response to endogenous stimulus |
| GO:0023056 | 0.00000 | 2.07162 | 67 | 122 | 1851 | positive regulation of signaling |
| GO:0009967 | 0.00000 | 2.12053 | 61 | 114 | 1685 | positive regulation of signal transduction |
| GO:0032879 | 0.00000 | 1.86987 | 103 | 167 | 2853 | regulation of localization |
| GO:0032501 | 0.00000 | 1.66490 | 281 | 363 | 7751 | multicellular organismal process |
| GO:0043066 | 0.00000 | 2.51971 | 33 | 74 | 911 | negative regulation of apoptotic process |
| GO:0060548 | 0.00000 | 2.42707 | 37 | 80 | 1023 | negative regulation of cell death |
| GO:0002682 | 0.00000 | 2.11123 | 60 | 112 | 1659 | regulation of immune system process |
| GO:0006955 | 0.00000 | 1.95457 | 83 | 141 | 2279 | immune response |
| GO:0010562 | 0.00000 | 2.34036 | 41 | 86 | 1141 | positive regulation of phosphorus metabolic process |
| GO:0045937 | 0.00000 | 2.34036 | 41 | 86 | 1141 | positive regulation of phosphate metabolic process |
| GO:0050863 | 0.00000 | 3.82357 | 11 | 38 | 314 | regulation of T cell activation |
| GO:2000145 | 0.00000 | 2.41978 | 37 | 79 | 1012 | regulation of cell motility |
| GO:0022408 | 0.00000 | 5.03861 | 7 | 28 | 181 | negative regulation of cell-cell adhesion |
| GO:0002274 | 0.00000 | 2.81089 | 24 | 59 | 651 | myeloid leukocyte activation |
| GO:0045859 | 0.00000 | 2.62052 | 29 | 67 | 792 | regulation of protein kinase activity |
| GO:0050727 | 0.00000 | 3.14715 | 18 | 49 | 485 | regulation of inflammatory response |
| GO:0051249 | 0.00000 | 3.14715 | 18 | 49 | 485 | regulation of lymphocyte activation |
| GO:0051171 | 0.00000 | 1.67231 | 220 | 298 | 6063 | regulation of nitrogen compound metabolic process |
| GO:0032270 | 0.00000 | 2.11080 | 58 | 109 | 1611 | positive regulation of cellular protein metabolic process |
| GO:0010243 | 0.00000 | 2.42070 | 36 | 78 | 998 | response to organonitrogen compound |
| GO:0045936 | 0.00000 | 2.91270 | 21 | 55 | 586 | negative regulation of phosphate metabolic process |
| GO:0010563 | 0.00000 | 2.90706 | 21 | 55 | 587 | negative regulation of phosphorus metabolic process |
| GO:0006469 | 0.00000 | 4.35480 | 9 | 32 | 235 | negative regulation of protein kinase activity |
| GO:0006793 | 0.00000 | 1.79516 | 121 | 187 | 3347 | phosphorus metabolic process |
| GO:0051094 | 0.00000 | 2.16910 | 51 | 99 | 1418 | positive regulation of developmental process |
| GO:0098609 | 0.00000 | 2.54275 | 30 | 69 | 839 | cell-cell adhesion |
| GO:0040012 | 0.00000 | 2.34101 | 39 | 82 | 1084 | regulation of locomotion |
| GO:0044092 | 0.00000 | 2.29183 | 42 | 86 | 1162 | negative regulation of molecular function |
| GO:2000026 | 0.00000 | 1.95183 | 78 | 134 | 2157 | regulation of multicellular organismal development |
| GO:0032940 | 0.00000 | 2.12215 | 55 | 104 | 1524 | secretion by cell |
| GO:0042110 | 0.00000 | 3.14960 | 17 | 47 | 464 | T cell activation |
| GO:0031347 | 0.00000 | 2.46823 | 33 | 72 | 901 | regulation of defense response |
| GO:0006796 | 0.00000 | 1.78584 | 120 | 185 | 3320 | phosphate-containing compound metabolic process |
| GO:0022409 | 0.00000 | 4.10853 | 9 | 33 | 255 | positive regulation of cell-cell adhesion |
| GO:0001934 | 0.00000 | 2.36908 | 37 | 78 | 1017 | positive regulation of protein phosphorylation |
| GO:0042326 | 0.00000 | 3.11897 | 17 | 47 | 468 | negative regulation of phosphorylation |
| GO:0033673 | 0.00000 | 4.07139 | 9 | 33 | 257 | negative regulation of kinase activity |
| GO:0046903 | 0.00000 | 2.06037 | 60 | 110 | 1661 | secretion |
| GO:0042592 | 0.00000 | 1.98858 | 69 | 122 | 1916 | homeostatic process |
| GO:0055076 | 0.00000 | 5.83316 | 5 | 23 | 131 | transition metal ion homeostasis |
| GO:0001525 | 0.00000 | 2.84410 | 21 | 54 | 587 | angiogenesis |
| GO:1903039 | 0.00000 | 4.39843 | 8 | 30 | 218 | positive regulation of leukocyte cell-cell adhesion |
| GO:0007162 | 0.00000 | 3.81355 | 10 | 35 | 289 | negative regulation of cell adhesion |
| GO:0042327 | 0.00000 | 2.31041 | 39 | 80 | 1068 | positive regulation of phosphorylation |
| GO:1901698 | 0.00000 | 2.29403 | 39 | 81 | 1089 | response to nitrogen compound |
| GO:0006928 | 0.00000 | 1.91128 | 80 | 135 | 2213 | movement of cell or subcellular component |
| GO:0001933 | 0.00000 | 3.18427 | 16 | 44 | 429 | negative regulation of protein phosphorylation |
| GO:0030335 | 0.00000 | 2.89672 | 20 | 51 | 544 | positive regulation of cell migration |
| GO:0048646 | 0.00000 | 2.23482 | 42 | 85 | 1173 | anatomical structure formation involved in morphogenesis |
| GO:0006953 | 0.00000 | 11.51030 | 2 | 14 | 47 | acute-phase response |
| GO:0051270 | 0.00000 | 2.27489 | 40 | 81 | 1097 | regulation of cellular component movement |
| GO:0051241 | 0.00000 | 2.15837 | 48 | 92 | 1316 | negative regulation of multicellular organismal process |
| GO:0019538 | 0.00000 | 1.63233 | 217 | 291 | 5986 | protein metabolic process |
| GO:0002521 | 0.00000 | 2.93951 | 19 | 49 | 515 | leukocyte differentiation |
| GO:0031401 | 0.00000 | 2.19410 | 45 | 88 | 1237 | positive regulation of protein modification process |
| GO:0043549 | 0.00000 | 2.43994 | 32 | 69 | 870 | regulation of kinase activity |
| GO:0032269 | 0.00000 | 2.25734 | 41 | 82 | 1119 | negative regulation of cellular protein metabolic process |
| GO:0051272 | 0.00000 | 2.79235 | 21 | 53 | 585 | positive regulation of cellular component movement |
| GO:2000147 | 0.00000 | 2.82267 | 21 | 52 | 568 | positive regulation of cell motility |
| GO:0016310 | 0.00000 | 1.85469 | 88 | 143 | 2417 | phosphorylation |
| GO:0051348 | 0.00000 | 3.74367 | 10 | 34 | 285 | negative regulation of transferase activity |
| GO:0048008 | 0.00000 | 9.69959 | 2 | 15 | 57 | platelet-derived growth factor receptor signaling pathway |
| GO:0043408 | 0.00000 | 2.52035 | 28 | 63 | 768 | regulation of MAPK cascade |
| GO:0002526 | 0.00000 | 4.17786 | 8 | 29 | 220 | acute inflammatory response |
| GO:0045595 | 0.00000 | 1.92936 | 68 | 117 | 1878 | regulation of cell differentiation |
| GO:0044093 | 0.00000 | 1.95529 | 64 | 112 | 1771 | positive regulation of molecular function |
| GO:0000165 | 0.00000 | 2.30177 | 35 | 72 | 958 | MAPK cascade |
| GO:0046649 | 0.00000 | 2.50685 | 27 | 60 | 733 | lymphocyte activation |
| GO:0044267 | 0.00000 | 1.61708 | 191 | 260 | 5276 | cellular protein metabolic process |
| GO:0048869 | 0.00000 | 1.64688 | 160 | 226 | 4431 | cellular developmental process |
| GO:0050730 | 0.00000 | 3.79562 | 9 | 31 | 256 | regulation of peptidyl-tyrosine phosphorylation |
| GO:0030154 | 0.00000 | 1.65404 | 153 | 218 | 4239 | cell differentiation |
| GO:0040007 | 0.00000 | 2.26489 | 36 | 73 | 986 | growth |
| GO:0043086 | 0.00000 | 2.40105 | 30 | 64 | 815 | negative regulation of catalytic activity |
| GO:0040017 | 0.00000 | 2.66300 | 22 | 52 | 598 | positive regulation of locomotion |
| GO:0023014 | 0.00000 | 2.27208 | 35 | 72 | 969 | signal transduction by protein phosphorylation |
| GO:0019222 | 0.00000 | 1.57378 | 264 | 337 | 7303 | regulation of metabolic process |
| GO:0051338 | 0.00000 | 2.26411 | 35 | 72 | 972 | regulation of transferase activity |
| GO:0009991 | 0.00000 | 2.77106 | 19 | 48 | 531 | response to extracellular stimulus |
| GO:0001819 | 0.00000 | 2.91311 | 17 | 44 | 464 | positive regulation of cytokine production |
| GO:0097190 | 0.00000 | 2.64303 | 22 | 52 | 602 | apoptotic signaling pathway |
| GO:0006464 | 0.00000 | 1.64903 | 151 | 214 | 4160 | cellular protein modification process |
| GO:0036211 | 0.00000 | 1.64903 | 151 | 214 | 4160 | protein modification process |
| GO:0009888 | 0.00000 | 1.85786 | 75 | 124 | 2065 | tissue development |
| GO:0006810 | 0.00000 | 1.60281 | 188 | 255 | 5190 | transport |
| GO:0030097 | 0.00000 | 2.30417 | 32 | 67 | 887 | hemopoiesis |
| GO:1901342 | 0.00000 | 2.98482 | 15 | 41 | 422 | regulation of vasculature development |
| GO:0045444 | 0.00000 | 3.94406 | 8 | 28 | 223 | fat cell differentiation |
| GO:0048878 | 0.00000 | 2.10993 | 43 | 82 | 1187 | chemical homeostasis |
| GO:0045597 | 0.00000 | 2.21483 | 36 | 72 | 991 | positive regulation of cell differentiation |
| GO:0002366 | 0.00000 | 2.45708 | 26 | 57 | 707 | leukocyte activation involved in immune response |
| GO:0050867 | 0.00000 | 3.04208 | 14 | 39 | 394 | positive regulation of cell activation |
| GO:0009892 | 0.00000 | 1.66433 | 129 | 187 | 3549 | negative regulation of metabolic process |
| GO:0009891 | 0.00000 | 1.84239 | 73 | 121 | 2025 | positive regulation of biosynthetic process |
| GO:0002263 | 0.00000 | 2.44149 | 26 | 57 | 711 | cell activation involved in immune response |
| GO:0031667 | 0.00000 | 2.75522 | 18 | 45 | 499 | response to nutrient levels |
| GO:0051234 | 0.00000 | 1.57901 | 192 | 258 | 5315 | establishment of localization |
| GO:1904018 | 0.00000 | 3.80589 | 8 | 28 | 230 | positive regulation of vasculature development |
| GO:0002684 | 0.00000 | 2.08271 | 43 | 81 | 1185 | positive regulation of immune system process |
| GO:0048534 | 0.00000 | 2.22554 | 34 | 68 | 929 | hematopoietic or lymphoid organ development |
| GO:0071496 | 0.00000 | 3.17734 | 12 | 35 | 339 | cellular response to external stimulus |
| GO:0070555 | 0.00000 | 3.93657 | 7 | 26 | 207 | response to interleukin-1 |
| GO:0031328 | 0.00000 | 1.81904 | 72 | 118 | 1992 | positive regulation of cellular biosynthetic process |
| GO:0010942 | 0.00000 | 2.36997 | 26 | 57 | 730 | positive regulation of cell death |
| GO:0042493 | 0.00000 | 2.14105 | 37 | 72 | 1021 | response to drug |
| GO:0045619 | 0.00000 | 4.30578 | 6 | 23 | 169 | regulation of lymphocyte differentiation |
| GO:0002520 | 0.00000 | 2.15609 | 36 | 70 | 985 | immune system development |
| GO:0002696 | 0.00000 | 2.97972 | 14 | 37 | 380 | positive regulation of leukocyte activation |
| GO:0051093 | 0.00000 | 2.11777 | 38 | 73 | 1046 | negative regulation of developmental process |
| GO:0050663 | 0.00000 | 3.62433 | 9 | 28 | 240 | cytokine secretion |
| GO:0050900 | 0.00000 | 2.68367 | 18 | 44 | 499 | leukocyte migration |
| GO:0040008 | 0.00000 | 2.41267 | 25 | 54 | 679 | regulation of growth |
| GO:0043068 | 0.00000 | 2.40868 | 25 | 54 | 680 | positive regulation of programmed cell death |
| GO:0007169 | 0.00000 | 2.36106 | 26 | 56 | 719 | transmembrane receptor protein tyrosine kinase signaling pathway |
| GO:0043412 | 0.00000 | 1.58535 | 158 | 218 | 4373 | macromolecule modification |
| GO:0045765 | 0.00000 | 2.95339 | 14 | 37 | 383 | regulation of angiogenesis |
| GO:1902105 | 0.00000 | 3.40660 | 10 | 30 | 272 | regulation of leukocyte differentiation |
| GO:0034341 | 0.00000 | 3.93294 | 7 | 25 | 199 | response to interferon-gamma |
| GO:1901652 | 0.00000 | 2.63026 | 19 | 45 | 520 | response to peptide |
| GO:0030198 | 0.00000 | 2.99243 | 13 | 36 | 368 | extracellular matrix organization |
| GO:0010628 | 0.00000 | 1.79760 | 73 | 118 | 2012 | positive regulation of gene expression |
| GO:0097193 | 0.00000 | 3.30398 | 10 | 31 | 289 | intrinsic apoptotic signaling pathway |
| GO:2001234 | 0.00000 | 3.64606 | 8 | 27 | 230 | negative regulation of apoptotic signaling pathway |
| GO:0009636 | 0.00000 | 2.60212 | 19 | 45 | 525 | response to toxic substance |
| GO:0050870 | 0.00000 | 3.86563 | 7 | 25 | 202 | positive regulation of T cell activation |
| GO:1902042 | 0.00000 | 10.61364 | 1 | 11 | 39 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors |
| GO:0032103 | 0.00000 | 3.13312 | 12 | 33 | 323 | positive regulation of response to external stimulus |
| GO:0002252 | 0.00000 | 1.99079 | 46 | 83 | 1265 | immune effector process |
| GO:0043062 | 0.00000 | 2.81521 | 15 | 39 | 422 | extracellular structure organization |
| GO:0043065 | 0.00000 | 2.38793 | 24 | 53 | 672 | positive regulation of apoptotic process |
| GO:0031400 | 0.00000 | 2.45045 | 22 | 50 | 618 | negative regulation of protein modification process |
| GO:0007167 | 0.00000 | 2.08530 | 38 | 72 | 1045 | enzyme linked receptor protein signaling pathway |
| GO:0032602 | 0.00000 | 5.95135 | 3 | 16 | 89 | chemokine production |
| GO:0046632 | 0.00000 | 5.50022 | 4 | 17 | 101 | alpha-beta T cell differentiation |
| GO:0046631 | 0.00000 | 4.61864 | 5 | 20 | 138 | alpha-beta T cell activation |
| GO:0002683 | 0.00000 | 2.68855 | 17 | 41 | 463 | negative regulation of immune system process |
| GO:0071347 | 0.00000 | 4.02751 | 6 | 23 | 179 | cellular response to interleukin-1 |
| GO:0022603 | 0.00000 | 2.01717 | 42 | 77 | 1155 | regulation of anatomical structure morphogenesis |
| GO:0060255 | 0.00000 | 1.50680 | 246 | 310 | 6785 | regulation of macromolecule metabolic process |
| GO:0051090 | 0.00000 | 2.74202 | 16 | 39 | 432 | regulation of DNA-binding transcription factor activity |
| GO:0048871 | 0.00000 | 2.62457 | 18 | 42 | 485 | multicellular organismal homeostasis |
| GO:0045944 | 0.00000 | 1.98422 | 44 | 79 | 1204 | positive regulation of transcription by RNA polymerase II |
| GO:0032642 | 0.00000 | 6.07187 | 3 | 15 | 82 | regulation of chemokine production |
| GO:0061061 | 0.00000 | 2.33522 | 24 | 52 | 672 | muscle structure development |
| GO:0009725 | 0.00000 | 2.07802 | 36 | 68 | 987 | response to hormone |
| GO:0050866 | 0.00000 | 3.74808 | 7 | 24 | 199 | negative regulation of cell activation |
| GO:0032623 | 0.00000 | 7.18087 | 2 | 13 | 62 | interleukin-2 production |
| GO:2001233 | 0.00000 | 2.76569 | 15 | 37 | 406 | regulation of apoptotic signaling pathway |
| GO:0071417 | 0.00000 | 2.42443 | 21 | 47 | 585 | cellular response to organonitrogen compound |
| GO:0070848 | 0.00000 | 2.25163 | 27 | 55 | 736 | response to growth factor |
| GO:0051091 | 0.00000 | 3.29378 | 9 | 28 | 261 | positive regulation of DNA-binding transcription factor activity |
| GO:0031327 | 0.00000 | 1.82284 | 60 | 99 | 1647 | negative regulation of cellular biosynthetic process |
| GO:0046916 | 0.00000 | 5.07514 | 4 | 17 | 108 | cellular transition metal ion homeostasis |
| GO:0009890 | 0.00000 | 1.81490 | 61 | 100 | 1671 | negative regulation of biosynthetic process |
| GO:0071900 | 0.00000 | 2.52178 | 19 | 43 | 515 | regulation of protein serine/threonine kinase activity |
| GO:0014070 | 0.00000 | 2.10662 | 33 | 64 | 915 | response to organic cyclic compound |
| GO:0010605 | 0.00000 | 1.59999 | 120 | 171 | 3314 | negative regulation of macromolecule metabolic process |
| GO:0071495 | 0.00000 | 1.88740 | 50 | 87 | 1393 | cellular response to endogenous stimulus |
| GO:0010273 | 0.00000 | 23.52429 | 1 | 7 | 15 | detoxification of copper ion |
| GO:1990169 | 0.00000 | 23.52429 | 1 | 7 | 15 | stress response to copper ion |
| GO:0034612 | 0.00000 | 3.02962 | 11 | 31 | 312 | response to tumor necrosis factor |
| GO:0002573 | 0.00000 | 3.64294 | 7 | 24 | 204 | myeloid leukocyte differentiation |
| GO:1901699 | 0.00000 | 2.32351 | 23 | 50 | 648 | cellular response to nitrogen compound |
| GO:0018108 | 0.00000 | 2.84356 | 13 | 34 | 363 | peptidyl-tyrosine phosphorylation |
| GO:0080135 | 0.00000 | 2.21776 | 27 | 55 | 746 | regulation of cellular response to stress |
| GO:0043114 | 0.00000 | 9.99166 | 1 | 10 | 37 | regulation of vascular permeability |
| GO:0031668 | 0.00000 | 3.19645 | 10 | 28 | 268 | cellular response to extracellular stimulus |
| GO:0044706 | 0.00000 | 3.46928 | 8 | 25 | 222 | multi-multicellular organism process |
| GO:0018212 | 0.00000 | 2.81738 | 13 | 34 | 366 | peptidyl-tyrosine modification |
| GO:0070371 | 0.00000 | 2.97581 | 11 | 31 | 317 | ERK1 and ERK2 cascade |
| GO:0043434 | 0.00000 | 2.63326 | 16 | 38 | 436 | response to peptide hormone |
| GO:0051251 | 0.00000 | 2.91095 | 12 | 32 | 334 | positive regulation of lymphocyte activation |
| GO:0002275 | 0.00000 | 2.43587 | 20 | 44 | 544 | myeloid cell activation involved in immune response |
| GO:0033002 | 0.00000 | 3.33915 | 9 | 26 | 239 | muscle cell proliferation |
| GO:0071346 | 0.00000 | 3.79739 | 7 | 22 | 180 | cellular response to interferon-gamma |
| GO:0035690 | 0.00000 | 2.79168 | 13 | 34 | 369 | cellular response to drug |
| GO:0043410 | 0.00000 | 2.42589 | 20 | 44 | 546 | positive regulation of MAPK cascade |
| GO:0030217 | 0.00000 | 3.32336 | 9 | 26 | 240 | T cell differentiation |
| GO:0050707 | 0.00000 | 3.52424 | 8 | 24 | 210 | regulation of cytokine secretion |
| GO:0030098 | 0.00000 | 2.83457 | 13 | 33 | 353 | lymphocyte differentiation |
| GO:0050729 | 0.00000 | 4.09431 | 6 | 20 | 153 | positive regulation of inflammatory response |
| GO:0060326 | 0.00000 | 3.00332 | 11 | 30 | 304 | cell chemotaxis |
| GO:0002292 | 0.00000 | 6.39537 | 2 | 13 | 68 | T cell differentiation involved in immune response |
| GO:0055072 | 0.00000 | 5.83328 | 3 | 14 | 79 | iron ion homeostasis |
| GO:0002040 | 0.00000 | 3.72601 | 7 | 22 | 183 | sprouting angiogenesis |
| GO:0071294 | 0.00000 | 14.35449 | 1 | 8 | 23 | cellular response to zinc ion |
| GO:0051254 | 0.00000 | 1.77157 | 62 | 100 | 1706 | positive regulation of RNA metabolic process |
| GO:0031663 | 0.00000 | 7.05134 | 2 | 12 | 58 | lipopolysaccharide-mediated signaling pathway |
| GO:0032722 | 0.00000 | 7.05134 | 2 | 12 | 58 | positive regulation of chemokine production |
| GO:1902041 | 0.00000 | 7.05134 | 2 | 12 | 58 | regulation of extrinsic apoptotic signaling pathway via death domain receptors |
| GO:0043085 | 0.00000 | 1.84022 | 52 | 87 | 1424 | positive regulation of catalytic activity |
| GO:1903038 | 0.00000 | 4.40721 | 5 | 18 | 129 | negative regulation of leukocyte cell-cell adhesion |
| GO:0002675 | 0.00000 | 11.02276 | 1 | 9 | 31 | positive regulation of acute inflammatory response |
| GO:2000113 | 0.00000 | 1.81759 | 54 | 90 | 1492 | negative regulation of cellular macromolecule biosynthetic process |
| GO:0035710 | 0.00000 | 5.28037 | 3 | 15 | 92 | CD4-positive, alpha-beta T cell activation |
| GO:0010558 | 0.00000 | 1.79424 | 57 | 94 | 1580 | negative regulation of macromolecule biosynthetic process |
| GO:0045087 | 0.00000 | 1.99374 | 36 | 67 | 1008 | innate immune response |
| GO:0061687 | 0.00000 | 18.81734 | 1 | 7 | 17 | detoxification of inorganic compound |
| GO:0097501 | 0.00000 | 18.81734 | 1 | 7 | 17 | stress response to metal ion |
| GO:0046634 | 0.00000 | 5.21238 | 3 | 15 | 93 | regulation of alpha-beta T cell activation |
| GO:0032946 | 0.00000 | 4.32872 | 5 | 18 | 131 | positive regulation of mononuclear cell proliferation |
| GO:0003018 | 0.00000 | 3.76338 | 6 | 21 | 173 | vascular process in circulatory system |
| GO:0051049 | 0.00000 | 1.72152 | 68 | 107 | 1879 | regulation of transport |
| GO:0010557 | 0.00000 | 1.72044 | 68 | 107 | 1880 | positive regulation of macromolecule biosynthetic process |
| GO:0045766 | 0.00000 | 3.46636 | 7 | 23 | 204 | positive regulation of angiogenesis |
| GO:0002443 | 0.00000 | 2.05575 | 32 | 60 | 874 | leukocyte mediated immunity |
| GO:0009611 | 0.00000 | 2.20870 | 25 | 50 | 678 | response to wounding |
| GO:0032147 | 0.00000 | 2.81561 | 12 | 31 | 333 | activation of protein kinase activity |
| GO:0031669 | 0.00000 | 3.22110 | 9 | 25 | 237 | cellular response to nutrient levels |
| GO:1903706 | 0.00000 | 2.46555 | 17 | 39 | 475 | regulation of hemopoiesis |
| GO:0007249 | 0.00000 | 3.05176 | 10 | 27 | 269 | I-kappaB kinase/NF-kappaB signaling |
| GO:0051050 | 0.00000 | 1.98114 | 36 | 65 | 982 | positive regulation of transport |
| GO:0007565 | 0.00000 | 3.52697 | 7 | 22 | 192 | female pregnancy |
| GO:0006935 | 0.00000 | 2.23118 | 23 | 48 | 644 | chemotaxis |
| GO:0045860 | 0.00000 | 2.36647 | 19 | 42 | 532 | positive regulation of protein kinase activity |
| GO:0007044 | 0.00000 | 4.95701 | 4 | 15 | 97 | cell-substrate junction assembly |
| GO:0002444 | 0.00000 | 2.33825 | 20 | 43 | 551 | myeloid leukocyte mediated immunity |
| GO:0042330 | 0.00000 | 2.22346 | 23 | 48 | 646 | taxis |
| GO:0043299 | 0.00000 | 2.35658 | 19 | 42 | 534 | leukocyte degranulation |
| GO:0071363 | 0.00000 | 2.16010 | 26 | 51 | 706 | cellular response to growth factor stimulus |
| GO:0043367 | 0.00000 | 5.76438 | 3 | 13 | 74 | CD4-positive, alpha-beta T cell differentiation |
| GO:1903670 | 0.00000 | 4.10909 | 5 | 18 | 137 | regulation of sprouting angiogenesis |
| GO:0038066 | 0.00000 | 7.07025 | 2 | 11 | 53 | p38MAPK cascade |
| GO:0044260 | 0.00000 | 1.43458 | 302 | 361 | 8352 | cellular macromolecule metabolic process |
| GO:0045600 | 0.00000 | 6.23563 | 2 | 12 | 64 | positive regulation of fat cell differentiation |
| GO:0071356 | 0.00000 | 2.91313 | 11 | 28 | 291 | cellular response to tumor necrosis factor |
| GO:0045580 | 0.00000 | 4.04072 | 5 | 18 | 139 | regulation of T cell differentiation |
| GO:0070665 | 0.00000 | 4.04072 | 5 | 18 | 139 | positive regulation of leukocyte proliferation |
| GO:0050801 | 0.00000 | 2.06235 | 29 | 56 | 811 | ion homeostasis |
| GO:0031349 | 0.00000 | 2.35589 | 19 | 41 | 521 | positive regulation of defense response |
| GO:0032663 | 0.00000 | 6.90544 | 2 | 11 | 54 | regulation of interleukin-2 production |
| GO:0043123 | 0.00000 | 3.52909 | 7 | 21 | 183 | positive regulation of I-kappaB kinase/NF-kappaB signaling |
| GO:0009750 | 0.00000 | 44.68703 | 0 | 5 | 8 | response to fructose |
| GO:0042113 | 0.00000 | 2.82540 | 11 | 29 | 310 | B cell activation |
| GO:0048660 | 0.00000 | 3.65138 | 6 | 20 | 169 | regulation of smooth muscle cell proliferation |
| GO:0043409 | 0.00000 | 3.50724 | 7 | 21 | 184 | negative regulation of MAPK cascade |
| GO:0030099 | 0.00000 | 2.52417 | 15 | 35 | 416 | myeloid cell differentiation |
| GO:0009889 | 0.00000 | 1.48280 | 159 | 210 | 4404 | regulation of biosynthetic process |
| GO:0045935 | 0.00000 | 1.68032 | 69 | 106 | 1899 | positive regulation of nucleobase-containing compound metabolic process |
| GO:0001818 | 0.00000 | 2.85798 | 11 | 28 | 296 | negative regulation of cytokine production |
| GO:0006882 | 0.00000 | 8.97901 | 1 | 9 | 36 | cellular zinc ion homeostasis |
| GO:0048659 | 0.00000 | 3.60261 | 6 | 20 | 171 | smooth muscle cell proliferation |
| GO:0045926 | 0.00000 | 3.04648 | 9 | 25 | 249 | negative regulation of growth |
| GO:0050671 | 0.00000 | 4.08204 | 5 | 17 | 130 | positive regulation of lymphocyte proliferation |
| GO:0070372 | 0.00000 | 2.81531 | 11 | 28 | 300 | regulation of ERK1 and ERK2 cascade |
| GO:0042119 | 0.00001 | 2.33894 | 18 | 39 | 498 | neutrophil activation |
| GO:0002695 | 0.00001 | 3.50885 | 6 | 20 | 175 | negative regulation of leukocyte activation |
| GO:0051403 | 0.00001 | 2.84872 | 10 | 27 | 286 | stress-activated MAPK cascade |
| GO:0045893 | 0.00001 | 1.73512 | 56 | 89 | 1535 | positive regulation of transcription, DNA-templated |
| GO:0043405 | 0.00001 | 2.67550 | 12 | 30 | 337 | regulation of MAP kinase activity |
| GO:0002446 | 0.00001 | 2.33372 | 18 | 39 | 499 | neutrophil mediated immunity |
| GO:0070663 | 0.00001 | 3.14963 | 8 | 23 | 222 | regulation of leukocyte proliferation |
| GO:0055069 | 0.00001 | 8.35884 | 1 | 9 | 38 | zinc ion homeostasis |
| GO:0045055 | 0.00001 | 2.02424 | 29 | 54 | 794 | regulated exocytosis |
| GO:0050731 | 0.00001 | 3.34166 | 7 | 21 | 192 | positive regulation of peptidyl-tyrosine phosphorylation |
| GO:0097286 | 0.00001 | 33.51341 | 0 | 5 | 9 | iron ion import |
| GO:0043312 | 0.00001 | 2.33807 | 18 | 38 | 485 | neutrophil degranulation |
| GO:0043542 | 0.00001 | 2.87401 | 10 | 26 | 273 | endothelial cell migration |
| GO:0036230 | 0.00001 | 2.30797 | 18 | 39 | 504 | granulocyte activation |
| GO:0034330 | 0.00001 | 2.80477 | 11 | 27 | 290 | cell junction organization |
| GO:0032944 | 0.00001 | 3.20327 | 8 | 22 | 209 | regulation of mononuclear cell proliferation |
| GO:0030968 | 0.00001 | 4.13022 | 4 | 16 | 121 | endoplasmic reticulum unfolded protein response |
| GO:0045892 | 0.00001 | 1.81224 | 44 | 74 | 1217 | negative regulation of transcription, DNA-templated |
| GO:0031326 | 0.00001 | 1.46567 | 157 | 205 | 4325 | regulation of cellular biosynthetic process |
| GO:0034329 | 0.00001 | 3.01552 | 9 | 24 | 241 | cell junction assembly |
| GO:0010035 | 0.00001 | 2.22612 | 20 | 42 | 562 | response to inorganic substance |
| GO:0032763 | 0.00001 | 107.10119 | 0 | 4 | 5 | regulation of mast cell cytokine production |
| GO:0051770 | 0.00001 | 17.89552 | 1 | 6 | 15 | positive regulation of nitric-oxide synthase biosynthetic process |
| GO:0006970 | 0.00001 | 5.02073 | 3 | 13 | 83 | response to osmotic stress |
| GO:0002283 | 0.00001 | 2.32209 | 18 | 38 | 488 | neutrophil activation involved in immune response |
| GO:0002294 | 0.00001 | 6.05785 | 2 | 11 | 60 | CD4-positive, alpha-beta T cell differentiation involved in immune response |
| GO:0032755 | 0.00001 | 4.61956 | 3 | 14 | 96 | positive regulation of interleukin-6 production |
| GO:0050673 | 0.00001 | 2.40783 | 16 | 35 | 434 | epithelial cell proliferation |
| GO:0072001 | 0.00001 | 2.77266 | 11 | 27 | 293 | renal system development |
| GO:1903508 | 0.00001 | 1.69640 | 59 | 92 | 1621 | positive regulation of nucleic acid-templated transcription |
| GO:1902680 | 0.00001 | 1.69519 | 59 | 92 | 1622 | positive regulation of RNA biosynthetic process |
| GO:0070741 | 0.00001 | 6.73949 | 2 | 10 | 50 | response to interleukin-6 |
| GO:0098542 | 0.00001 | 2.19997 | 21 | 42 | 568 | defense response to other organism |
| GO:0002287 | 0.00001 | 5.93636 | 2 | 11 | 61 | alpha-beta T cell activation involved in immune response |
| GO:0002293 | 0.00001 | 5.93636 | 2 | 11 | 61 | alpha-beta T cell differentiation involved in immune response |
| GO:2000514 | 0.00001 | 5.93636 | 2 | 11 | 61 | regulation of CD4-positive, alpha-beta T cell activation |
| GO:0002042 | 0.00001 | 4.50906 | 4 | 14 | 98 | cell migration involved in sprouting angiogenesis |
| GO:0051336 | 0.00001 | 1.76742 | 47 | 77 | 1297 | regulation of hydrolase activity |
| GO:0009306 | 0.00001 | 2.16262 | 21 | 43 | 591 | protein secretion |
| GO:0070059 | 0.00001 | 5.81964 | 2 | 11 | 62 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress |
| GO:0050868 | 0.00001 | 4.18696 | 4 | 15 | 112 | negative regulation of T cell activation |
| GO:0008625 | 0.00001 | 4.81359 | 3 | 13 | 86 | extrinsic apoptotic signaling pathway via death domain receptors |
| GO:0033674 | 0.00001 | 2.17863 | 21 | 42 | 573 | positive regulation of kinase activity |
| GO:0034620 | 0.00001 | 3.74807 | 5 | 17 | 140 | cellular response to unfolded protein |
| GO:0009628 | 0.00001 | 1.77896 | 45 | 74 | 1237 | response to abiotic stimulus |
| GO:0055065 | 0.00001 | 2.09148 | 24 | 46 | 653 | metal ion homeostasis |
| GO:0046637 | 0.00001 | 5.70740 | 2 | 11 | 63 | regulation of alpha-beta T cell differentiation |
| GO:0009887 | 0.00001 | 1.83481 | 39 | 66 | 1068 | animal organ morphogenesis |
| GO:0050878 | 0.00002 | 2.25522 | 18 | 38 | 501 | regulation of body fluid levels |
| GO:0045446 | 0.00002 | 4.10191 | 4 | 15 | 114 | endothelial cell differentiation |
| GO:1901888 | 0.00002 | 4.68471 | 3 | 13 | 88 | regulation of cell junction assembly |
| GO:0048661 | 0.00002 | 4.35285 | 4 | 14 | 101 | positive regulation of smooth muscle cell proliferation |
| GO:0043491 | 0.00002 | 2.79362 | 10 | 25 | 269 | protein kinase B signaling |
| GO:0010043 | 0.00002 | 6.26824 | 2 | 10 | 53 | response to zinc ion |
| GO:0007568 | 0.00002 | 2.61044 | 12 | 28 | 321 | aging |
| GO:0043122 | 0.00002 | 2.92639 | 9 | 23 | 237 | regulation of I-kappaB kinase/NF-kappaB signaling |
| GO:0051253 | 0.00002 | 1.72792 | 49 | 79 | 1359 | negative regulation of RNA metabolic process |
| GO:0070482 | 0.00002 | 2.42023 | 14 | 32 | 394 | response to oxygen levels |
| GO:0042060 | 0.00002 | 2.15688 | 20 | 41 | 564 | wound healing |
| GO:0002822 | 0.00002 | 3.60065 | 5 | 17 | 145 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0002790 | 0.00002 | 2.09029 | 23 | 44 | 624 | peptide secretion |
| GO:0002819 | 0.00002 | 3.43910 | 6 | 18 | 160 | regulation of adaptive immune response |
| GO:0042594 | 0.00002 | 3.17769 | 7 | 20 | 191 | response to starvation |
| GO:0050678 | 0.00002 | 2.44424 | 14 | 31 | 378 | regulation of epithelial cell proliferation |
| GO:0030183 | 0.00002 | 3.76896 | 5 | 16 | 131 | B cell differentiation |
| GO:0002064 | 0.00002 | 3.06959 | 7 | 21 | 207 | epithelial cell development |
| GO:0051250 | 0.00002 | 3.57254 | 5 | 17 | 146 | negative regulation of lymphocyte activation |
| GO:0051384 | 0.00002 | 3.57254 | 5 | 17 | 146 | response to glucocorticoid |
| GO:0002460 | 0.00002 | 2.47814 | 13 | 30 | 361 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0032635 | 0.00002 | 3.41486 | 6 | 18 | 161 | interleukin-6 production |
| GO:0097191 | 0.00002 | 2.96291 | 8 | 22 | 224 | extrinsic apoptotic signaling pathway |
| GO:2001237 | 0.00002 | 4.20705 | 4 | 14 | 104 | negative regulation of extrinsic apoptotic signaling pathway |
| GO:0050670 | 0.00002 | 3.05300 | 8 | 21 | 208 | regulation of lymphocyte proliferation |
| GO:0003158 | 0.00002 | 3.73626 | 5 | 16 | 132 | endothelium development |
| GO:0045598 | 0.00002 | 3.73626 | 5 | 16 | 132 | regulation of fat cell differentiation |
| GO:0060333 | 0.00002 | 4.50377 | 3 | 13 | 91 | interferon-gamma-mediated signaling pathway |
| GO:0051347 | 0.00002 | 2.05327 | 23 | 45 | 649 | positive regulation of transferase activity |
| GO:0097529 | 0.00003 | 3.02036 | 8 | 21 | 210 | myeloid leukocyte migration |
| GO:0048771 | 0.00003 | 3.22342 | 6 | 19 | 179 | tissue remodeling |
| GO:0002286 | 0.00003 | 4.11513 | 4 | 14 | 106 | T cell activation involved in immune response |
| GO:0001655 | 0.00003 | 2.53135 | 12 | 28 | 330 | urogenital system development |
| GO:0051092 | 0.00003 | 3.49076 | 5 | 17 | 149 | positive regulation of NF-kappaB transcription factor activity |
| GO:0001822 | 0.00003 | 2.69288 | 10 | 25 | 278 | kidney development |
| GO:1901653 | 0.00003 | 2.39495 | 14 | 31 | 385 | cellular response to peptide |
| GO:0001763 | 0.00003 | 3.08654 | 7 | 20 | 196 | morphogenesis of a branching structure |
| GO:2001242 | 0.00003 | 3.32120 | 6 | 18 | 165 | regulation of intrinsic apoptotic signaling pathway |
| GO:0060429 | 0.00003 | 1.72184 | 47 | 75 | 1291 | epithelium development |
| GO:0010594 | 0.00003 | 2.89053 | 8 | 22 | 229 | regulation of endothelial cell migration |
| GO:0006887 | 0.00003 | 1.86650 | 33 | 57 | 903 | exocytosis |
| GO:0001667 | 0.00003 | 2.25176 | 17 | 35 | 461 | ameboidal-type cell migration |
| GO:1903507 | 0.00003 | 1.72648 | 46 | 74 | 1270 | negative regulation of nucleic acid-templated transcription |
| GO:0031098 | 0.00003 | 2.55768 | 11 | 27 | 315 | stress-activated protein kinase signaling cascade |
| GO:0010631 | 0.00003 | 2.45993 | 13 | 29 | 351 | epithelial cell migration |
| GO:1902679 | 0.00003 | 1.72339 | 46 | 74 | 1272 | negative regulation of RNA biosynthetic process |
| GO:0046627 | 0.00003 | 7.68435 | 1 | 8 | 36 | negative regulation of insulin receptor signaling pathway |
| GO:0061138 | 0.00004 | 3.16356 | 7 | 19 | 182 | morphogenesis of a branching epithelium |
| GO:0036293 | 0.00004 | 2.41131 | 13 | 30 | 370 | response to decreased oxygen levels |
| GO:0098771 | 0.00004 | 1.95397 | 27 | 49 | 741 | inorganic ion homeostasis |
| GO:0032675 | 0.00004 | 3.41261 | 6 | 17 | 152 | regulation of interleukin-6 production |
| GO:0046209 | 0.00004 | 4.62754 | 3 | 12 | 82 | nitric oxide metabolic process |
| GO:0071407 | 0.00004 | 2.12898 | 20 | 39 | 542 | cellular response to organic cyclic compound |
| GO:0071621 | 0.00004 | 3.75819 | 4 | 15 | 123 | granulocyte chemotaxis |
| GO:0042093 | 0.00004 | 5.61374 | 2 | 10 | 58 | T-helper cell differentiation |
| GO:0036005 | 0.00004 | 19.14733 | 0 | 5 | 12 | response to macrophage colony-stimulating factor |
| GO:0036006 | 0.00004 | 19.14733 | 0 | 5 | 12 | cellular response to macrophage colony-stimulating factor stimulus |
| GO:0090132 | 0.00004 | 2.43681 | 13 | 29 | 354 | epithelium migration |
| GO:0034755 | 0.00004 | 12.38645 | 1 | 6 | 19 | iron ion transmembrane transport |
| GO:0043370 | 0.00004 | 6.37592 | 2 | 9 | 47 | regulation of CD4-positive, alpha-beta T cell differentiation |
| GO:0042098 | 0.00004 | 3.12487 | 7 | 19 | 184 | T cell proliferation |
| GO:0006355 | 0.00004 | 1.45203 | 127 | 168 | 3506 | regulation of transcription, DNA-templated |
| GO:0071276 | 0.00004 | 7.41896 | 1 | 8 | 37 | cellular response to cadmium ion |
| GO:0090050 | 0.00004 | 7.41896 | 1 | 8 | 37 | positive regulation of cell migration involved in sprouting angiogenesis |
| GO:1903708 | 0.00004 | 3.10587 | 7 | 19 | 185 | positive regulation of hemopoiesis |
| GO:0050715 | 0.00004 | 3.52225 | 5 | 16 | 139 | positive regulation of cytokine secretion |
| GO:0018130 | 0.00004 | 1.41605 | 157 | 201 | 4341 | heterocycle biosynthetic process |
| GO:0001885 | 0.00005 | 5.49887 | 2 | 10 | 59 | endothelial cell development |
| GO:0048608 | 0.00005 | 2.26900 | 16 | 33 | 431 | reproductive structure development |
| GO:0033216 | 0.00005 | Inf | 0 | 3 | 3 | ferric iron import |
| GO:0035633 | 0.00005 | Inf | 0 | 3 | 3 | maintenance of permeability of blood-brain barrier |
| GO:0098706 | 0.00005 | Inf | 0 | 3 | 3 | ferric iron import across cell outer membrane |
| GO:0050818 | 0.00005 | 4.49849 | 3 | 12 | 84 | regulation of coagulation |
| GO:2001236 | 0.00005 | 3.33786 | 6 | 17 | 155 | regulation of extrinsic apoptotic signaling pathway |
| GO:0006979 | 0.00005 | 2.23230 | 16 | 34 | 451 | response to oxidative stress |
| GO:0045577 | 0.00005 | 8.95516 | 1 | 7 | 28 | regulation of B cell differentiation |
| GO:0001666 | 0.00005 | 2.39921 | 13 | 29 | 359 | response to hypoxia |
| GO:0055080 | 0.00005 | 1.94019 | 26 | 48 | 730 | cation homeostasis |
| GO:0019438 | 0.00005 | 1.41161 | 158 | 201 | 4351 | aromatic compound biosynthetic process |
| GO:0045934 | 0.00005 | 1.65005 | 54 | 83 | 1490 | negative regulation of nucleobase-containing compound metabolic process |
| GO:0042129 | 0.00005 | 3.31366 | 6 | 17 | 156 | regulation of T cell proliferation |
| GO:0050708 | 0.00005 | 2.19371 | 17 | 35 | 472 | regulation of protein secretion |
| GO:0061458 | 0.00005 | 2.25164 | 16 | 33 | 434 | reproductive system development |
| GO:0015804 | 0.00005 | 7.17126 | 1 | 8 | 38 | neutral amino acid transport |
| GO:1900077 | 0.00005 | 7.17126 | 1 | 8 | 38 | negative regulation of cellular response to insulin stimulus |
| GO:0090130 | 0.00005 | 2.39183 | 13 | 29 | 360 | tissue migration |
| GO:0007050 | 0.00005 | 2.78172 | 9 | 22 | 237 | cell cycle arrest |
| GO:2001057 | 0.00005 | 4.43662 | 3 | 12 | 85 | reactive nitrogen species metabolic process |
| GO:0030324 | 0.00005 | 3.16899 | 6 | 18 | 172 | lung development |
| GO:0034654 | 0.00005 | 1.41263 | 155 | 198 | 4278 | nucleobase-containing compound biosynthetic process |
| GO:0032762 | 0.00005 | 35.69643 | 0 | 4 | 7 | mast cell cytokine production |
| GO:1903530 | 0.00006 | 1.91934 | 27 | 49 | 753 | regulation of secretion by cell |
| GO:0034104 | 0.00006 | 11.50107 | 1 | 6 | 20 | negative regulation of tissue remodeling |
| GO:0051767 | 0.00006 | 11.50107 | 1 | 6 | 20 | nitric-oxide synthase biosynthetic process |
| GO:0051769 | 0.00006 | 11.50107 | 1 | 6 | 20 | regulation of nitric-oxide synthase biosynthetic process |
| GO:0050776 | 0.00006 | 1.74775 | 40 | 66 | 1115 | regulation of immune response |
| GO:2001141 | 0.00006 | 1.43896 | 129 | 170 | 3576 | regulation of RNA biosynthetic process |
| GO:0032868 | 0.00006 | 2.63398 | 10 | 24 | 272 | response to insulin |
| GO:0045596 | 0.00006 | 1.91368 | 27 | 49 | 755 | negative regulation of cell differentiation |
| GO:0044271 | 0.00006 | 1.38889 | 182 | 227 | 5029 | cellular nitrogen compound biosynthetic process |
| GO:0071280 | 0.00006 | 8.54763 | 1 | 7 | 29 | cellular response to copper ion |
| GO:0050701 | 0.00006 | 5.28264 | 2 | 10 | 61 | interleukin-1 secretion |
| GO:0010595 | 0.00006 | 3.59090 | 5 | 15 | 128 | positive regulation of endothelial cell migration |
| GO:0010876 | 0.00006 | 2.29565 | 14 | 31 | 400 | lipid localization |
| GO:0045779 | 0.00006 | 16.75298 | 0 | 5 | 13 | negative regulation of bone resorption |
| GO:0032774 | 0.00006 | 1.42868 | 135 | 176 | 3733 | RNA biosynthetic process |
| GO:0032943 | 0.00006 | 2.61261 | 10 | 24 | 274 | mononuclear cell proliferation |
| GO:0014015 | 0.00007 | 4.70798 | 3 | 11 | 74 | positive regulation of gliogenesis |
| GO:0070373 | 0.00007 | 4.70798 | 3 | 11 | 74 | negative regulation of ERK1 and ERK2 cascade |
| GO:1902107 | 0.00007 | 3.38371 | 5 | 16 | 144 | positive regulation of leukocyte differentiation |
| GO:0032102 | 0.00007 | 2.35557 | 13 | 29 | 365 | negative regulation of response to external stimulus |
| GO:0030595 | 0.00007 | 2.80984 | 8 | 21 | 224 | leukocyte chemotaxis |
| GO:0032880 | 0.00007 | 1.77360 | 37 | 61 | 1014 | regulation of protein localization |
| GO:1901362 | 0.00007 | 1.39839 | 163 | 206 | 4500 | organic cyclic compound biosynthetic process |
| GO:0032612 | 0.00007 | 3.74655 | 4 | 14 | 115 | interleukin-1 production |
| GO:0046660 | 0.00007 | 3.74655 | 4 | 14 | 115 | female sex differentiation |
| GO:0032611 | 0.00007 | 3.98975 | 4 | 13 | 101 | interleukin-1 beta production |
| GO:0032649 | 0.00007 | 3.98975 | 4 | 13 | 101 | regulation of interferon-gamma production |
| GO:1903506 | 0.00007 | 1.43182 | 129 | 169 | 3567 | regulation of nucleic acid-templated transcription |
| GO:0006351 | 0.00007 | 1.42682 | 133 | 173 | 3668 | transcription, DNA-templated |
| GO:0007160 | 0.00007 | 2.79591 | 8 | 21 | 225 | cell-matrix adhesion |
| GO:0006986 | 0.00007 | 3.08807 | 6 | 18 | 176 | response to unfolded protein |
| GO:0030323 | 0.00007 | 3.08807 | 6 | 18 | 176 | respiratory tube development |
| GO:0048545 | 0.00007 | 2.30746 | 14 | 30 | 385 | response to steroid hormone |
| GO:0051235 | 0.00007 | 2.42901 | 12 | 27 | 330 | maintenance of location |
| GO:0071901 | 0.00007 | 3.35729 | 5 | 16 | 145 | negative regulation of protein serine/threonine kinase activity |
| GO:0009790 | 0.00007 | 1.76773 | 37 | 61 | 1017 | embryo development |
| GO:0030728 | 0.00008 | 10.73373 | 1 | 6 | 21 | ovulation |
| GO:0036499 | 0.00008 | 10.73373 | 1 | 6 | 21 | PERK-mediated unfolded protein response |
| GO:1903392 | 0.00008 | 10.73373 | 1 | 6 | 21 | negative regulation of adherens junction organization |
| GO:0002791 | 0.00008 | 2.12513 | 18 | 36 | 500 | regulation of peptide secretion |
| GO:0035967 | 0.00008 | 3.19771 | 6 | 17 | 161 | cellular response to topologically incorrect protein |
| GO:0032743 | 0.00008 | 8.17554 | 1 | 7 | 30 | positive regulation of interleukin-2 production |
| GO:0045124 | 0.00008 | 6.72231 | 1 | 8 | 40 | regulation of bone resorption |
| GO:0071470 | 0.00008 | 6.72231 | 1 | 8 | 40 | cellular response to osmotic stress |
| GO:0098754 | 0.00008 | 3.49744 | 5 | 15 | 131 | detoxification |
| GO:0031960 | 0.00008 | 3.17548 | 6 | 17 | 162 | response to corticosteroid |
| GO:0044237 | 0.00009 | 1.36634 | 409 | 456 | 11301 | cellular metabolic process |
| GO:0030162 | 0.00009 | 1.84157 | 30 | 52 | 831 | regulation of proteolysis |
| GO:1903555 | 0.00009 | 3.15355 | 6 | 17 | 163 | regulation of tumor necrosis factor superfamily cytokine production |
| GO:0070661 | 0.00009 | 2.49278 | 11 | 25 | 298 | leukocyte proliferation |
| GO:0010556 | 0.00009 | 1.40155 | 150 | 191 | 4138 | regulation of macromolecule biosynthetic process |
| GO:0051046 | 0.00009 | 1.85039 | 29 | 51 | 811 | regulation of secretion |
| GO:1903672 | 0.00009 | 4.98832 | 2 | 10 | 64 | positive regulation of sprouting angiogenesis |
| GO:0061028 | 0.00009 | 6.51824 | 1 | 8 | 41 | establishment of endothelial barrier |
| GO:0061041 | 0.00009 | 3.28044 | 5 | 16 | 148 | regulation of wound healing |
| GO:0008630 | 0.00010 | 3.85757 | 4 | 13 | 104 | intrinsic apoptotic signaling pathway in response to DNA damage |
| GO:0030593 | 0.00010 | 3.85757 | 4 | 13 | 104 | neutrophil chemotaxis |
| GO:0007517 | 0.00010 | 2.23381 | 15 | 31 | 410 | muscle organ development |
| GO:0019216 | 0.00010 | 2.23381 | 15 | 31 | 410 | regulation of lipid metabolic process |
| GO:0090087 | 0.00010 | 1.89675 | 26 | 47 | 729 | regulation of peptide transport |
| GO:0031589 | 0.00010 | 2.34182 | 13 | 28 | 354 | cell-substrate adhesion |
| GO:0006809 | 0.00010 | 4.49323 | 3 | 11 | 77 | nitric oxide biosynthetic process |
| GO:0014074 | 0.00010 | 3.25559 | 5 | 16 | 149 | response to purine-containing compound |
| GO:0097659 | 0.00010 | 1.41425 | 135 | 174 | 3716 | nucleic acid-templated transcription |
| GO:0030260 | 0.00010 | 3.40870 | 5 | 15 | 134 | entry into host cell |
| GO:0044409 | 0.00010 | 3.40870 | 5 | 15 | 134 | entry into host |
| GO:0046683 | 0.00010 | 3.40870 | 5 | 15 | 134 | response to organophosphorus |
| GO:0051806 | 0.00010 | 3.40870 | 5 | 15 | 134 | entry into cell of other organism involved in symbiotic interaction |
| GO:0051828 | 0.00010 | 3.40870 | 5 | 15 | 134 | entry into other organism involved in symbiotic interaction |
| GO:0050702 | 0.00011 | 5.50463 | 2 | 9 | 53 | interleukin-1 beta secretion |
| GO:0050704 | 0.00011 | 5.50463 | 2 | 9 | 53 | regulation of interleukin-1 secretion |
| GO:0050732 | 0.00011 | 5.50463 | 2 | 9 | 53 | negative regulation of peptidyl-tyrosine phosphorylation |
| GO:0060541 | 0.00011 | 2.87820 | 7 | 19 | 198 | respiratory system development |
| GO:0051252 | 0.00011 | 1.40755 | 138 | 178 | 3822 | regulation of RNA metabolic process |
| GO:0016192 | 0.00011 | 1.52141 | 76 | 108 | 2107 | vesicle-mediated transport |
| GO:0000122 | 0.00011 | 1.82200 | 30 | 52 | 839 | negative regulation of transcription by RNA polymerase II |
| GO:0052547 | 0.00011 | 2.15270 | 16 | 33 | 452 | regulation of peptidase activity |
| GO:0048732 | 0.00012 | 2.17447 | 16 | 32 | 434 | gland development |
| GO:1900745 | 0.00012 | 7.52066 | 1 | 7 | 32 | positive regulation of p38MAPK cascade |
| GO:0030193 | 0.00012 | 4.36059 | 3 | 11 | 79 | regulation of blood coagulation |
| GO:0008406 | 0.00013 | 2.75427 | 8 | 20 | 217 | gonad development |
| GO:0030330 | 0.00013 | 3.73383 | 4 | 13 | 107 | DNA damage response, signal transduction by p53 class mediator |
| GO:0071706 | 0.00013 | 3.04828 | 6 | 17 | 168 | tumor necrosis factor superfamily cytokine production |
| GO:0046851 | 0.00014 | 13.40089 | 1 | 5 | 15 | negative regulation of bone remodeling |
| GO:0007548 | 0.00014 | 2.53071 | 10 | 23 | 270 | sex differentiation |
| GO:0042108 | 0.00014 | 4.72499 | 2 | 10 | 67 | positive regulation of cytokine biosynthetic process |
| GO:1900046 | 0.00014 | 4.29716 | 3 | 11 | 80 | regulation of hemostasis |
| GO:0051223 | 0.00014 | 1.89084 | 25 | 45 | 699 | regulation of protein transport |
| GO:0045621 | 0.00015 | 3.94769 | 3 | 12 | 94 | positive regulation of lymphocyte differentiation |
| GO:0045862 | 0.00015 | 2.27774 | 13 | 28 | 363 | positive regulation of proteolysis |
| GO:0009615 | 0.00015 | 2.35920 | 12 | 26 | 326 | response to virus |
| GO:0046651 | 0.00015 | 2.51010 | 10 | 23 | 272 | lymphocyte proliferation |
| GO:0007045 | 0.00016 | 4.23553 | 3 | 11 | 81 | cell-substrate adherens junction assembly |
| GO:0048041 | 0.00016 | 4.23553 | 3 | 11 | 81 | focal adhesion assembly |
| GO:0035924 | 0.00016 | 4.64326 | 2 | 10 | 68 | cellular response to vascular endothelial growth factor stimulus |
| GO:0046688 | 0.00016 | 5.97405 | 2 | 8 | 44 | response to copper ion |
| GO:0042102 | 0.00016 | 3.89991 | 3 | 12 | 95 | positive regulation of T cell proliferation |
| GO:0045786 | 0.00016 | 1.92379 | 23 | 42 | 641 | negative regulation of cell cycle |
| GO:1901576 | 0.00016 | 1.34162 | 227 | 271 | 6259 | organic substance biosynthetic process |
| GO:0009058 | 0.00016 | 1.34060 | 230 | 274 | 6339 | biosynthetic process |
| GO:1903707 | 0.00016 | 3.11402 | 6 | 16 | 155 | negative regulation of hemopoiesis |
| GO:0006357 | 0.00017 | 1.45445 | 97 | 131 | 2683 | regulation of transcription by RNA polymerase II |
| GO:0010640 | 0.00017 | 8.94328 | 1 | 6 | 24 | regulation of platelet-derived growth factor receptor signaling pathway |
| GO:0009896 | 0.00017 | 2.15813 | 15 | 31 | 423 | positive regulation of catabolic process |
| GO:0090049 | 0.00017 | 4.17564 | 3 | 11 | 82 | regulation of cell migration involved in sprouting angiogenesis |
| GO:1905954 | 0.00017 | 4.17564 | 3 | 11 | 82 | positive regulation of lipid localization |
| GO:0008585 | 0.00018 | 3.85327 | 3 | 12 | 96 | female gonad development |
| GO:0008152 | 0.00018 | 1.36788 | 454 | 497 | 12552 | metabolic process |
| GO:0045137 | 0.00018 | 2.67196 | 8 | 20 | 223 | development of primary sexual characteristics |
| GO:0097530 | 0.00019 | 3.21807 | 5 | 15 | 141 | granulocyte migration |
| GO:0052548 | 0.00019 | 2.14693 | 15 | 31 | 425 | regulation of endopeptidase activity |
| GO:0048845 | 0.00019 | 21.41548 | 0 | 4 | 9 | venous blood vessel morphogenesis |
| GO:0043406 | 0.00019 | 2.53120 | 9 | 22 | 258 | positive regulation of MAP kinase activity |
| GO:0048468 | 0.00019 | 1.49261 | 79 | 110 | 2183 | cell development |
| GO:1905952 | 0.00019 | 3.06950 | 6 | 16 | 157 | regulation of lipid localization |
| GO:0071214 | 0.00019 | 2.31987 | 12 | 26 | 331 | cellular response to abiotic stimulus |
| GO:0104004 | 0.00019 | 2.31987 | 12 | 26 | 331 | cellular response to environmental stimulus |
| GO:0042509 | 0.00019 | 4.11742 | 3 | 11 | 83 | regulation of tyrosine phosphorylation of STAT protein |
| GO:0045582 | 0.00019 | 4.11742 | 3 | 11 | 83 | positive regulation of T cell differentiation |
| GO:0071702 | 0.00020 | 1.44104 | 101 | 135 | 2791 | organic substance transport |
| GO:0006366 | 0.00020 | 1.43787 | 102 | 136 | 2818 | transcription by RNA polymerase II |
| GO:0001935 | 0.00021 | 2.81795 | 7 | 18 | 191 | endothelial cell proliferation |
| GO:0051047 | 0.00021 | 2.13035 | 15 | 31 | 428 | positive regulation of secretion |
| GO:0006820 | 0.00021 | 1.91131 | 23 | 41 | 629 | anion transport |
| GO:2001243 | 0.00022 | 3.76324 | 4 | 12 | 98 | negative regulation of intrinsic apoptotic signaling pathway |
| GO:0050706 | 0.00022 | 5.65900 | 2 | 8 | 46 | regulation of interleukin-1 beta secretion |
| GO:0071354 | 0.00022 | 5.65900 | 2 | 8 | 46 | cellular response to interleukin-6 |
| GO:2000112 | 0.00022 | 1.37961 | 145 | 183 | 3998 | regulation of cellular macromolecule biosynthetic process |
| GO:0071385 | 0.00022 | 4.94156 | 2 | 9 | 58 | cellular response to glucocorticoid stimulus |
| GO:0032609 | 0.00023 | 3.50863 | 4 | 13 | 113 | interferon-gamma production |
| GO:0051128 | 0.00023 | 1.45639 | 91 | 123 | 2507 | regulation of cellular component organization |
| GO:0032680 | 0.00023 | 3.00505 | 6 | 16 | 160 | regulation of tumor necrosis factor production |
| GO:1901654 | 0.00024 | 2.78543 | 7 | 18 | 193 | response to ketone |
| GO:0048589 | 0.00024 | 1.86922 | 24 | 43 | 674 | developmental growth |
| GO:0042035 | 0.00025 | 3.47369 | 4 | 13 | 114 | regulation of cytokine biosynthetic process |
| GO:0048872 | 0.00026 | 2.53197 | 9 | 21 | 246 | homeostasis of number of cells |
| GO:1900744 | 0.00026 | 5.51359 | 2 | 8 | 47 | regulation of p38MAPK cascade |
| GO:1903556 | 0.00026 | 4.34273 | 3 | 10 | 72 | negative regulation of tumor necrosis factor superfamily cytokine production |
| GO:0030224 | 0.00026 | 6.48188 | 1 | 7 | 36 | monocyte differentiation |
| GO:0032733 | 0.00026 | 6.48188 | 1 | 7 | 36 | positive regulation of interleukin-10 production |
| GO:1903131 | 0.00026 | 6.48188 | 1 | 7 | 36 | mononuclear cell differentiation |
| GO:0019219 | 0.00027 | 1.36883 | 150 | 188 | 4140 | regulation of nucleobase-containing compound metabolic process |
| GO:0007260 | 0.00027 | 3.95206 | 3 | 11 | 86 | tyrosine phosphorylation of STAT protein |
| GO:0072539 | 0.00027 | 8.04806 | 1 | 6 | 26 | T-helper 17 cell differentiation |
| GO:1903034 | 0.00028 | 2.83954 | 6 | 17 | 179 | regulation of response to wounding |
| GO:0002685 | 0.00029 | 2.73802 | 7 | 18 | 196 | regulation of leukocyte migration |
| GO:0071375 | 0.00029 | 2.29610 | 12 | 25 | 321 | cellular response to peptide hormone stimulus |
| GO:0046545 | 0.00029 | 3.63578 | 4 | 12 | 101 | development of primary female sexual characteristics |
| GO:0032640 | 0.00029 | 2.94323 | 6 | 16 | 163 | tumor necrosis factor production |
| GO:0046850 | 0.00030 | 5.37545 | 2 | 8 | 48 | regulation of bone remodeling |
| GO:0070391 | 0.00030 | 17.84524 | 0 | 4 | 10 | response to lipoteichoic acid |
| GO:0071223 | 0.00030 | 17.84524 | 0 | 4 | 10 | cellular response to lipoteichoic acid |
| GO:0043534 | 0.00030 | 2.82196 | 7 | 17 | 180 | blood vessel endothelial cell migration |
| GO:0051222 | 0.00031 | 2.10726 | 15 | 30 | 418 | positive regulation of protein transport |
| GO:1903532 | 0.00031 | 2.13499 | 14 | 29 | 399 | positive regulation of secretion by cell |
| GO:0070201 | 0.00032 | 1.80391 | 27 | 46 | 746 | regulation of establishment of protein localization |
| GO:0006875 | 0.00032 | 1.92148 | 21 | 38 | 579 | cellular metal ion homeostasis |
| GO:0002697 | 0.00032 | 2.04916 | 17 | 32 | 458 | regulation of immune effector process |
| GO:0050714 | 0.00032 | 2.42694 | 10 | 22 | 268 | positive regulation of protein secretion |
| GO:1901222 | 0.00032 | 3.37293 | 4 | 13 | 117 | regulation of NIK/NF-kappaB signaling |
| GO:0031331 | 0.00032 | 2.19970 | 13 | 27 | 361 | positive regulation of cellular catabolic process |
| GO:0051147 | 0.00032 | 2.80460 | 7 | 17 | 181 | regulation of muscle cell differentiation |
| GO:0046890 | 0.00032 | 2.70729 | 7 | 18 | 198 | regulation of lipid biosynthetic process |
| GO:0032370 | 0.00033 | 4.65569 | 2 | 9 | 61 | positive regulation of lipid transport |
| GO:0034113 | 0.00033 | 4.65569 | 2 | 9 | 61 | heterotypic cell-cell adhesion |
| GO:0071384 | 0.00033 | 4.65569 | 2 | 9 | 61 | cellular response to corticosteroid stimulus |
| GO:0034103 | 0.00033 | 3.84898 | 3 | 11 | 88 | regulation of tissue remodeling |
| GO:1904035 | 0.00033 | 3.84898 | 3 | 11 | 88 | regulation of epithelial cell apoptotic process |
| GO:0042770 | 0.00034 | 3.17665 | 5 | 14 | 133 | signal transduction in response to DNA damage |
| GO:0009267 | 0.00034 | 3.02459 | 5 | 15 | 149 | cellular response to starvation |
| GO:0000188 | 0.00034 | 7.66439 | 1 | 6 | 27 | inactivation of MAPK activity |
| GO:0035966 | 0.00034 | 2.69219 | 7 | 18 | 199 | response to topologically incorrect protein |
| GO:0032652 | 0.00035 | 3.55547 | 4 | 12 | 103 | regulation of interleukin-1 production |
| GO:1902106 | 0.00035 | 3.55547 | 4 | 12 | 103 | negative regulation of leukocyte differentiation |
| GO:1990266 | 0.00035 | 3.34062 | 4 | 13 | 118 | neutrophil migration |
| GO:0006873 | 0.00035 | 1.84713 | 24 | 42 | 665 | cellular ion homeostasis |
| GO:0051345 | 0.00035 | 1.78238 | 28 | 47 | 771 | positive regulation of hydrolase activity |
| GO:1900153 | 0.00035 | 10.30666 | 1 | 5 | 18 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay |
| GO:0071241 | 0.00036 | 2.59923 | 8 | 19 | 217 | cellular response to inorganic substance |
| GO:0046427 | 0.00036 | 3.79942 | 3 | 11 | 89 | positive regulation of JAK-STAT cascade |
| GO:0050778 | 0.00036 | 1.71798 | 33 | 53 | 902 | positive regulation of immune response |
| GO:0018193 | 0.00037 | 1.60519 | 46 | 69 | 1259 | peptidyl-amino acid modification |
| GO:0045453 | 0.00037 | 4.56759 | 2 | 9 | 62 | bone resorption |
| GO:0046635 | 0.00037 | 4.56759 | 2 | 9 | 62 | positive regulation of alpha-beta T cell activation |
| GO:0050716 | 0.00037 | 6.06302 | 1 | 7 | 38 | positive regulation of interleukin-1 secretion |
| GO:0006869 | 0.00038 | 2.17317 | 13 | 27 | 365 | lipid transport |
| GO:0050864 | 0.00039 | 2.75376 | 7 | 17 | 184 | regulation of B cell activation |
| GO:0009056 | 0.00039 | 1.42710 | 95 | 126 | 2615 | catabolic process |
| GO:0030855 | 0.00039 | 1.77218 | 28 | 47 | 775 | epithelial cell differentiation |
| GO:0019058 | 0.00040 | 2.24217 | 12 | 25 | 328 | viral life cycle |
| GO:0032651 | 0.00040 | 3.75112 | 3 | 11 | 90 | regulation of interleukin-1 beta production |
| GO:0034333 | 0.00040 | 3.75112 | 3 | 11 | 90 | adherens junction assembly |
| GO:0043900 | 0.00040 | 2.10021 | 15 | 29 | 405 | regulation of multi-organism process |
| GO:0010632 | 0.00040 | 2.32965 | 11 | 23 | 291 | regulation of epithelial cell migration |
| GO:0007507 | 0.00041 | 1.89261 | 21 | 38 | 587 | heart development |
| GO:0035886 | 0.00044 | 5.87322 | 1 | 7 | 39 | vascular smooth muscle cell differentiation |
| GO:0046718 | 0.00044 | 3.24728 | 4 | 13 | 121 | viral entry into host cell |
| GO:1901224 | 0.00045 | 4.01752 | 3 | 10 | 77 | positive regulation of NIK/NF-kappaB signaling |
| GO:0030321 | 0.00045 | 40.10104 | 0 | 3 | 5 | transepithelial chloride transport |
| GO:0070487 | 0.00045 | 40.10104 | 0 | 3 | 5 | monocyte aggregation |
| GO:0071224 | 0.00045 | 40.10104 | 0 | 3 | 5 | cellular response to peptidoglycan |
| GO:0071332 | 0.00045 | 40.10104 | 0 | 3 | 5 | cellular response to fructose stimulus |
| GO:1902219 | 0.00045 | 40.10104 | 0 | 3 | 5 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress |
| GO:1903969 | 0.00045 | 40.10104 | 0 | 3 | 5 | regulation of response to macrophage colony-stimulating factor |
| GO:1903972 | 0.00045 | 40.10104 | 0 | 3 | 5 | regulation of cellular response to macrophage colony-stimulating factor stimulus |
| GO:0060537 | 0.00045 | 2.08323 | 15 | 29 | 408 | muscle tissue development |
| GO:0046425 | 0.00045 | 3.07265 | 5 | 14 | 137 | regulation of JAK-STAT cascade |
| GO:2000116 | 0.00046 | 2.47452 | 9 | 20 | 239 | regulation of cysteine-type endopeptidase activity |
| GO:0032494 | 0.00046 | 15.29507 | 0 | 4 | 11 | response to peptidoglycan |
| GO:0036462 | 0.00046 | 15.29507 | 0 | 4 | 11 | TRAIL-activated apoptotic signaling pathway |
| GO:0044793 | 0.00046 | 15.29507 | 0 | 4 | 11 | negative regulation by host of viral process |
| GO:0046007 | 0.00046 | 15.29507 | 0 | 4 | 11 | negative regulation of activated T cell proliferation |
| GO:0070278 | 0.00046 | 15.29507 | 0 | 4 | 11 | extracellular matrix constituent secretion |
| GO:0010888 | 0.00047 | 9.56994 | 1 | 5 | 19 | negative regulation of lipid storage |
| GO:0030949 | 0.00047 | 9.56994 | 1 | 5 | 19 | positive regulation of vascular endothelial growth factor receptor signaling pathway |
| GO:0044249 | 0.00047 | 1.31216 | 223 | 264 | 6168 | cellular biosynthetic process |
| GO:0043500 | 0.00048 | 3.21731 | 4 | 13 | 122 | muscle adaptation |
| GO:1904894 | 0.00048 | 3.65809 | 3 | 11 | 92 | positive regulation of STAT cascade |
| GO:0043407 | 0.00049 | 3.95822 | 3 | 10 | 78 | negative regulation of MAP kinase activity |
| GO:0043901 | 0.00050 | 2.79007 | 6 | 16 | 171 | negative regulation of multi-organism process |
| GO:0061099 | 0.00051 | 6.99714 | 1 | 6 | 29 | negative regulation of protein tyrosine kinase activity |
| GO:0072538 | 0.00051 | 6.99714 | 1 | 6 | 29 | T-helper 17 type immune response |
| GO:0071902 | 0.00052 | 2.19789 | 12 | 25 | 334 | positive regulation of protein serine/threonine kinase activity |
| GO:0042089 | 0.00052 | 3.18788 | 4 | 13 | 123 | cytokine biosynthetic process |
| GO:0071548 | 0.00052 | 5.69493 | 1 | 7 | 40 | response to dexamethasone |
| GO:0032653 | 0.00052 | 4.88568 | 2 | 8 | 52 | regulation of interleukin-10 production |
| GO:0002831 | 0.00053 | 3.02315 | 5 | 14 | 139 | regulation of response to biotic stimulus |
| GO:0050854 | 0.00053 | 4.32218 | 2 | 9 | 65 | regulation of antigen receptor-mediated signaling pathway |
| GO:0032874 | 0.00053 | 2.77203 | 6 | 16 | 172 | positive regulation of stress-activated MAPK cascade |
| GO:0071260 | 0.00055 | 3.90064 | 3 | 10 | 79 | cellular response to mechanical stimulus |
| GO:0007259 | 0.00055 | 2.87331 | 6 | 15 | 156 | JAK-STAT cascade |
| GO:0042107 | 0.00056 | 3.15898 | 4 | 13 | 124 | cytokine metabolic process |
| GO:0070304 | 0.00056 | 2.75422 | 6 | 16 | 173 | positive regulation of stress-activated protein kinase signaling cascade |
| GO:0046626 | 0.00059 | 4.24611 | 2 | 9 | 66 | regulation of insulin receptor signaling pathway |
| GO:1902475 | 0.00059 | 4.77685 | 2 | 8 | 53 | L-alpha-amino acid transmembrane transport |
| GO:1900151 | 0.00060 | 8.93145 | 1 | 5 | 20 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay |
| GO:0048286 | 0.00061 | 5.52713 | 1 | 7 | 41 | lung alveolus development |
| GO:0050798 | 0.00061 | 5.52713 | 1 | 7 | 41 | activated T cell proliferation |
| GO:0150077 | 0.00061 | 5.52713 | 1 | 7 | 41 | regulation of neuroinflammatory response |
| GO:0051701 | 0.00062 | 2.54980 | 8 | 18 | 209 | interaction with host |
| GO:0071549 | 0.00062 | 6.70522 | 1 | 6 | 30 | cellular response to dexamethasone stimulus |
| GO:0098657 | 0.00062 | 1.66647 | 34 | 54 | 945 | import into cell |
| GO:0042116 | 0.00064 | 3.52685 | 3 | 11 | 95 | macrophage activation |
| GO:0009612 | 0.00065 | 2.53638 | 8 | 18 | 210 | response to mechanical stimulus |
| GO:1903391 | 0.00066 | 4.17267 | 2 | 9 | 67 | regulation of adherens junction organization |
| GO:0008228 | 0.00067 | 13.38244 | 0 | 4 | 12 | opsonization |
| GO:0070486 | 0.00067 | 13.38244 | 0 | 4 | 12 | leukocyte aggregation |
| GO:1904019 | 0.00069 | 3.26670 | 4 | 12 | 111 | epithelial cell apoptotic process |
| GO:1903531 | 0.00069 | 2.52310 | 8 | 18 | 211 | negative regulation of secretion by cell |
| GO:0097237 | 0.00070 | 2.38624 | 9 | 20 | 247 | cellular response to toxic substance |
| GO:0008015 | 0.00070 | 1.88712 | 20 | 35 | 541 | blood circulation |
| GO:0035296 | 0.00070 | 2.92876 | 5 | 14 | 143 | regulation of tube diameter |
| GO:0050880 | 0.00070 | 2.92876 | 5 | 14 | 143 | regulation of blood vessel size |
| GO:0097746 | 0.00070 | 2.92876 | 5 | 14 | 143 | regulation of blood vessel diameter |
| GO:0007599 | 0.00070 | 2.14835 | 12 | 25 | 341 | hemostasis |
| GO:0042149 | 0.00071 | 5.36891 | 2 | 7 | 42 | cellular response to glucose starvation |
| GO:0050817 | 0.00073 | 2.14145 | 12 | 25 | 342 | coagulation |
| GO:0034976 | 0.00073 | 2.26789 | 10 | 22 | 285 | response to endoplasmic reticulum stress |
| GO:0051051 | 0.00074 | 1.89981 | 19 | 34 | 522 | negative regulation of transport |
| GO:0050918 | 0.00074 | 4.10172 | 2 | 9 | 68 | positive chemotaxis |
| GO:0010543 | 0.00075 | 6.43666 | 1 | 6 | 31 | regulation of platelet activation |
| GO:0035150 | 0.00075 | 2.90607 | 5 | 14 | 144 | regulation of tube size |
| GO:0002576 | 0.00076 | 3.04842 | 5 | 13 | 128 | platelet degranulation |
| GO:0015711 | 0.00076 | 1.93723 | 17 | 32 | 482 | organic anion transport |
| GO:0001101 | 0.00076 | 2.13460 | 12 | 25 | 343 | response to acid chemical |
| GO:0001541 | 0.00077 | 4.57307 | 2 | 8 | 55 | ovarian follicle development |
| GO:0032613 | 0.00077 | 4.57307 | 2 | 8 | 55 | interleukin-10 production |
| GO:0045620 | 0.00077 | 4.57307 | 2 | 8 | 55 | negative regulation of lymphocyte differentiation |
| GO:0072111 | 0.00077 | 8.37276 | 1 | 5 | 21 | cell proliferation involved in kidney development |
| GO:2000810 | 0.00077 | 8.37276 | 1 | 5 | 21 | regulation of bicellular tight junction assembly |
| GO:0010950 | 0.00077 | 2.66846 | 6 | 16 | 178 | positive regulation of endopeptidase activity |
| GO:0034248 | 0.00079 | 1.93282 | 17 | 32 | 483 | regulation of cellular amide metabolic process |
| GO:0046620 | 0.00081 | 3.20166 | 4 | 12 | 113 | regulation of organ growth |
| GO:0050764 | 0.00083 | 3.40467 | 4 | 11 | 98 | regulation of phagocytosis |
| GO:0002793 | 0.00084 | 2.24194 | 10 | 22 | 288 | positive regulation of peptide secretion |
| GO:0098656 | 0.00084 | 2.24194 | 10 | 22 | 288 | anion transmembrane transport |
| GO:0030003 | 0.00084 | 1.78629 | 24 | 40 | 652 | cellular cation homeostasis |
| GO:0002221 | 0.00085 | 2.55301 | 7 | 17 | 197 | pattern recognition receptor signaling pathway |
| GO:1904892 | 0.00086 | 2.86171 | 5 | 14 | 146 | regulation of STAT cascade |
| GO:0043281 | 0.00086 | 2.47131 | 8 | 18 | 215 | regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0015677 | 0.00087 | 26.73254 | 0 | 3 | 6 | copper ion import |
| GO:0015803 | 0.00087 | 26.73254 | 0 | 3 | 6 | branched-chain amino acid transport |
| GO:0060426 | 0.00087 | 26.73254 | 0 | 3 | 6 | lung vasculature development |
| GO:1900241 | 0.00087 | 26.73254 | 0 | 3 | 6 | positive regulation of phenotypic switching |
| GO:1902218 | 0.00087 | 26.73254 | 0 | 3 | 6 | regulation of intrinsic apoptotic signaling pathway in response to osmotic stress |
| GO:0001975 | 0.00089 | 6.18875 | 1 | 6 | 32 | response to amphetamine |
| GO:0071353 | 0.00089 | 6.18875 | 1 | 6 | 32 | cellular response to interleukin-4 |
| GO:0060420 | 0.00089 | 3.63607 | 3 | 10 | 84 | regulation of heart growth |
| GO:1905897 | 0.00089 | 3.63607 | 3 | 10 | 84 | regulation of response to endoplasmic reticulum stress |
| GO:0048525 | 0.00090 | 3.36579 | 4 | 11 | 99 | negative regulation of viral process |
| GO:0003006 | 0.00091 | 1.76507 | 24 | 41 | 676 | developmental process involved in reproduction |
| GO:0006807 | 0.00091 | 1.29011 | 391 | 431 | 10812 | nitrogen compound metabolic process |
| GO:0034121 | 0.00092 | 3.96680 | 3 | 9 | 70 | regulation of toll-like receptor signaling pathway |
| GO:0002262 | 0.00092 | 2.84004 | 5 | 14 | 147 | myeloid cell homeostasis |
| GO:0002285 | 0.00092 | 2.61950 | 7 | 16 | 181 | lymphocyte activation involved in immune response |
| GO:0010642 | 0.00094 | 11.89484 | 0 | 4 | 13 | negative regulation of platelet-derived growth factor receptor signaling pathway |
| GO:0060712 | 0.00094 | 11.89484 | 0 | 4 | 13 | spongiotrophoblast layer development |
| GO:0070431 | 0.00094 | 11.89484 | 0 | 4 | 13 | nucleotide-binding oligomerization domain containing 2 signaling pathway |
| GO:1901550 | 0.00094 | 11.89484 | 0 | 4 | 13 | regulation of endothelial cell development |
| GO:1903140 | 0.00094 | 11.89484 | 0 | 4 | 13 | regulation of establishment of endothelial barrier |
| GO:0030225 | 0.00094 | 5.07813 | 2 | 7 | 44 | macrophage differentiation |
| GO:0045601 | 0.00094 | 5.07813 | 2 | 7 | 44 | regulation of endothelial cell differentiation |
| GO:0061756 | 0.00094 | 5.07813 | 2 | 7 | 44 | leukocyte adhesion to vascular endothelial cell |
| GO:0003013 | 0.00096 | 1.84949 | 20 | 35 | 551 | circulatory system process |
| GO:0045649 | 0.00097 | 7.87981 | 1 | 5 | 22 | regulation of macrophage differentiation |
| GO:0048305 | 0.00097 | 7.87981 | 1 | 5 | 22 | immunoglobulin secretion |
| GO:0060575 | 0.00097 | 7.87981 | 1 | 5 | 22 | intestinal epithelial cell differentiation |
| GO:1901522 | 0.00097 | 7.87981 | 1 | 5 | 22 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus |
| GO:0050819 | 0.00098 | 4.38592 | 2 | 8 | 57 | negative regulation of coagulation |
| GO:1904705 | 0.00098 | 3.58739 | 3 | 10 | 85 | regulation of vascular smooth muscle cell proliferation |
| GO:1990874 | 0.00098 | 3.58739 | 3 | 10 | 85 | vascular smooth muscle cell proliferation |
| GO:0008643 | 0.00098 | 2.81869 | 5 | 14 | 148 | carbohydrate transport |
| GO:0042742 | 0.00099 | 2.12775 | 12 | 24 | 330 | defense response to bacterium |
| GO:0032870 | 0.00100 | 1.74260 | 25 | 42 | 701 | cellular response to hormone stimulus |
| GO:0006974 | 0.00101 | 1.66872 | 31 | 49 | 854 | cellular response to DNA damage stimulus |
| GO:0042531 | 0.00102 | 3.90260 | 3 | 9 | 71 | positive regulation of tyrosine phosphorylation of STAT protein |
| GO:0038061 | 0.00104 | 2.58784 | 7 | 16 | 183 | NIK/NF-kappaB signaling |
| GO:0002253 | 0.00104 | 1.72699 | 26 | 43 | 724 | activation of immune response |
| GO:0097696 | 0.00105 | 2.68152 | 6 | 15 | 166 | STAT cascade |
| GO:0032872 | 0.00105 | 2.35812 | 9 | 19 | 237 | regulation of stress-activated MAPK cascade |
| GO:0050718 | 0.00106 | 5.95920 | 1 | 6 | 33 | positive regulation of interleukin-1 beta secretion |
| GO:1901890 | 0.00106 | 5.95920 | 1 | 6 | 33 | positive regulation of cell junction assembly |
| GO:0055082 | 0.00106 | 1.68285 | 29 | 47 | 812 | cellular chemical homeostasis |
| GO:0007584 | 0.00106 | 2.42159 | 8 | 18 | 219 | response to nutrient |
| GO:0045581 | 0.00108 | 4.94422 | 2 | 7 | 45 | negative regulation of T cell differentiation |
| GO:0019229 | 0.00110 | 4.29796 | 2 | 8 | 58 | regulation of vasoconstriction |
| GO:0045088 | 0.00110 | 1.93374 | 16 | 30 | 452 | regulation of innate immune response |
| GO:0009059 | 0.00112 | 1.30050 | 185 | 221 | 5114 | macromolecule biosynthetic process |
| GO:0015849 | 0.00113 | 2.10674 | 12 | 24 | 333 | organic acid transport |
| GO:0046942 | 0.00113 | 2.10674 | 12 | 24 | 333 | carboxylic acid transport |
| GO:0002367 | 0.00116 | 3.25428 | 4 | 11 | 102 | cytokine production involved in immune response |
| GO:0035335 | 0.00116 | 3.25428 | 4 | 11 | 102 | peptidyl-tyrosine dephosphorylation |
| GO:0007369 | 0.00116 | 2.55693 | 7 | 16 | 185 | gastrulation |
| GO:0070302 | 0.00116 | 2.33642 | 9 | 19 | 239 | regulation of stress-activated protein kinase signaling cascade |
| GO:0007266 | 0.00118 | 2.46982 | 7 | 17 | 203 | Rho protein signal transduction |
| GO:0061436 | 0.00120 | 7.44163 | 1 | 5 | 23 | establishment of skin barrier |
| GO:1901889 | 0.00120 | 7.44163 | 1 | 5 | 23 | negative regulation of cell junction assembly |
| GO:0006914 | 0.00122 | 1.87728 | 18 | 32 | 496 | autophagy |
| GO:0061919 | 0.00122 | 1.87728 | 18 | 32 | 496 | process utilizing autophagic mechanism |
| GO:0032732 | 0.00123 | 4.21346 | 2 | 8 | 59 | positive regulation of interleukin-1 production |
| GO:0045071 | 0.00123 | 4.21346 | 2 | 8 | 59 | negative regulation of viral genome replication |
| GO:0006984 | 0.00124 | 4.81718 | 2 | 7 | 46 | ER-nucleus signaling pathway |
| GO:0007157 | 0.00124 | 4.81718 | 2 | 7 | 46 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules |
| GO:0010883 | 0.00124 | 4.81718 | 2 | 7 | 46 | regulation of lipid storage |
| GO:0014075 | 0.00124 | 4.81718 | 2 | 7 | 46 | response to amine |
| GO:1904036 | 0.00124 | 4.81718 | 2 | 7 | 46 | negative regulation of epithelial cell apoptotic process |
| GO:0070670 | 0.00125 | 5.74606 | 1 | 6 | 34 | response to interleukin-4 |
| GO:0071402 | 0.00125 | 5.74606 | 1 | 6 | 34 | cellular response to lipoprotein particle stimulus |
| GO:0050728 | 0.00126 | 2.62884 | 6 | 15 | 169 | negative regulation of inflammatory response |
| GO:1904951 | 0.00127 | 1.91514 | 17 | 30 | 456 | positive regulation of establishment of protein localization |
| GO:0007596 | 0.00127 | 2.08613 | 12 | 24 | 336 | blood coagulation |
| GO:0000187 | 0.00127 | 2.73637 | 6 | 14 | 152 | activation of MAPK activity |
| GO:0035791 | 0.00128 | 10.70476 | 1 | 4 | 14 | platelet-derived growth factor receptor-beta signaling pathway |
| GO:0010468 | 0.00129 | 1.29577 | 186 | 221 | 5127 | regulation of gene expression |
| GO:0006897 | 0.00130 | 1.66466 | 30 | 47 | 820 | endocytosis |
| GO:0002268 | 0.00131 | Inf | 0 | 2 | 2 | follicular dendritic cell differentiation |
| GO:0002384 | 0.00131 | Inf | 0 | 2 | 2 | hepatic immune response |
| GO:0006434 | 0.00131 | Inf | 0 | 2 | 2 | seryl-tRNA aminoacylation |
| GO:0032764 | 0.00131 | Inf | 0 | 2 | 2 | negative regulation of mast cell cytokine production |
| GO:0034633 | 0.00131 | Inf | 0 | 2 | 2 | retinol transport |
| GO:0046864 | 0.00131 | Inf | 0 | 2 | 2 | isoprenoid transport |
| GO:0046865 | 0.00131 | Inf | 0 | 2 | 2 | terpenoid transport |
| GO:0048250 | 0.00131 | Inf | 0 | 2 | 2 | iron import into the mitochondrion |
| GO:1903489 | 0.00131 | Inf | 0 | 2 | 2 | positive regulation of lactation |
| GO:2000866 | 0.00131 | Inf | 0 | 2 | 2 | positive regulation of estradiol secretion |
| GO:0042133 | 0.00135 | 2.71653 | 6 | 14 | 153 | neurotransmitter metabolic process |
| GO:0045807 | 0.00135 | 2.71653 | 6 | 14 | 153 | positive regulation of endocytosis |
| GO:0062013 | 0.00135 | 2.71653 | 6 | 14 | 153 | positive regulation of small molecule metabolic process |
| GO:0022612 | 0.00137 | 2.99297 | 4 | 12 | 120 | gland morphogenesis |
| GO:0030104 | 0.00137 | 3.72185 | 3 | 9 | 74 | water homeostasis |
| GO:1900076 | 0.00137 | 3.72185 | 3 | 9 | 74 | regulation of cellular response to insulin stimulus |
| GO:0051893 | 0.00138 | 4.13220 | 2 | 8 | 60 | regulation of focal adhesion assembly |
| GO:0090109 | 0.00138 | 4.13220 | 2 | 8 | 60 | regulation of cell-substrate junction assembly |
| GO:0009894 | 0.00139 | 1.60203 | 35 | 54 | 979 | regulation of catabolic process |
| GO:0050679 | 0.00139 | 2.43021 | 7 | 17 | 206 | positive regulation of epithelial cell proliferation |
| GO:0048729 | 0.00140 | 1.73345 | 24 | 40 | 670 | tissue morphogenesis |
| GO:0046638 | 0.00141 | 4.69649 | 2 | 7 | 47 | positive regulation of alpha-beta T cell differentiation |
| GO:0010634 | 0.00142 | 2.59484 | 6 | 15 | 171 | positive regulation of epithelial cell migration |
| GO:0019932 | 0.00142 | 1.92233 | 16 | 29 | 439 | second-messenger-mediated signaling |
| GO:0030100 | 0.00144 | 2.18681 | 10 | 21 | 281 | regulation of endocytosis |
| GO:0032689 | 0.00146 | 5.54761 | 1 | 6 | 35 | negative regulation of interferon-gamma production |
| GO:0032735 | 0.00146 | 5.54761 | 1 | 6 | 35 | positive regulation of interleukin-12 production |
| GO:0045622 | 0.00146 | 5.54761 | 1 | 6 | 35 | regulation of T-helper cell differentiation |
| GO:0070423 | 0.00146 | 5.54761 | 1 | 6 | 35 | nucleotide-binding oligomerization domain containing signaling pathway |
| GO:0042832 | 0.00147 | 7.04957 | 1 | 5 | 24 | defense response to protozoan |
| GO:0150076 | 0.00151 | 3.66526 | 3 | 9 | 75 | neuroinflammatory response |
| GO:0008584 | 0.00153 | 2.80298 | 5 | 13 | 138 | male gonad development |
| GO:0046849 | 0.00153 | 3.36224 | 3 | 10 | 90 | bone remodeling |
| GO:1903035 | 0.00153 | 3.36224 | 3 | 10 | 90 | negative regulation of response to wounding |
| GO:1901861 | 0.00153 | 2.67770 | 6 | 14 | 155 | regulation of muscle tissue development |
| GO:0006879 | 0.00153 | 4.05401 | 2 | 8 | 61 | cellular iron ion homeostasis |
| GO:0060759 | 0.00154 | 2.48276 | 7 | 16 | 190 | regulation of response to cytokine stimulus |
| GO:0071248 | 0.00154 | 2.48276 | 7 | 16 | 190 | cellular response to metal ion |
| GO:0034599 | 0.00155 | 2.12816 | 11 | 22 | 302 | cellular response to oxidative stress |
| GO:0051726 | 0.00155 | 1.53313 | 44 | 64 | 1213 | regulation of cell cycle |
| GO:0071704 | 0.00156 | 1.28747 | 438 | 474 | 12093 | organic substance metabolic process |
| GO:0019079 | 0.00158 | 2.93823 | 4 | 12 | 122 | viral genome replication |
| GO:0042136 | 0.00159 | 3.11657 | 4 | 11 | 106 | neurotransmitter biosynthetic process |
| GO:0001894 | 0.00160 | 2.32785 | 8 | 18 | 227 | tissue homeostasis |
| GO:0061014 | 0.00160 | 4.58168 | 2 | 7 | 48 | positive regulation of mRNA catabolic process |
| GO:0016049 | 0.00162 | 1.86105 | 18 | 31 | 484 | cell growth |
| GO:0017148 | 0.00162 | 2.39183 | 8 | 17 | 209 | negative regulation of translation |
| GO:0046546 | 0.00163 | 2.78058 | 5 | 13 | 139 | development of primary male sexual characteristics |
| GO:0030856 | 0.00163 | 2.65870 | 6 | 14 | 156 | regulation of epithelial cell differentiation |
| GO:0043535 | 0.00163 | 2.65870 | 6 | 14 | 156 | regulation of blood vessel endothelial cell migration |
| GO:0061045 | 0.00166 | 3.61035 | 3 | 9 | 76 | negative regulation of wound healing |
| GO:0002467 | 0.00169 | 9.73106 | 1 | 4 | 15 | germinal center formation |
| GO:0032352 | 0.00169 | 9.73106 | 1 | 4 | 15 | positive regulation of hormone metabolic process |
| GO:0060841 | 0.00169 | 9.73106 | 1 | 4 | 15 | venous blood vessel development |
| GO:2001185 | 0.00169 | 9.73106 | 1 | 4 | 15 | regulation of CD8-positive, alpha-beta T cell activation |
| GO:0035872 | 0.00170 | 5.36239 | 1 | 6 | 36 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway |
| GO:2000516 | 0.00170 | 5.36239 | 1 | 6 | 36 | positive regulation of CD4-positive, alpha-beta T cell activation |
| GO:0002753 | 0.00171 | 3.97871 | 2 | 8 | 62 | cytoplasmic pattern recognition receptor signaling pathway |
| GO:0070265 | 0.00171 | 3.97871 | 2 | 8 | 62 | necrotic cell death |
| GO:1901862 | 0.00171 | 3.97871 | 2 | 8 | 62 | negative regulation of muscle tissue development |
| GO:0003012 | 0.00171 | 1.87456 | 17 | 30 | 465 | muscle system process |
| GO:0043502 | 0.00171 | 3.08393 | 4 | 11 | 107 | regulation of muscle adaptation |
| GO:0034249 | 0.00176 | 2.30552 | 8 | 18 | 229 | negative regulation of cellular amide metabolic process |
| GO:0001562 | 0.00178 | 6.69672 | 1 | 5 | 25 | response to protozoan |
| GO:0031664 | 0.00178 | 6.69672 | 1 | 5 | 25 | regulation of lipopolysaccharide-mediated signaling pathway |
| GO:0050927 | 0.00178 | 6.69672 | 1 | 5 | 25 | positive regulation of positive chemotaxis |
| GO:1900101 | 0.00178 | 6.69672 | 1 | 5 | 25 | regulation of endoplasmic reticulum unfolded protein response |
| GO:0044248 | 0.00180 | 1.38518 | 84 | 110 | 2324 | cellular catabolic process |
| GO:0008347 | 0.00181 | 4.47235 | 2 | 7 | 49 | glial cell migration |
| GO:1904707 | 0.00181 | 4.47235 | 2 | 7 | 49 | positive regulation of vascular smooth muscle cell proliferation |
| GO:0042692 | 0.00181 | 1.96490 | 14 | 26 | 385 | muscle cell differentiation |
| GO:0010629 | 0.00182 | 1.37607 | 89 | 115 | 2448 | negative regulation of gene expression |
| GO:0014013 | 0.00182 | 2.88543 | 4 | 12 | 124 | regulation of gliogenesis |
| GO:0000288 | 0.00182 | 3.55706 | 3 | 9 | 77 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay |
| GO:1904659 | 0.00185 | 3.05196 | 4 | 11 | 108 | glucose transmembrane transport |
| GO:0046622 | 0.00189 | 3.90615 | 2 | 8 | 63 | positive regulation of organ growth |
| GO:0046686 | 0.00189 | 3.90615 | 2 | 8 | 63 | response to cadmium ion |
| GO:0006811 | 0.00192 | 1.44198 | 61 | 84 | 1696 | ion transport |
| GO:0010506 | 0.00194 | 2.04960 | 12 | 23 | 327 | regulation of autophagy |
| GO:0002673 | 0.00195 | 2.60325 | 6 | 14 | 159 | regulation of acute inflammatory response |
| GO:0048638 | 0.00195 | 2.01383 | 13 | 24 | 347 | regulation of developmental growth |
| GO:0007431 | 0.00196 | 5.18912 | 1 | 6 | 37 | salivary gland development |
| GO:0046006 | 0.00196 | 5.18912 | 1 | 6 | 37 | regulation of activated T cell proliferation |
| GO:0034332 | 0.00197 | 2.71546 | 5 | 13 | 142 | adherens junction organization |
| GO:0001959 | 0.00200 | 2.49790 | 6 | 15 | 177 | regulation of cytokine-mediated signaling pathway |
| GO:0002757 | 0.00207 | 1.71779 | 23 | 38 | 641 | immune response-activating signal transduction |
| GO:0046661 | 0.00207 | 2.58528 | 6 | 14 | 160 | male sex differentiation |
| GO:0045667 | 0.00208 | 2.83450 | 5 | 12 | 126 | regulation of osteoblast differentiation |
| GO:0006826 | 0.00210 | 3.83618 | 2 | 8 | 64 | iron ion transport |
| GO:0060284 | 0.00212 | 1.58093 | 35 | 52 | 953 | regulation of cell development |
| GO:0033561 | 0.00214 | 6.37747 | 1 | 5 | 26 | regulation of water loss via skin |
| GO:0034114 | 0.00214 | 6.37747 | 1 | 5 | 26 | regulation of heterotypic cell-cell adhesion |
| GO:0050926 | 0.00214 | 6.37747 | 1 | 5 | 26 | regulation of positive chemotaxis |
| GO:1904754 | 0.00214 | 6.37747 | 1 | 5 | 26 | positive regulation of vascular associated smooth muscle cell migration |
| GO:0014706 | 0.00216 | 1.93736 | 14 | 26 | 390 | striated muscle tissue development |
| GO:0001570 | 0.00218 | 3.45504 | 3 | 9 | 79 | vasculogenesis |
| GO:0043536 | 0.00218 | 3.45504 | 3 | 9 | 79 | positive regulation of blood vessel endothelial cell migration |
| GO:0042447 | 0.00219 | 8.91964 | 1 | 4 | 16 | hormone catabolic process |
| GO:0061158 | 0.00219 | 8.91964 | 1 | 4 | 16 | 3'-UTR-mediated mRNA destabilization |
| GO:0070374 | 0.00219 | 2.31857 | 8 | 17 | 215 | positive regulation of ERK1 and ERK2 cascade |
| GO:0032368 | 0.00222 | 2.80969 | 5 | 12 | 127 | regulation of lipid transport |
| GO:0010952 | 0.00223 | 2.38580 | 7 | 16 | 197 | positive regulation of peptidase activity |
| GO:0071453 | 0.00223 | 2.25152 | 8 | 18 | 234 | cellular response to oxygen levels |
| GO:0009792 | 0.00224 | 1.70899 | 23 | 38 | 644 | embryo development ending in birth or egg hatching |
| GO:0010939 | 0.00226 | 5.02668 | 1 | 6 | 38 | regulation of necrotic cell death |
| GO:0046636 | 0.00226 | 5.02668 | 1 | 6 | 38 | negative regulation of alpha-beta T cell activation |
| GO:0002009 | 0.00227 | 1.78099 | 19 | 33 | 537 | morphogenesis of an epithelium |
| GO:0007566 | 0.00229 | 4.26858 | 2 | 7 | 51 | embryo implantation |
| GO:0097366 | 0.00229 | 4.26858 | 2 | 7 | 51 | response to bronchodilator |
| GO:0009410 | 0.00229 | 2.09675 | 11 | 21 | 292 | response to xenobiotic stimulus |
| GO:0032869 | 0.00230 | 2.30679 | 8 | 17 | 216 | cellular response to insulin stimulus |
| GO:0008627 | 0.00231 | 16.03774 | 0 | 3 | 8 | intrinsic apoptotic signaling pathway in response to osmotic stress |
| GO:0038027 | 0.00231 | 16.03774 | 0 | 3 | 8 | apolipoprotein A-I-mediated signaling pathway |
| GO:0032729 | 0.00232 | 3.76867 | 2 | 8 | 65 | positive regulation of interferon-gamma production |
| GO:0022617 | 0.00238 | 3.40619 | 3 | 9 | 80 | extracellular matrix disassembly |
| GO:0002687 | 0.00238 | 2.78531 | 5 | 12 | 128 | positive regulation of leukocyte migration |
| GO:0036294 | 0.00241 | 2.29513 | 8 | 17 | 217 | cellular response to decreased oxygen levels |
| GO:0001938 | 0.00247 | 2.93044 | 4 | 11 | 112 | positive regulation of endothelial cell proliferation |
| GO:0008645 | 0.00247 | 2.93044 | 4 | 11 | 112 | hexose transmembrane transport |
| GO:0044238 | 0.00247 | 1.26215 | 409 | 444 | 11287 | primary metabolic process |
| GO:0097327 | 0.00248 | 3.12661 | 3 | 10 | 96 | response to antineoplastic agent |
| GO:0002224 | 0.00253 | 2.63320 | 5 | 13 | 146 | toll-like receptor signaling pathway |
| GO:0034754 | 0.00254 | 2.76135 | 5 | 12 | 129 | cellular hormone metabolic process |
| GO:0043009 | 0.00254 | 1.70804 | 23 | 37 | 627 | chordate embryonic development |
| GO:0048668 | 0.00255 | 6.08725 | 1 | 5 | 27 | collateral sprouting |
| GO:0045428 | 0.00255 | 3.70349 | 2 | 8 | 66 | regulation of nitric oxide biosynthetic process |
| GO:0032731 | 0.00257 | 4.17349 | 2 | 7 | 52 | positive regulation of interleukin-1 beta production |
| GO:0050856 | 0.00259 | 4.87408 | 1 | 6 | 39 | regulation of T cell receptor signaling pathway |
| GO:0060969 | 0.00259 | 4.87408 | 1 | 6 | 39 | negative regulation of gene silencing |
| GO:0051048 | 0.00268 | 2.21009 | 9 | 18 | 238 | negative regulation of secretion |
| GO:0051591 | 0.00268 | 3.09050 | 4 | 10 | 97 | response to cAMP |
| GO:1990868 | 0.00268 | 3.09050 | 4 | 10 | 97 | response to chemokine |
| GO:1990869 | 0.00268 | 3.09050 | 4 | 10 | 97 | cellular response to chemokine |
| GO:0006825 | 0.00278 | 8.23306 | 1 | 4 | 17 | copper ion transport |
| GO:0032740 | 0.00278 | 8.23306 | 1 | 4 | 17 | positive regulation of interleukin-17 production |
| GO:0031348 | 0.00280 | 2.19996 | 9 | 18 | 239 | negative regulation of defense response |
| GO:0015807 | 0.00281 | 3.64052 | 2 | 8 | 67 | L-amino acid transport |
| GO:0048662 | 0.00281 | 3.64052 | 2 | 8 | 67 | negative regulation of smooth muscle cell proliferation |
| GO:0032637 | 0.00282 | 3.31250 | 3 | 9 | 82 | interleukin-8 production |
| GO:0071158 | 0.00282 | 3.31250 | 3 | 9 | 82 | positive regulation of cell cycle arrest |
| GO:0015749 | 0.00284 | 2.87322 | 4 | 11 | 114 | monosaccharide transmembrane transport |
| GO:0002764 | 0.00285 | 1.67097 | 24 | 39 | 675 | immune response-regulating signaling pathway |
| GO:0001503 | 0.00285 | 1.89484 | 14 | 26 | 398 | ossification |
| GO:0030195 | 0.00287 | 4.08254 | 2 | 7 | 53 | negative regulation of blood coagulation |
| GO:0071320 | 0.00287 | 4.08254 | 2 | 7 | 53 | cellular response to cAMP |
| GO:0090257 | 0.00291 | 2.13931 | 9 | 19 | 259 | regulation of muscle system process |
| GO:0030278 | 0.00301 | 2.30848 | 7 | 16 | 203 | regulation of ossification |
| GO:0006972 | 0.00302 | 5.82226 | 1 | 5 | 28 | hyperosmotic response |
| GO:1902932 | 0.00302 | 5.82226 | 1 | 5 | 28 | positive regulation of alcohol biosynthetic process |
| GO:2001056 | 0.00302 | 2.57468 | 5 | 13 | 149 | positive regulation of cysteine-type endopeptidase activity |
| GO:0019725 | 0.00305 | 1.55011 | 35 | 52 | 970 | cellular homeostasis |
| GO:0043280 | 0.00307 | 2.69187 | 5 | 12 | 132 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0010812 | 0.00309 | 3.57964 | 2 | 8 | 68 | negative regulation of cell-substrate adhesion |
| GO:0019915 | 0.00309 | 3.57964 | 2 | 8 | 68 | lipid storage |
| GO:1900047 | 0.00319 | 3.99545 | 2 | 7 | 54 | negative regulation of hemostasis |
| GO:0048754 | 0.00320 | 2.55575 | 5 | 13 | 150 | branching morphogenesis of an epithelial tube |
| GO:0050777 | 0.00320 | 2.55575 | 5 | 13 | 150 | negative regulation of immune response |
| GO:0045089 | 0.00321 | 1.90265 | 14 | 25 | 381 | positive regulation of innate immune response |
| GO:0007264 | 0.00324 | 1.72163 | 21 | 34 | 571 | small GTPase mediated signal transduction |
| GO:0034219 | 0.00325 | 2.81817 | 4 | 11 | 116 | carbohydrate transmembrane transport |
| GO:0002718 | 0.00332 | 3.22381 | 3 | 9 | 84 | regulation of cytokine production involved in immune response |
| GO:0046889 | 0.00332 | 3.22381 | 3 | 9 | 84 | positive regulation of lipid biosynthetic process |
| GO:0097756 | 0.00332 | 3.22381 | 3 | 9 | 84 | negative regulation of blood vessel diameter |
| GO:0002824 | 0.00335 | 2.98699 | 4 | 10 | 100 | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0055024 | 0.00335 | 2.98699 | 4 | 10 | 100 | regulation of cardiac muscle tissue development |
| GO:0070498 | 0.00335 | 2.98699 | 4 | 10 | 100 | interleukin-1-mediated signaling pathway |
| GO:0050873 | 0.00336 | 4.59505 | 1 | 6 | 41 | brown fat cell differentiation |
| GO:0014012 | 0.00337 | 13.36404 | 0 | 3 | 9 | peripheral nervous system axon regeneration |
| GO:0034145 | 0.00337 | 13.36404 | 0 | 3 | 9 | positive regulation of toll-like receptor 4 signaling pathway |
| GO:0043569 | 0.00337 | 13.36404 | 0 | 3 | 9 | negative regulation of insulin-like growth factor receptor signaling pathway |
| GO:0070970 | 0.00337 | 13.36404 | 0 | 3 | 9 | interleukin-2 secretion |
| GO:0097011 | 0.00337 | 13.36404 | 0 | 3 | 9 | cellular response to granulocyte macrophage colony-stimulating factor stimulus |
| GO:0097012 | 0.00337 | 13.36404 | 0 | 3 | 9 | response to granulocyte macrophage colony-stimulating factor |
| GO:0051346 | 0.00341 | 1.80079 | 17 | 29 | 466 | negative regulation of hydrolase activity |
| GO:0034645 | 0.00346 | 1.26519 | 180 | 211 | 4961 | cellular macromolecule biosynthetic process |
| GO:0002761 | 0.00347 | 2.79143 | 4 | 11 | 117 | regulation of myeloid leukocyte differentiation |
| GO:0010508 | 0.00347 | 2.79143 | 4 | 11 | 117 | positive regulation of autophagy |
| GO:0051153 | 0.00347 | 2.79143 | 4 | 11 | 117 | regulation of striated muscle cell differentiation |
| GO:0006607 | 0.00348 | 7.64456 | 1 | 4 | 18 | NLS-bearing protein import into nucleus |
| GO:0007250 | 0.00348 | 7.64456 | 1 | 4 | 18 | activation of NF-kappaB-inducing kinase activity |
| GO:0051895 | 0.00348 | 7.64456 | 1 | 4 | 18 | negative regulation of focal adhesion assembly |
| GO:0060192 | 0.00348 | 7.64456 | 1 | 4 | 18 | negative regulation of lipase activity |
| GO:0060546 | 0.00348 | 7.64456 | 1 | 4 | 18 | negative regulation of necroptotic process |
| GO:0071605 | 0.00348 | 7.64456 | 1 | 4 | 18 | monocyte chemotactic protein-1 production |
| GO:0071637 | 0.00348 | 7.64456 | 1 | 4 | 18 | regulation of monocyte chemotactic protein-1 production |
| GO:0001649 | 0.00351 | 2.20586 | 8 | 17 | 225 | osteoblast differentiation |
| GO:2000515 | 0.00354 | 5.57936 | 1 | 5 | 29 | negative regulation of CD4-positive, alpha-beta T cell activation |
| GO:0043030 | 0.00355 | 3.91200 | 2 | 7 | 55 | regulation of macrophage activation |
| GO:1903901 | 0.00360 | 3.18121 | 3 | 9 | 85 | negative regulation of viral life cycle |
| GO:0010038 | 0.00361 | 1.91130 | 13 | 24 | 364 | response to metal ion |
| GO:0071456 | 0.00364 | 2.25962 | 7 | 16 | 207 | cellular response to hypoxia |
| GO:0072593 | 0.00366 | 2.04753 | 10 | 20 | 284 | reactive oxygen species metabolic process |
| GO:0001889 | 0.00369 | 2.62577 | 5 | 12 | 135 | liver development |
| GO:1903825 | 0.00369 | 2.62577 | 5 | 12 | 135 | organic acid transmembrane transport |
| GO:1905039 | 0.00369 | 2.62577 | 5 | 12 | 135 | carboxylic acid transmembrane transport |
| GO:0032720 | 0.00370 | 3.46378 | 3 | 8 | 70 | negative regulation of tumor necrosis factor production |
| GO:0050766 | 0.00370 | 3.46378 | 3 | 8 | 70 | positive regulation of phagocytosis |
| GO:0007265 | 0.00374 | 1.80802 | 16 | 28 | 448 | Ras protein signal transduction |
| GO:0033003 | 0.00381 | 4.46716 | 2 | 6 | 42 | regulation of mast cell activation |
| GO:0001550 | 0.00383 | 53.39169 | 0 | 2 | 3 | ovarian cumulus expansion |
| GO:0002266 | 0.00383 | 53.39169 | 0 | 2 | 3 | follicular dendritic cell activation |
| GO:0006982 | 0.00383 | 53.39169 | 0 | 2 | 3 | response to lipid hydroperoxide |
| GO:0015820 | 0.00383 | 53.39169 | 0 | 2 | 3 | leucine transport |
| GO:0032765 | 0.00383 | 53.39169 | 0 | 2 | 3 | positive regulation of mast cell cytokine production |
| GO:0035938 | 0.00383 | 53.39169 | 0 | 2 | 3 | estradiol secretion |
| GO:0048165 | 0.00383 | 53.39169 | 0 | 2 | 3 | fused antrum stage |
| GO:0072138 | 0.00383 | 53.39169 | 0 | 2 | 3 | mesenchymal cell proliferation involved in ureteric bud development |
| GO:0097532 | 0.00383 | 53.39169 | 0 | 2 | 3 | stress response to acid chemical |
| GO:0097533 | 0.00383 | 53.39169 | 0 | 2 | 3 | cellular stress response to acid chemical |
| GO:1900623 | 0.00383 | 53.39169 | 0 | 2 | 3 | regulation of monocyte aggregation |
| GO:1900625 | 0.00383 | 53.39169 | 0 | 2 | 3 | positive regulation of monocyte aggregation |
| GO:1902226 | 0.00383 | 53.39169 | 0 | 2 | 3 | regulation of macrophage colony-stimulating factor signaling pathway |
| GO:1903971 | 0.00383 | 53.39169 | 0 | 2 | 3 | positive regulation of response to macrophage colony-stimulating factor |
| GO:1903974 | 0.00383 | 53.39169 | 0 | 2 | 3 | positive regulation of cellular response to macrophage colony-stimulating factor stimulus |
| GO:1904580 | 0.00383 | 53.39169 | 0 | 2 | 3 | regulation of intracellular mRNA localization |
| GO:1904582 | 0.00383 | 53.39169 | 0 | 2 | 3 | positive regulation of intracellular mRNA localization |
| GO:1905917 | 0.00383 | 53.39169 | 0 | 2 | 3 | positive regulation of cell differentiation involved in phenotypic switching |
| GO:1905932 | 0.00383 | 53.39169 | 0 | 2 | 3 | positive regulation of vascular smooth muscle cell differentiation involved in phenotypic switching |
| GO:2000864 | 0.00383 | 53.39169 | 0 | 2 | 3 | regulation of estradiol secretion |
| GO:0003333 | 0.00389 | 3.13972 | 3 | 9 | 86 | amino acid transmembrane transport |
| GO:0006919 | 0.00389 | 3.13972 | 3 | 9 | 86 | activation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0032760 | 0.00389 | 3.13972 | 3 | 9 | 86 | positive regulation of tumor necrosis factor production |
| GO:0070542 | 0.00389 | 3.13972 | 3 | 9 | 86 | response to fatty acid |
| GO:0006977 | 0.00393 | 3.83195 | 2 | 7 | 56 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest |
| GO:0090183 | 0.00393 | 3.83195 | 2 | 7 | 56 | regulation of kidney development |
| GO:0002440 | 0.00395 | 2.03191 | 10 | 20 | 286 | production of molecular mediator of immune response |
| GO:0001952 | 0.00396 | 2.73943 | 4 | 11 | 119 | regulation of cell-matrix adhesion |
| GO:0071229 | 0.00400 | 2.23596 | 8 | 16 | 209 | cellular response to acid chemical |
| GO:0043372 | 0.00412 | 5.35589 | 1 | 5 | 30 | positive regulation of CD4-positive, alpha-beta T cell differentiation |
| GO:0046640 | 0.00412 | 5.35589 | 1 | 5 | 30 | regulation of alpha-beta T cell proliferation |
| GO:0070997 | 0.00421 | 1.91489 | 13 | 23 | 348 | neuron death |
| GO:0001659 | 0.00422 | 2.37217 | 6 | 14 | 173 | temperature homeostasis |
| GO:0010544 | 0.00428 | 7.13452 | 1 | 4 | 19 | negative regulation of platelet activation |
| GO:0060252 | 0.00428 | 7.13452 | 1 | 4 | 19 | positive regulation of glial cell proliferation |
| GO:0071071 | 0.00428 | 7.13452 | 1 | 4 | 19 | regulation of phospholipid biosynthetic process |
| GO:0071243 | 0.00428 | 7.13452 | 1 | 4 | 19 | cellular response to arsenic-containing substance |
| GO:0098581 | 0.00428 | 7.13452 | 1 | 4 | 19 | detection of external biotic stimulus |
| GO:0006909 | 0.00428 | 1.88306 | 13 | 24 | 369 | phagocytosis |
| GO:0001953 | 0.00429 | 4.34619 | 2 | 6 | 43 | negative regulation of cell-matrix adhesion |
| GO:0042088 | 0.00429 | 4.34619 | 2 | 6 | 43 | T-helper 1 type immune response |
| GO:0045687 | 0.00429 | 4.34619 | 2 | 6 | 43 | positive regulation of glial cell differentiation |
| GO:0071364 | 0.00429 | 4.34619 | 2 | 6 | 43 | cellular response to epidermal growth factor stimulus |
| GO:1901136 | 0.00434 | 2.28429 | 7 | 15 | 192 | carbohydrate derivative catabolic process |
| GO:0051055 | 0.00434 | 3.75510 | 2 | 7 | 57 | negative regulation of lipid biosynthetic process |
| GO:0072431 | 0.00434 | 3.75510 | 2 | 7 | 57 | signal transduction involved in mitotic G1 DNA damage checkpoint |
| GO:1902400 | 0.00434 | 3.75510 | 2 | 7 | 57 | intracellular signal transduction involved in G1 DNA damage checkpoint |
| GO:0061008 | 0.00441 | 2.56282 | 5 | 12 | 138 | hepaticobiliary system development |
| GO:0002532 | 0.00441 | 3.35516 | 3 | 8 | 72 | production of molecular mediator involved in inflammatory response |
| GO:0014812 | 0.00444 | 2.85924 | 4 | 10 | 104 | muscle cell migration |
| GO:0071887 | 0.00444 | 2.85924 | 4 | 10 | 104 | leukocyte apoptotic process |
| GO:0001704 | 0.00449 | 2.68932 | 4 | 11 | 121 | formation of primary germ layer |
| GO:0070098 | 0.00454 | 3.05989 | 3 | 9 | 88 | chemokine-mediated signaling pathway |
| GO:1903557 | 0.00454 | 3.05989 | 3 | 9 | 88 | positive regulation of tumor necrosis factor superfamily cytokine production |
| GO:0002291 | 0.00469 | 11.45426 | 0 | 3 | 10 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
| GO:0015801 | 0.00469 | 11.45426 | 0 | 3 | 10 | aromatic amino acid transport |
| GO:0033690 | 0.00469 | 11.45426 | 0 | 3 | 10 | positive regulation of osteoblast proliferation |
| GO:0072531 | 0.00469 | 11.45426 | 0 | 3 | 10 | pyrimidine-containing compound transmembrane transport |
| GO:0090557 | 0.00469 | 11.45426 | 0 | 3 | 10 | establishment of endothelial intestinal barrier |
| GO:0106049 | 0.00469 | 11.45426 | 0 | 3 | 10 | regulation of cellular response to osmotic stress |
| GO:0002821 | 0.00476 | 2.82899 | 4 | 10 | 105 | positive regulation of adaptive immune response |
| GO:0070306 | 0.00477 | 5.14960 | 1 | 5 | 31 | lens fiber cell differentiation |
| GO:0000302 | 0.00477 | 2.13320 | 8 | 17 | 232 | response to reactive oxygen species |
| GO:0042445 | 0.00477 | 2.13320 | 8 | 17 | 232 | hormone metabolic process |
| GO:0034101 | 0.00478 | 2.66495 | 4 | 11 | 122 | erythrocyte homeostasis |
| GO:1903409 | 0.00478 | 2.66495 | 4 | 11 | 122 | reactive oxygen species biosynthetic process |
| GO:0070266 | 0.00482 | 4.23158 | 2 | 6 | 44 | necroptotic process |
| GO:1903573 | 0.00482 | 4.23158 | 2 | 6 | 44 | negative regulation of response to endoplasmic reticulum stress |
| GO:0002449 | 0.00483 | 1.89118 | 13 | 23 | 352 | lymphocyte mediated immunity |
| GO:0001936 | 0.00491 | 2.32785 | 6 | 14 | 176 | regulation of endothelial cell proliferation |
| GO:0046330 | 0.00494 | 2.52250 | 5 | 12 | 140 | positive regulation of JNK cascade |
| GO:0001558 | 0.00509 | 1.80554 | 15 | 26 | 416 | regulation of cell growth |
| GO:1901214 | 0.00514 | 1.94365 | 11 | 21 | 313 | regulation of neuron death |
| GO:0002250 | 0.00515 | 1.61766 | 25 | 38 | 677 | adaptive immune response |
| GO:0032495 | 0.00520 | 6.68824 | 1 | 4 | 20 | response to muramyl dipeptide |
| GO:0034143 | 0.00520 | 6.68824 | 1 | 4 | 20 | regulation of toll-like receptor 4 signaling pathway |
| GO:0062012 | 0.00520 | 1.76078 | 17 | 28 | 459 | regulation of small molecule metabolic process |
| GO:0051145 | 0.00521 | 3.25313 | 3 | 8 | 74 | smooth muscle cell differentiation |
| GO:1903671 | 0.00521 | 3.25313 | 3 | 8 | 74 | negative regulation of sprouting angiogenesis |
| GO:0030336 | 0.00526 | 1.90643 | 12 | 22 | 334 | negative regulation of cell migration |
| GO:0010656 | 0.00527 | 3.61027 | 2 | 7 | 59 | negative regulation of muscle cell apoptotic process |
| GO:0072413 | 0.00527 | 3.61027 | 2 | 7 | 59 | signal transduction involved in mitotic cell cycle checkpoint |
| GO:0097755 | 0.00527 | 3.61027 | 2 | 7 | 59 | positive regulation of blood vessel diameter |
| GO:1902402 | 0.00527 | 3.61027 | 2 | 7 | 59 | signal transduction involved in mitotic DNA damage checkpoint |
| GO:1902403 | 0.00527 | 3.61027 | 2 | 7 | 59 | signal transduction involved in mitotic DNA integrity checkpoint |
| GO:1901566 | 0.00527 | 1.36240 | 71 | 92 | 1957 | organonitrogen compound biosynthetic process |
| GO:0032570 | 0.00539 | 4.12285 | 2 | 6 | 45 | response to progesterone |
| GO:0002699 | 0.00549 | 2.15685 | 8 | 16 | 216 | positive regulation of immune effector process |
| GO:0045589 | 0.00549 | 4.95860 | 1 | 5 | 32 | regulation of regulatory T cell differentiation |
| GO:0046685 | 0.00549 | 4.95860 | 1 | 5 | 32 | response to arsenic-containing substance |
| GO:0050779 | 0.00549 | 4.95860 | 1 | 5 | 32 | RNA destabilization |
| GO:0055094 | 0.00549 | 4.95860 | 1 | 5 | 32 | response to lipoprotein particle |
| GO:1902235 | 0.00549 | 4.95860 | 1 | 5 | 32 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway |
| GO:1904467 | 0.00549 | 4.95860 | 1 | 5 | 32 | regulation of tumor necrosis factor secretion |
| GO:0050871 | 0.00553 | 2.48341 | 5 | 12 | 142 | positive regulation of B cell activation |
| GO:0033036 | 0.00559 | 1.29338 | 113 | 138 | 3116 | macromolecule localization |
| GO:0007422 | 0.00565 | 3.20440 | 3 | 8 | 75 | peripheral nervous system development |
| GO:0014909 | 0.00566 | 2.94745 | 3 | 9 | 91 | smooth muscle cell migration |
| GO:0045638 | 0.00566 | 2.94745 | 3 | 9 | 91 | negative regulation of myeloid cell differentiation |
| GO:0050851 | 0.00572 | 1.92356 | 11 | 21 | 316 | antigen receptor-mediated signaling pathway |
| GO:0007611 | 0.00574 | 2.04087 | 9 | 18 | 256 | learning or memory |
| GO:0045576 | 0.00578 | 3.54195 | 2 | 7 | 60 | mast cell activation |
| GO:0106106 | 0.00584 | 2.46432 | 5 | 12 | 143 | cold-induced thermogenesis |
| GO:0120161 | 0.00584 | 2.46432 | 5 | 12 | 143 | regulation of cold-induced thermogenesis |
| GO:1990928 | 0.00602 | 4.01955 | 2 | 6 | 46 | response to amino acid starvation |
| GO:0051056 | 0.00603 | 1.88188 | 12 | 22 | 338 | regulation of small GTPase mediated signal transduction |
| GO:0010817 | 0.00603 | 1.68854 | 19 | 31 | 529 | regulation of hormone levels |
| GO:0045833 | 0.00608 | 2.91178 | 3 | 9 | 92 | negative regulation of lipid metabolic process |
| GO:0042310 | 0.00613 | 3.15710 | 3 | 8 | 76 | vasoconstriction |
| GO:0051607 | 0.00613 | 2.07459 | 9 | 17 | 238 | defense response to virus |
| GO:0051149 | 0.00619 | 2.71408 | 4 | 10 | 109 | positive regulation of muscle cell differentiation |
| GO:0002758 | 0.00620 | 1.94288 | 11 | 20 | 298 | innate immune response-activating signal transduction |
| GO:0010893 | 0.00624 | 6.29447 | 1 | 4 | 21 | positive regulation of steroid biosynthetic process |
| GO:0032682 | 0.00624 | 6.29447 | 1 | 4 | 21 | negative regulation of chemokine production |
| GO:0032986 | 0.00624 | 6.29447 | 1 | 4 | 21 | protein-DNA complex disassembly |
| GO:0071498 | 0.00624 | 6.29447 | 1 | 4 | 21 | cellular response to fluid shear stress |
| GO:1904469 | 0.00624 | 6.29447 | 1 | 4 | 21 | positive regulation of tumor necrosis factor secretion |
| GO:0000185 | 0.00627 | 10.02192 | 0 | 3 | 11 | activation of MAPKKK activity |
| GO:0002604 | 0.00627 | 10.02192 | 0 | 3 | 11 | regulation of dendritic cell antigen processing and presentation |
| GO:0002887 | 0.00627 | 10.02192 | 0 | 3 | 11 | negative regulation of myeloid leukocyte mediated immunity |
| GO:0019852 | 0.00627 | 10.02192 | 0 | 3 | 11 | L-ascorbic acid metabolic process |
| GO:0032490 | 0.00627 | 10.02192 | 0 | 3 | 11 | detection of molecule of bacterial origin |
| GO:0034115 | 0.00627 | 10.02192 | 0 | 3 | 11 | negative regulation of heterotypic cell-cell adhesion |
| GO:0035739 | 0.00627 | 10.02192 | 0 | 3 | 11 | CD4-positive, alpha-beta T cell proliferation |
| GO:0043117 | 0.00627 | 10.02192 | 0 | 3 | 11 | positive regulation of vascular permeability |
| GO:0043129 | 0.00627 | 10.02192 | 0 | 3 | 11 | surfactant homeostasis |
| GO:0046886 | 0.00627 | 10.02192 | 0 | 3 | 11 | positive regulation of hormone biosynthetic process |
| GO:0051024 | 0.00627 | 10.02192 | 0 | 3 | 11 | positive regulation of immunoglobulin secretion |
| GO:0055091 | 0.00627 | 10.02192 | 0 | 3 | 11 | phospholipid homeostasis |
| GO:0070587 | 0.00627 | 10.02192 | 0 | 3 | 11 | regulation of cell-cell adhesion involved in gastrulation |
| GO:1990440 | 0.00627 | 10.02192 | 0 | 3 | 11 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress |
| GO:2000561 | 0.00627 | 10.02192 | 0 | 3 | 11 | regulation of CD4-positive, alpha-beta T cell proliferation |
| GO:0036003 | 0.00628 | 4.78124 | 1 | 5 | 33 | positive regulation of transcription from RNA polymerase II promoter in response to stress |
| GO:0046633 | 0.00628 | 4.78124 | 1 | 5 | 33 | alpha-beta T cell proliferation |
| GO:2000352 | 0.00628 | 4.78124 | 1 | 5 | 33 | negative regulation of endothelial cell apoptotic process |
| GO:0003170 | 0.00633 | 3.47617 | 2 | 7 | 61 | heart valve development |
| GO:2001244 | 0.00633 | 3.47617 | 2 | 7 | 61 | positive regulation of intrinsic apoptotic signaling pathway |
| GO:0000082 | 0.00647 | 1.97252 | 10 | 19 | 279 | G1/S transition of mitotic cell cycle |
| GO:0006417 | 0.00649 | 1.76844 | 15 | 26 | 424 | regulation of translation |
| GO:0007612 | 0.00652 | 2.42699 | 5 | 12 | 145 | learning |
| GO:0002703 | 0.00658 | 2.17266 | 7 | 15 | 201 | regulation of leukocyte mediated immunity |
| GO:0032481 | 0.00662 | 3.11117 | 3 | 8 | 77 | positive regulation of type I interferon production |
| GO:0014911 | 0.00669 | 3.92130 | 2 | 6 | 47 | positive regulation of smooth muscle cell migration |
| GO:0070849 | 0.00669 | 3.92130 | 2 | 6 | 47 | response to epidermal growth factor |
| GO:0031329 | 0.00676 | 1.51953 | 32 | 46 | 871 | regulation of cellular catabolic process |
| GO:0072507 | 0.00703 | 1.68365 | 19 | 30 | 513 | divalent inorganic cation homeostasis |
| GO:0060562 | 0.00703 | 1.88457 | 12 | 21 | 322 | epithelial tube morphogenesis |
| GO:0007435 | 0.00715 | 4.61612 | 1 | 5 | 34 | salivary gland morphogenesis |
| GO:0032660 | 0.00715 | 4.61612 | 1 | 5 | 34 | regulation of interleukin-17 production |
| GO:0045066 | 0.00715 | 4.61612 | 1 | 5 | 34 | regulatory T cell differentiation |
| GO:0010827 | 0.00715 | 3.06655 | 3 | 8 | 78 | regulation of glucose transmembrane transport |
| GO:0014743 | 0.00715 | 3.06655 | 3 | 8 | 78 | regulation of muscle hypertrophy |
| GO:0055021 | 0.00715 | 3.06655 | 3 | 8 | 78 | regulation of cardiac muscle tissue growth |
| GO:0010466 | 0.00724 | 1.99001 | 9 | 18 | 262 | negative regulation of peptidase activity |
| GO:0072503 | 0.00737 | 1.69339 | 18 | 29 | 493 | cellular divalent inorganic cation homeostasis |
| GO:0035024 | 0.00741 | 5.94444 | 1 | 4 | 22 | negative regulation of Rho protein signal transduction |
| GO:0035584 | 0.00741 | 5.94444 | 1 | 4 | 22 | calcium-mediated signaling using intracellular calcium source |
| GO:0044342 | 0.00741 | 5.94444 | 1 | 4 | 22 | type B pancreatic cell proliferation |
| GO:0045117 | 0.00741 | 5.94444 | 1 | 4 | 22 | azole transport |
| GO:0060547 | 0.00741 | 5.94444 | 1 | 4 | 22 | negative regulation of necrotic cell death |
| GO:1903077 | 0.00741 | 5.94444 | 1 | 4 | 22 | negative regulation of protein localization to plasma membrane |
| GO:2000773 | 0.00741 | 5.94444 | 1 | 4 | 22 | negative regulation of cellular senescence |
| GO:0002762 | 0.00742 | 3.82772 | 2 | 6 | 48 | negative regulation of myeloid leukocyte differentiation |
| GO:0035272 | 0.00742 | 3.82772 | 2 | 6 | 48 | exocrine system development |
| GO:0072604 | 0.00742 | 3.82772 | 2 | 6 | 48 | interleukin-6 secretion |
| GO:0060419 | 0.00746 | 2.63381 | 4 | 10 | 112 | heart growth |
| GO:0045069 | 0.00748 | 2.80973 | 3 | 9 | 95 | regulation of viral genome replication |
| GO:0060337 | 0.00748 | 2.80973 | 3 | 9 | 95 | type I interferon signaling pathway |
| GO:0071357 | 0.00748 | 2.80973 | 3 | 9 | 95 | cellular response to type I interferon |
| GO:0001922 | 0.00748 | 26.69436 | 0 | 2 | 4 | B-1 B cell homeostasis |
| GO:0002528 | 0.00748 | 26.69436 | 0 | 2 | 4 | regulation of vascular permeability involved in acute inflammatory response |
| GO:0002605 | 0.00748 | 26.69436 | 0 | 2 | 4 | negative regulation of dendritic cell antigen processing and presentation |
| GO:0002677 | 0.00748 | 26.69436 | 0 | 2 | 4 | negative regulation of chronic inflammatory response |
| GO:0003332 | 0.00748 | 26.69436 | 0 | 2 | 4 | negative regulation of extracellular matrix constituent secretion |
| GO:0006598 | 0.00748 | 26.69436 | 0 | 2 | 4 | polyamine catabolic process |
| GO:0007598 | 0.00748 | 26.69436 | 0 | 2 | 4 | blood coagulation, extrinsic pathway |
| GO:0014028 | 0.00748 | 26.69436 | 0 | 2 | 4 | notochord formation |
| GO:0015827 | 0.00748 | 26.69436 | 0 | 2 | 4 | tryptophan transport |
| GO:0036337 | 0.00748 | 26.69436 | 0 | 2 | 4 | Fas signaling pathway |
| GO:0038165 | 0.00748 | 26.69436 | 0 | 2 | 4 | oncostatin-M-mediated signaling pathway |
| GO:0038189 | 0.00748 | 26.69436 | 0 | 2 | 4 | neuropilin signaling pathway |
| GO:0045082 | 0.00748 | 26.69436 | 0 | 2 | 4 | positive regulation of interleukin-10 biosynthetic process |
| GO:0046136 | 0.00748 | 26.69436 | 0 | 2 | 4 | positive regulation of vitamin metabolic process |
| GO:0050748 | 0.00748 | 26.69436 | 0 | 2 | 4 | negative regulation of lipoprotein metabolic process |
| GO:0060708 | 0.00748 | 26.69436 | 0 | 2 | 4 | spongiotrophoblast differentiation |
| GO:0061209 | 0.00748 | 26.69436 | 0 | 2 | 4 | cell proliferation involved in mesonephros development |
| GO:0061709 | 0.00748 | 26.69436 | 0 | 2 | 4 | reticulophagy |
| GO:0070427 | 0.00748 | 26.69436 | 0 | 2 | 4 | nucleotide-binding oligomerization domain containing 1 signaling pathway |
| GO:0071934 | 0.00748 | 26.69436 | 0 | 2 | 4 | thiamine transmembrane transport |
| GO:0097056 | 0.00748 | 26.69436 | 0 | 2 | 4 | selenocysteinyl-tRNA(Sec) biosynthetic process |
| GO:1903348 | 0.00748 | 26.69436 | 0 | 2 | 4 | positive regulation of bicellular tight junction assembly |
| GO:1903487 | 0.00748 | 26.69436 | 0 | 2 | 4 | regulation of lactation |
| GO:1990834 | 0.00748 | 26.69436 | 0 | 2 | 4 | response to odorant |
| GO:2000587 | 0.00748 | 26.69436 | 0 | 2 | 4 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway |
| GO:0035265 | 0.00751 | 2.13781 | 7 | 15 | 204 | organ growth |
| GO:0031571 | 0.00755 | 3.35164 | 2 | 7 | 63 | mitotic G1 DNA damage checkpoint |
| GO:0044819 | 0.00755 | 3.35164 | 2 | 7 | 63 | mitotic G1/S transition checkpoint |
| GO:0051896 | 0.00780 | 2.01907 | 9 | 17 | 244 | regulation of protein kinase B signaling |
| GO:0043200 | 0.00793 | 2.60809 | 4 | 10 | 113 | response to amino acid |
| GO:0010660 | 0.00799 | 2.77728 | 3 | 9 | 96 | regulation of muscle cell apoptotic process |
| GO:1990823 | 0.00799 | 2.77728 | 3 | 9 | 96 | response to leukemia inhibitory factor |
| GO:1990830 | 0.00799 | 2.77728 | 3 | 9 | 96 | cellular response to leukemia inhibitory factor |
| GO:0034142 | 0.00809 | 4.46200 | 1 | 5 | 35 | toll-like receptor 4 signaling pathway |
| GO:0042092 | 0.00809 | 4.46200 | 1 | 5 | 35 | type 2 immune response |
| GO:1990774 | 0.00809 | 4.46200 | 1 | 5 | 35 | tumor necrosis factor secretion |
| GO:0002468 | 0.00814 | 8.90788 | 0 | 3 | 12 | dendritic cell antigen processing and presentation |
| GO:0015697 | 0.00814 | 8.90788 | 0 | 3 | 12 | quaternary ammonium group transport |
| GO:0016045 | 0.00814 | 8.90788 | 0 | 3 | 12 | detection of bacterium |
| GO:0035630 | 0.00814 | 8.90788 | 0 | 3 | 12 | bone mineralization involved in bone maturation |
| GO:0045579 | 0.00814 | 8.90788 | 0 | 3 | 12 | positive regulation of B cell differentiation |
| GO:0060707 | 0.00814 | 8.90788 | 0 | 3 | 12 | trophoblast giant cell differentiation |
| GO:0070586 | 0.00814 | 8.90788 | 0 | 3 | 12 | cell-cell adhesion involved in gastrulation |
| GO:0071639 | 0.00814 | 8.90788 | 0 | 3 | 12 | positive regulation of monocyte chemotactic protein-1 production |
| GO:0072540 | 0.00814 | 8.90788 | 0 | 3 | 12 | T-helper 17 cell lineage commitment |
| GO:1904181 | 0.00814 | 8.90788 | 0 | 3 | 12 | positive regulation of membrane depolarization |
| GO:0002686 | 0.00820 | 3.73849 | 2 | 6 | 49 | negative regulation of leukocyte migration |
| GO:0002704 | 0.00820 | 3.73849 | 2 | 6 | 49 | negative regulation of leukocyte mediated immunity |
| GO:0032757 | 0.00820 | 3.73849 | 2 | 6 | 49 | positive regulation of interleukin-8 production |
| GO:0097300 | 0.00820 | 3.73849 | 2 | 6 | 49 | programmed necrotic cell death |
| GO:0044783 | 0.00822 | 3.29266 | 2 | 7 | 64 | G1 DNA damage checkpoint |
| GO:0045669 | 0.00822 | 3.29266 | 2 | 7 | 64 | positive regulation of osteoblast differentiation |
| GO:0060135 | 0.00822 | 3.29266 | 2 | 7 | 64 | maternal process involved in female pregnancy |
| GO:0044281 | 0.00829 | 1.32629 | 77 | 97 | 2115 | small molecule metabolic process |
| GO:0048598 | 0.00837 | 1.61864 | 21 | 33 | 586 | embryonic morphogenesis |
| GO:0030282 | 0.00842 | 2.58287 | 4 | 10 | 114 | bone mineralization |
| GO:0030316 | 0.00854 | 2.74557 | 4 | 9 | 97 | osteoclast differentiation |
| GO:1902882 | 0.00854 | 2.74557 | 4 | 9 | 97 | regulation of response to oxidative stress |
| GO:0022414 | 0.00856 | 1.39033 | 52 | 69 | 1429 | reproductive process |
| GO:1901361 | 0.00859 | 1.54235 | 27 | 40 | 745 | organic cyclic compound catabolic process |
| GO:2000146 | 0.00864 | 1.81744 | 13 | 22 | 349 | negative regulation of cell motility |
| GO:0009595 | 0.00871 | 5.63127 | 1 | 4 | 23 | detection of biotic stimulus |
| GO:0016338 | 0.00871 | 5.63127 | 1 | 4 | 23 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules |
| GO:0032703 | 0.00871 | 5.63127 | 1 | 4 | 23 | negative regulation of interleukin-2 production |
| GO:0034123 | 0.00871 | 5.63127 | 1 | 4 | 23 | positive regulation of toll-like receptor signaling pathway |
| GO:0036037 | 0.00871 | 5.63127 | 1 | 4 | 23 | CD8-positive, alpha-beta T cell activation |
| GO:0060445 | 0.00871 | 5.63127 | 1 | 4 | 23 | branching involved in salivary gland morphogenesis |
| GO:0006629 | 0.00885 | 1.39114 | 51 | 68 | 1407 | lipid metabolic process |
| GO:0032963 | 0.00893 | 2.55813 | 4 | 10 | 115 | collagen metabolic process |
| GO:0110110 | 0.00893 | 2.94004 | 3 | 8 | 81 | positive regulation of animal organ morphogenesis |
| GO:0000003 | 0.00896 | 1.38702 | 52 | 69 | 1432 | reproduction |
| GO:0010171 | 0.00904 | 3.65332 | 2 | 6 | 50 | body morphogenesis |
| GO:0032608 | 0.00904 | 3.65332 | 2 | 6 | 50 | interferon-beta production |
| GO:0043433 | 0.00904 | 2.22768 | 6 | 13 | 170 | negative regulation of DNA-binding transcription factor activity |
| GO:0010573 | 0.00912 | 4.31782 | 1 | 5 | 36 | vascular endothelial growth factor production |
| GO:0030947 | 0.00912 | 4.31782 | 1 | 5 | 36 | regulation of vascular endothelial growth factor receptor signaling pathway |
| GO:0060428 | 0.00912 | 4.31782 | 1 | 5 | 36 | lung epithelium development |
| GO:0044057 | 0.00934 | 1.59290 | 22 | 34 | 613 | regulation of system process |
| GO:0016202 | 0.00935 | 2.30473 | 6 | 12 | 152 | regulation of striated muscle tissue development |
| GO:1901575 | 0.00941 | 1.31559 | 79 | 99 | 2175 | organic substance catabolic process |
| GO:0006766 | 0.00952 | 2.40334 | 5 | 11 | 134 | vitamin metabolic process |
| GO:0042063 | 0.00959 | 1.89128 | 11 | 19 | 290 | gliogenesis |
| GO:0006855 | 0.00960 | 2.90015 | 3 | 8 | 82 | drug transmembrane transport |
| GO:0043523 | 0.00968 | 2.07134 | 8 | 15 | 210 | regulation of neuron apoptotic process |
| GO:0034340 | 0.00971 | 2.68426 | 4 | 9 | 99 | response to type I interferon |
| GO:0070301 | 0.00971 | 2.68426 | 4 | 9 | 99 | cellular response to hydrogen peroxide |
| GO:0045927 | 0.00973 | 1.92597 | 10 | 18 | 270 | positive regulation of growth |
| GO:0034250 | 0.00983 | 2.28826 | 6 | 12 | 153 | positive regulation of cellular amide metabolic process |
| GO:0048146 | 0.00994 | 3.57194 | 2 | 6 | 51 | positive regulation of fibroblast proliferation |
| GO:0040013 | 0.00995 | 1.74372 | 14 | 24 | 396 | negative regulation of locomotion |
| GO:0050921 | 0.01003 | 2.38382 | 5 | 11 | 135 | positive regulation of chemotaxis |
| GO:0045603 | 0.01016 | 5.34940 | 1 | 4 | 24 | positive regulation of endothelial cell differentiation |
| GO:0046426 | 0.01016 | 5.34940 | 1 | 4 | 24 | negative regulation of JAK-STAT cascade |
| GO:0046639 | 0.01016 | 5.34940 | 1 | 4 | 24 | negative regulation of alpha-beta T cell differentiation |
| GO:0050857 | 0.01016 | 5.34940 | 1 | 4 | 24 | positive regulation of antigen receptor-mediated signaling pathway |
| GO:1904376 | 0.01016 | 5.34940 | 1 | 4 | 24 | negative regulation of protein localization to cell periphery |
| GO:0045637 | 0.01017 | 1.95790 | 9 | 17 | 251 | regulation of myeloid cell differentiation |
| GO:0030212 | 0.01024 | 4.18266 | 1 | 5 | 37 | hyaluronan metabolic process |
| GO:0034405 | 0.01024 | 4.18266 | 1 | 5 | 37 | response to fluid shear stress |
| GO:0050691 | 0.01024 | 4.18266 | 1 | 5 | 37 | regulation of defense response to virus by host |
| GO:1903432 | 0.01024 | 4.18266 | 1 | 5 | 37 | regulation of TORC1 signaling |
| GO:0048145 | 0.01029 | 2.86132 | 3 | 8 | 83 | regulation of fibroblast proliferation |
| GO:2000106 | 0.01029 | 2.86132 | 3 | 8 | 83 | regulation of leukocyte apoptotic process |
| GO:0006596 | 0.01030 | 8.01664 | 0 | 3 | 13 | polyamine biosynthetic process |
| GO:0008298 | 0.01030 | 8.01664 | 0 | 3 | 13 | intracellular mRNA localization |
| GO:0010745 | 0.01030 | 8.01664 | 0 | 3 | 13 | negative regulation of macrophage derived foam cell differentiation |
| GO:0031650 | 0.01030 | 8.01664 | 0 | 3 | 13 | regulation of heat generation |
| GO:0031665 | 0.01030 | 8.01664 | 0 | 3 | 13 | negative regulation of lipopolysaccharide-mediated signaling pathway |
| GO:0032488 | 0.01030 | 8.01664 | 0 | 3 | 13 | Cdc42 protein signal transduction |
| GO:0042532 | 0.01030 | 8.01664 | 0 | 3 | 13 | negative regulation of tyrosine phosphorylation of STAT protein |
| GO:0043116 | 0.01030 | 8.01664 | 0 | 3 | 13 | negative regulation of vascular permeability |
| GO:0043301 | 0.01030 | 8.01664 | 0 | 3 | 13 | negative regulation of leukocyte degranulation |
| GO:0047484 | 0.01030 | 8.01664 | 0 | 3 | 13 | regulation of response to osmotic stress |
| GO:0048711 | 0.01030 | 8.01664 | 0 | 3 | 13 | positive regulation of astrocyte differentiation |
| GO:0048875 | 0.01030 | 8.01664 | 0 | 3 | 13 | chemical homeostasis within a tissue |
| GO:0051386 | 0.01030 | 8.01664 | 0 | 3 | 13 | regulation of neurotrophin TRK receptor signaling pathway |
| GO:0060312 | 0.01030 | 8.01664 | 0 | 3 | 13 | regulation of blood vessel remodeling |
| GO:0060576 | 0.01030 | 8.01664 | 0 | 3 | 13 | intestinal epithelial cell development |
| GO:0061029 | 0.01030 | 8.01664 | 0 | 3 | 13 | eyelid development in camera-type eye |
| GO:0061469 | 0.01030 | 8.01664 | 0 | 3 | 13 | regulation of type B pancreatic cell proliferation |
| GO:0070831 | 0.01030 | 8.01664 | 0 | 3 | 13 | basement membrane assembly |
| GO:0090677 | 0.01030 | 8.01664 | 0 | 3 | 13 | reversible differentiation |
| GO:1900103 | 0.01030 | 8.01664 | 0 | 3 | 13 | positive regulation of endoplasmic reticulum unfolded protein response |
| GO:1902713 | 0.01030 | 8.01664 | 0 | 3 | 13 | regulation of interferon-gamma secretion |
| GO:1990845 | 0.01032 | 2.27202 | 6 | 12 | 154 | adaptive thermogenesis |
| GO:0010657 | 0.01033 | 2.65461 | 4 | 9 | 100 | muscle cell apoptotic process |
| GO:0060840 | 0.01033 | 2.65461 | 4 | 9 | 100 | artery development |
| GO:0046580 | 0.01090 | 3.49409 | 2 | 6 | 52 | negative regulation of Ras protein signal transduction |
| GO:0060421 | 0.01090 | 3.49409 | 2 | 6 | 52 | positive regulation of heart growth |
| GO:0014910 | 0.01103 | 2.82351 | 3 | 8 | 84 | regulation of smooth muscle cell migration |
| GO:0048144 | 0.01103 | 2.82351 | 3 | 8 | 84 | fibroblast proliferation |
| GO:0010720 | 0.01103 | 1.60870 | 20 | 31 | 553 | positive regulation of cell development |
| GO:0016239 | 0.01134 | 3.07606 | 2 | 7 | 68 | positive regulation of macroautophagy |
| GO:0033627 | 0.01134 | 3.07606 | 2 | 7 | 68 | cell adhesion mediated by integrin |
| GO:0050891 | 0.01134 | 3.07606 | 2 | 7 | 68 | multicellular organismal water homeostasis |
| GO:0071230 | 0.01134 | 3.07606 | 2 | 7 | 68 | cellular response to amino acid stimulus |
| GO:0048634 | 0.01136 | 2.24021 | 6 | 12 | 156 | regulation of muscle organ development |
| GO:0032350 | 0.01145 | 4.05568 | 1 | 5 | 38 | regulation of hormone metabolic process |
| GO:0032620 | 0.01145 | 4.05568 | 1 | 5 | 38 | interleukin-17 production |
| GO:1905898 | 0.01145 | 4.05568 | 1 | 5 | 38 | positive regulation of response to endoplasmic reticulum stress |
| GO:0009987 | 0.01159 | 1.42222 | 614 | 631 | 16968 | cellular process |
| GO:2000379 | 0.01168 | 2.59723 | 4 | 9 | 102 | positive regulation of reactive oxygen species metabolic process |
| GO:2000377 | 0.01169 | 2.08127 | 7 | 14 | 195 | regulation of reactive oxygen species metabolic process |
| GO:0043604 | 0.01169 | 1.47291 | 32 | 45 | 876 | amide biosynthetic process |
| GO:0001945 | 0.01176 | 5.09439 | 1 | 4 | 25 | lymph vessel development |
| GO:0051894 | 0.01176 | 5.09439 | 1 | 4 | 25 | positive regulation of focal adhesion assembly |
| GO:0045930 | 0.01180 | 1.78783 | 12 | 21 | 338 | negative regulation of mitotic cell cycle |
| GO:0010810 | 0.01184 | 2.01899 | 8 | 15 | 215 | regulation of cell-substrate adhesion |
| GO:1901185 | 0.01193 | 3.41956 | 2 | 6 | 53 | negative regulation of ERBB signaling pathway |
| GO:0006710 | 0.01217 | 17.79525 | 0 | 2 | 5 | androgen catabolic process |
| GO:0014805 | 0.01217 | 17.79525 | 0 | 2 | 5 | smooth muscle adaptation |
| GO:0014900 | 0.01217 | 17.79525 | 0 | 2 | 5 | muscle hyperplasia |
| GO:0022614 | 0.01217 | 17.79525 | 0 | 2 | 5 | membrane to membrane docking |
| GO:0038033 | 0.01217 | 17.79525 | 0 | 2 | 5 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway |
| GO:0043435 | 0.01217 | 17.79525 | 0 | 2 | 5 | response to corticotropin-releasing hormone |
| GO:0045636 | 0.01217 | 17.79525 | 0 | 2 | 5 | positive regulation of melanocyte differentiation |
| GO:0061181 | 0.01217 | 17.79525 | 0 | 2 | 5 | regulation of chondrocyte development |
| GO:0071284 | 0.01217 | 17.79525 | 0 | 2 | 5 | cellular response to lead ion |
| GO:0071376 | 0.01217 | 17.79525 | 0 | 2 | 5 | cellular response to corticotropin-releasing hormone stimulus |
| GO:0090679 | 0.01217 | 17.79525 | 0 | 2 | 5 | cell differentiation involved in phenotypic switching |
| GO:1905076 | 0.01217 | 17.79525 | 0 | 2 | 5 | regulation of interleukin-17 secretion |
| GO:1905420 | 0.01217 | 17.79525 | 0 | 2 | 5 | vascular smooth muscle cell differentiation involved in phenotypic switching |
| GO:1905915 | 0.01217 | 17.79525 | 0 | 2 | 5 | regulation of cell differentiation involved in phenotypic switching |
| GO:1905930 | 0.01217 | 17.79525 | 0 | 2 | 5 | regulation of vascular smooth muscle cell differentiation involved in phenotypic switching |
| GO:2000504 | 0.01217 | 17.79525 | 0 | 2 | 5 | positive regulation of blood vessel remodeling |
| GO:2000563 | 0.01217 | 17.79525 | 0 | 2 | 5 | positive regulation of CD4-positive, alpha-beta T cell proliferation |
| GO:2000630 | 0.01217 | 17.79525 | 0 | 2 | 5 | positive regulation of miRNA metabolic process |
| GO:2000660 | 0.01217 | 17.79525 | 0 | 2 | 5 | negative regulation of interleukin-1-mediated signaling pathway |
| GO:2001245 | 0.01217 | 17.79525 | 0 | 2 | 5 | regulation of phosphatidylcholine biosynthetic process |
| GO:0002700 | 0.01232 | 2.30881 | 5 | 11 | 139 | regulation of production of molecular mediator of immune response |
| GO:0044843 | 0.01254 | 1.83622 | 11 | 19 | 298 | cell cycle G1/S phase transition |
| GO:0002218 | 0.01258 | 1.80429 | 12 | 20 | 319 | activation of innate immune response |
| GO:0007204 | 0.01258 | 1.80429 | 12 | 20 | 319 | positive regulation of cytosolic calcium ion concentration |
| GO:0042058 | 0.01261 | 2.75081 | 3 | 8 | 86 | regulation of epidermal growth factor receptor signaling pathway |
| GO:0042446 | 0.01261 | 2.75081 | 3 | 8 | 86 | hormone biosynthetic process |
| GO:0002251 | 0.01276 | 3.93618 | 1 | 5 | 39 | organ or tissue specific immune response |
| GO:1901998 | 0.01276 | 3.93618 | 1 | 5 | 39 | toxin transport |
| GO:0002523 | 0.01276 | 7.28745 | 1 | 3 | 14 | leukocyte migration involved in inflammatory response |
| GO:0007175 | 0.01276 | 7.28745 | 1 | 3 | 14 | negative regulation of epidermal growth factor-activated receptor activity |
| GO:0034356 | 0.01276 | 7.28745 | 1 | 3 | 14 | NAD biosynthesis via nicotinamide riboside salvage pathway |
| GO:0043374 | 0.01276 | 7.28745 | 1 | 3 | 14 | CD8-positive, alpha-beta T cell differentiation |
| GO:0045064 | 0.01276 | 7.28745 | 1 | 3 | 14 | T-helper 2 cell differentiation |
| GO:0045591 | 0.01276 | 7.28745 | 1 | 3 | 14 | positive regulation of regulatory T cell differentiation |
| GO:0045651 | 0.01276 | 7.28745 | 1 | 3 | 14 | positive regulation of macrophage differentiation |
| GO:0046033 | 0.01276 | 7.28745 | 1 | 3 | 14 | AMP metabolic process |
| GO:0050930 | 0.01276 | 7.28745 | 1 | 3 | 14 | induction of positive chemotaxis |
| GO:0070307 | 0.01276 | 7.28745 | 1 | 3 | 14 | lens fiber cell development |
| GO:0072216 | 0.01276 | 7.28745 | 1 | 3 | 14 | positive regulation of metanephros development |
| GO:0098543 | 0.01276 | 7.28745 | 1 | 3 | 14 | detection of other organism |
| GO:1901722 | 0.01276 | 7.28745 | 1 | 3 | 14 | regulation of cell proliferation involved in kidney development |
| GO:0050920 | 0.01280 | 1.99877 | 8 | 15 | 217 | regulation of chemotaxis |
| GO:0043547 | 0.01283 | 1.70166 | 15 | 24 | 405 | positive regulation of GTPase activity |
| GO:0035023 | 0.01295 | 2.29079 | 5 | 11 | 140 | regulation of Rho protein signal transduction |
| GO:0002720 | 0.01302 | 3.34813 | 2 | 6 | 54 | positive regulation of cytokine production involved in immune response |
| GO:0032655 | 0.01302 | 3.34813 | 2 | 6 | 54 | regulation of interleukin-12 production |
| GO:0043170 | 0.01309 | 1.19780 | 380 | 409 | 10507 | macromolecule metabolic process |
| GO:0090100 | 0.01316 | 2.54227 | 4 | 9 | 104 | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0002709 | 0.01318 | 2.97808 | 3 | 7 | 70 | regulation of T cell mediated immunity |
| GO:0045861 | 0.01321 | 1.74144 | 13 | 22 | 363 | negative regulation of proteolysis |
| GO:0031099 | 0.01322 | 2.04699 | 7 | 14 | 198 | regeneration |
| GO:0046578 | 0.01325 | 1.94070 | 9 | 16 | 238 | regulation of Ras protein signal transduction |
| GO:0019722 | 0.01331 | 1.98881 | 8 | 15 | 218 | calcium-mediated signaling |
| GO:0002360 | 0.01351 | 4.86255 | 1 | 4 | 26 | T cell lineage commitment |
| GO:0006700 | 0.01351 | 4.86255 | 1 | 4 | 26 | C21-steroid hormone biosynthetic process |
| GO:0030194 | 0.01351 | 4.86255 | 1 | 4 | 26 | positive regulation of blood coagulation |
| GO:0051497 | 0.01351 | 4.86255 | 1 | 4 | 26 | negative regulation of stress fiber assembly |
| GO:0060544 | 0.01351 | 4.86255 | 1 | 4 | 26 | regulation of necroptotic process |
| GO:1900048 | 0.01351 | 4.86255 | 1 | 4 | 26 | positive regulation of hemostasis |
| GO:2001235 | 0.01353 | 2.10584 | 6 | 13 | 179 | positive regulation of apoptotic signaling pathway |
| GO:0008286 | 0.01360 | 2.27304 | 5 | 11 | 141 | insulin receptor signaling pathway |
| GO:0048705 | 0.01375 | 1.93189 | 9 | 16 | 239 | skeletal system morphogenesis |
| GO:0051402 | 0.01375 | 1.93189 | 9 | 16 | 239 | neuron apoptotic process |
| GO:0009914 | 0.01381 | 1.78606 | 12 | 20 | 322 | hormone transport |
| GO:0001501 | 0.01388 | 1.60453 | 19 | 29 | 518 | skeletal system development |
| GO:0033138 | 0.01395 | 2.51565 | 4 | 9 | 105 | positive regulation of peptidyl-serine phosphorylation |
| GO:0002369 | 0.01415 | 3.82350 | 1 | 5 | 40 | T cell cytokine production |
| GO:0002823 | 0.01415 | 3.82350 | 1 | 5 | 40 | negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0042036 | 0.01415 | 3.82350 | 1 | 5 | 40 | negative regulation of cytokine biosynthetic process |
| GO:0051281 | 0.01415 | 3.82350 | 1 | 5 | 40 | positive regulation of release of sequestered calcium ion into cytosol |
| GO:0090184 | 0.01415 | 3.82350 | 1 | 5 | 40 | positive regulation of kidney development |
| GO:0009791 | 0.01435 | 2.68174 | 3 | 8 | 88 | post-embryonic development |
| GO:0050829 | 0.01435 | 2.68174 | 3 | 8 | 88 | defense response to Gram-negative bacterium |
| GO:0061097 | 0.01435 | 2.68174 | 3 | 8 | 88 | regulation of protein tyrosine kinase activity |
| GO:1900407 | 0.01435 | 2.68174 | 3 | 8 | 88 | regulation of cellular response to oxidative stress |
| GO:1903725 | 0.01435 | 2.68174 | 3 | 8 | 88 | regulation of phospholipid metabolic process |
| GO:0014066 | 0.01468 | 2.35499 | 4 | 10 | 124 | regulation of phosphatidylinositol 3-kinase signaling |
| GO:0051209 | 0.01468 | 2.35499 | 4 | 10 | 124 | release of sequestered calcium ion into cytosol |
| GO:0010565 | 0.01473 | 2.08053 | 7 | 13 | 181 | regulation of cellular ketone metabolic process |
| GO:0048015 | 0.01473 | 2.08053 | 7 | 13 | 181 | phosphatidylinositol-mediated signaling |
| GO:0002456 | 0.01477 | 2.48957 | 4 | 9 | 106 | T cell mediated immunity |
| GO:0044344 | 0.01499 | 2.23835 | 5 | 11 | 143 | cellular response to fibroblast growth factor stimulus |
| GO:0034504 | 0.01504 | 1.86884 | 9 | 17 | 262 | protein localization to nucleus |
| GO:0032615 | 0.01541 | 3.21385 | 2 | 6 | 56 | interleukin-12 production |
| GO:1903202 | 0.01541 | 3.21385 | 2 | 6 | 56 | negative regulation of oxidative stress-induced cell death |
| GO:0002825 | 0.01541 | 4.65088 | 1 | 4 | 27 | regulation of T-helper 1 type immune response |
| GO:0006706 | 0.01541 | 4.65088 | 1 | 4 | 27 | steroid catabolic process |
| GO:0007176 | 0.01541 | 4.65088 | 1 | 4 | 27 | regulation of epidermal growth factor-activated receptor activity |
| GO:0009651 | 0.01541 | 4.65088 | 1 | 4 | 27 | response to salt stress |
| GO:0045932 | 0.01541 | 4.65088 | 1 | 4 | 27 | negative regulation of muscle contraction |
| GO:0046885 | 0.01541 | 4.65088 | 1 | 4 | 27 | regulation of hormone biosynthetic process |
| GO:0050820 | 0.01541 | 4.65088 | 1 | 4 | 27 | positive regulation of coagulation |
| GO:0017014 | 0.01553 | 6.67979 | 1 | 3 | 15 | protein nitrosylation |
| GO:0018119 | 0.01553 | 6.67979 | 1 | 3 | 15 | peptidyl-cysteine S-nitrosylation |
| GO:0034134 | 0.01553 | 6.67979 | 1 | 3 | 15 | toll-like receptor 2 signaling pathway |
| GO:0043584 | 0.01553 | 6.67979 | 1 | 3 | 15 | nose development |
| GO:0045073 | 0.01553 | 6.67979 | 1 | 3 | 15 | regulation of chemokine biosynthetic process |
| GO:0071474 | 0.01553 | 6.67979 | 1 | 3 | 15 | cellular hyperosmotic response |
| GO:1900239 | 0.01553 | 6.67979 | 1 | 3 | 15 | regulation of phenotypic switching |
| GO:1905065 | 0.01553 | 6.67979 | 1 | 3 | 15 | positive regulation of vascular smooth muscle cell differentiation |
| GO:2000402 | 0.01553 | 6.67979 | 1 | 3 | 15 | negative regulation of lymphocyte migration |
| GO:2001028 | 0.01553 | 6.67979 | 1 | 3 | 15 | positive regulation of endothelial cell chemotaxis |
| GO:0030890 | 0.01565 | 3.71709 | 1 | 5 | 41 | positive regulation of B cell proliferation |
| GO:1903053 | 0.01565 | 3.71709 | 1 | 5 | 41 | regulation of extracellular matrix organization |
| GO:0032479 | 0.01627 | 2.31412 | 5 | 10 | 126 | regulation of type I interferon production |
| GO:0051283 | 0.01627 | 2.31412 | 5 | 10 | 126 | negative regulation of sequestering of calcium ion |
| GO:0031100 | 0.01634 | 2.84223 | 3 | 7 | 73 | animal organ regeneration |
| GO:0045685 | 0.01634 | 2.84223 | 3 | 7 | 73 | regulation of glial cell differentiation |
| GO:0050688 | 0.01634 | 2.84223 | 3 | 7 | 73 | regulation of defense response to virus |
| GO:0072401 | 0.01634 | 2.84223 | 3 | 7 | 73 | signal transduction involved in DNA integrity checkpoint |
| GO:0072422 | 0.01634 | 2.84223 | 3 | 7 | 73 | signal transduction involved in DNA damage checkpoint |
| GO:1903524 | 0.01634 | 2.84223 | 3 | 7 | 73 | positive regulation of blood circulation |
| GO:0006821 | 0.01652 | 2.43901 | 4 | 9 | 108 | chloride transport |
| GO:0071156 | 0.01652 | 2.43901 | 4 | 9 | 108 | regulation of cell cycle arrest |
| GO:0055085 | 0.01659 | 1.32845 | 58 | 74 | 1598 | transmembrane transport |
| GO:0048699 | 0.01659 | 1.33598 | 55 | 71 | 1524 | generation of neurons |
| GO:0022008 | 0.01665 | 1.32579 | 59 | 75 | 1623 | neurogenesis |
| GO:0048017 | 0.01667 | 2.04369 | 7 | 13 | 184 | inositol lipid-mediated signaling |
| GO:0048639 | 0.01667 | 2.04369 | 7 | 13 | 184 | positive regulation of developmental growth |
| GO:0060043 | 0.01671 | 3.15066 | 2 | 6 | 57 | regulation of cardiac muscle cell proliferation |
| GO:0071398 | 0.01671 | 3.15066 | 2 | 6 | 57 | cellular response to fatty acid |
| GO:1900408 | 0.01671 | 3.15066 | 2 | 6 | 57 | negative regulation of cellular response to oxidative stress |
| GO:0042542 | 0.01725 | 2.18824 | 5 | 11 | 146 | response to hydrogen peroxide |
| GO:0045834 | 0.01725 | 2.18824 | 5 | 11 | 146 | positive regulation of lipid metabolic process |
| GO:0055123 | 0.01725 | 2.18824 | 5 | 11 | 146 | digestive system development |
| GO:1901031 | 0.01725 | 3.61643 | 2 | 5 | 42 | regulation of response to reactive oxygen species |
| GO:0045639 | 0.01729 | 2.58437 | 3 | 8 | 91 | positive regulation of myeloid cell differentiation |
| GO:0014897 | 0.01745 | 2.41448 | 4 | 9 | 109 | striated muscle hypertrophy |
| GO:0034698 | 0.01748 | 4.45685 | 1 | 4 | 28 | response to gonadotropin |
| GO:0035456 | 0.01748 | 4.45685 | 1 | 4 | 28 | response to interferon-beta |
| GO:0090344 | 0.01748 | 4.45685 | 1 | 4 | 28 | negative regulation of cell aging |
| GO:1904994 | 0.01748 | 4.45685 | 1 | 4 | 28 | regulation of leukocyte adhesion to vascular endothelial cell |
| GO:1905063 | 0.01748 | 4.45685 | 1 | 4 | 28 | regulation of vascular smooth muscle cell differentiation |
| GO:0031670 | 0.01750 | 2.79966 | 3 | 7 | 74 | cellular response to nutrient |
| GO:0032418 | 0.01750 | 2.79966 | 3 | 7 | 74 | lysosome localization |
| GO:0032677 | 0.01750 | 2.79966 | 3 | 7 | 74 | regulation of interleukin-8 production |
| GO:0072395 | 0.01750 | 2.79966 | 3 | 7 | 74 | signal transduction involved in cell cycle checkpoint |
| GO:0051098 | 0.01753 | 1.69087 | 14 | 22 | 373 | regulation of binding |
| GO:0014916 | 0.01782 | 13.34570 | 0 | 2 | 6 | regulation of lung blood pressure |
| GO:0015822 | 0.01782 | 13.34570 | 0 | 2 | 6 | ornithine transport |
| GO:0031394 | 0.01782 | 13.34570 | 0 | 2 | 6 | positive regulation of prostaglandin biosynthetic process |
| GO:0032792 | 0.01782 | 13.34570 | 0 | 2 | 6 | negative regulation of CREB transcription factor activity |
| GO:0032962 | 0.01782 | 13.34570 | 0 | 2 | 6 | positive regulation of inositol trisphosphate biosynthetic process |
| GO:0036018 | 0.01782 | 13.34570 | 0 | 2 | 6 | cellular response to erythropoietin |
| GO:0038145 | 0.01782 | 13.34570 | 0 | 2 | 6 | macrophage colony-stimulating factor signaling pathway |
| GO:0042091 | 0.01782 | 13.34570 | 0 | 2 | 6 | interleukin-10 biosynthetic process |
| GO:0043376 | 0.01782 | 13.34570 | 0 | 2 | 6 | regulation of CD8-positive, alpha-beta T cell differentiation |
| GO:0045074 | 0.01782 | 13.34570 | 0 | 2 | 6 | regulation of interleukin-10 biosynthetic process |
| GO:0045634 | 0.01782 | 13.34570 | 0 | 2 | 6 | regulation of melanocyte differentiation |
| GO:0070309 | 0.01782 | 13.34570 | 0 | 2 | 6 | lens fiber cell morphogenesis |
| GO:0071072 | 0.01782 | 13.34570 | 0 | 2 | 6 | negative regulation of phospholipid biosynthetic process |
| GO:0071839 | 0.01782 | 13.34570 | 0 | 2 | 6 | apoptotic process in bone marrow |
| GO:0090673 | 0.01782 | 13.34570 | 0 | 2 | 6 | endothelial cell-matrix adhesion |
| GO:0097283 | 0.01782 | 13.34570 | 0 | 2 | 6 | keratinocyte apoptotic process |
| GO:1900157 | 0.01782 | 13.34570 | 0 | 2 | 6 | regulation of bone mineralization involved in bone maturation |
| GO:1902022 | 0.01782 | 13.34570 | 0 | 2 | 6 | L-lysine transport |
| GO:1902172 | 0.01782 | 13.34570 | 0 | 2 | 6 | regulation of keratinocyte apoptotic process |
| GO:1903121 | 0.01782 | 13.34570 | 0 | 2 | 6 | regulation of TRAIL-activated apoptotic signaling pathway |
| GO:1903352 | 0.01782 | 13.34570 | 0 | 2 | 6 | L-ornithine transmembrane transport |
| GO:1903400 | 0.01782 | 13.34570 | 0 | 2 | 6 | L-arginine transmembrane transport |
| GO:1903401 | 0.01782 | 13.34570 | 0 | 2 | 6 | L-lysine transmembrane transport |
| GO:2001186 | 0.01782 | 13.34570 | 0 | 2 | 6 | negative regulation of CD8-positive, alpha-beta T cell activation |
| GO:0032606 | 0.01798 | 2.27465 | 5 | 10 | 128 | type I interferon production |
| GO:0051282 | 0.01798 | 2.27465 | 5 | 10 | 128 | regulation of sequestering of calcium ion |
| GO:0035904 | 0.01809 | 3.08990 | 2 | 6 | 58 | aorta development |
| GO:0051058 | 0.01809 | 3.08990 | 2 | 6 | 58 | negative regulation of small GTPase mediated signal transduction |
| GO:2000117 | 0.01836 | 2.55346 | 3 | 8 | 92 | negative regulation of cysteine-type endopeptidase activity |
| GO:0044283 | 0.01842 | 1.45217 | 29 | 41 | 807 | small molecule biosynthetic process |
| GO:0002295 | 0.01861 | 6.16562 | 1 | 3 | 16 | T-helper cell lineage commitment |
| GO:0010566 | 0.01861 | 6.16562 | 1 | 3 | 16 | regulation of ketone biosynthetic process |
| GO:0030214 | 0.01861 | 6.16562 | 1 | 3 | 16 | hyaluronan catabolic process |
| GO:0035461 | 0.01861 | 6.16562 | 1 | 3 | 16 | vitamin transmembrane transport |
| GO:0042033 | 0.01861 | 6.16562 | 1 | 3 | 16 | chemokine biosynthetic process |
| GO:0045986 | 0.01861 | 6.16562 | 1 | 3 | 16 | negative regulation of smooth muscle contraction |
| GO:0050755 | 0.01861 | 6.16562 | 1 | 3 | 16 | chemokine metabolic process |
| GO:0051238 | 0.01861 | 6.16562 | 1 | 3 | 16 | sequestering of metal ion |
| GO:0060965 | 0.01861 | 6.16562 | 1 | 3 | 16 | negative regulation of gene silencing by miRNA |
| GO:1902004 | 0.01861 | 6.16562 | 1 | 3 | 16 | positive regulation of amyloid-beta formation |
| GO:0010611 | 0.01872 | 2.75833 | 3 | 7 | 75 | regulation of cardiac muscle hypertrophy |
| GO:0046173 | 0.01872 | 2.75833 | 3 | 7 | 75 | polyol biosynthetic process |
| GO:1903201 | 0.01872 | 2.75833 | 3 | 7 | 75 | regulation of oxidative stress-induced cell death |
| GO:0001505 | 0.01887 | 1.70039 | 13 | 21 | 354 | regulation of neurotransmitter levels |
| GO:0014065 | 0.01890 | 2.15605 | 5 | 11 | 148 | phosphatidylinositol 3-kinase signaling |
| GO:0034198 | 0.01896 | 3.52106 | 2 | 5 | 43 | cellular response to amino acid starvation |
| GO:0038202 | 0.01896 | 3.52106 | 2 | 5 | 43 | TORC1 signaling |
| GO:0045429 | 0.01896 | 3.52106 | 2 | 5 | 43 | positive regulation of nitric oxide biosynthetic process |
| GO:0055026 | 0.01896 | 3.52106 | 2 | 5 | 43 | negative regulation of cardiac muscle tissue development |
| GO:0060612 | 0.01896 | 3.52106 | 2 | 5 | 43 | adipose tissue development |
| GO:0055114 | 0.01914 | 1.40209 | 36 | 49 | 999 | oxidation-reduction process |
| GO:0034614 | 0.01939 | 2.06650 | 6 | 12 | 168 | cellular response to reactive oxygen species |
| GO:0051302 | 0.01939 | 2.06650 | 6 | 12 | 168 | regulation of cell division |
| GO:0046879 | 0.01940 | 1.74710 | 11 | 19 | 312 | hormone secretion |
| GO:0014896 | 0.01942 | 2.36688 | 4 | 9 | 111 | muscle hypertrophy |
| GO:0031623 | 0.01942 | 2.36688 | 4 | 9 | 111 | receptor internalization |
| GO:1901184 | 0.01947 | 2.52328 | 3 | 8 | 93 | regulation of ERBB signaling pathway |
| GO:1901655 | 0.01947 | 2.52328 | 3 | 8 | 93 | cellular response to ketone |
| GO:0050792 | 0.01949 | 1.94039 | 8 | 14 | 208 | regulation of viral process |
| GO:0042130 | 0.01954 | 3.03143 | 2 | 6 | 59 | negative regulation of T cell proliferation |
| GO:0045843 | 0.01954 | 3.03143 | 2 | 6 | 59 | negative regulation of striated muscle tissue development |
| GO:1902883 | 0.01954 | 3.03143 | 2 | 6 | 59 | negative regulation of response to oxidative stress |
| GO:2000351 | 0.01954 | 3.03143 | 2 | 6 | 59 | regulation of endothelial cell apoptotic process |
| GO:0007263 | 0.01971 | 4.27833 | 1 | 4 | 29 | nitric oxide mediated signal transduction |
| GO:0010800 | 0.01971 | 4.27833 | 1 | 4 | 29 | positive regulation of peptidyl-threonine phosphorylation |
| GO:0032232 | 0.01971 | 4.27833 | 1 | 4 | 29 | negative regulation of actin filament bundle assembly |
| GO:0044788 | 0.01971 | 4.27833 | 1 | 4 | 29 | modulation by host of viral process |
| GO:0070102 | 0.01971 | 4.27833 | 1 | 4 | 29 | interleukin-6-mediated signaling pathway |
| GO:0072606 | 0.01971 | 4.27833 | 1 | 4 | 29 | interleukin-8 secretion |
| GO:0002706 | 0.01976 | 2.14031 | 5 | 11 | 149 | regulation of lymphocyte mediated immunity |
| GO:1903900 | 0.01976 | 2.14031 | 5 | 11 | 149 | regulation of viral life cycle |
| GO:0006959 | 0.01994 | 1.69005 | 13 | 21 | 356 | humoral immune response |
| GO:0048844 | 0.02000 | 2.71820 | 3 | 7 | 76 | artery morphogenesis |
| GO:0010951 | 0.02016 | 1.83994 | 9 | 16 | 250 | negative regulation of endopeptidase activity |
| GO:0071383 | 0.02016 | 1.83994 | 9 | 16 | 250 | cellular response to steroid hormone stimulus |
| GO:0090287 | 0.02016 | 1.76913 | 11 | 18 | 292 | regulation of cellular response to growth factor stimulus |
| GO:0060538 | 0.02021 | 2.05322 | 6 | 12 | 169 | skeletal muscle organ development |
| GO:1901617 | 0.02023 | 1.80170 | 10 | 17 | 271 | organic hydroxy compound biosynthetic process |
| GO:0002065 | 0.02047 | 2.34377 | 4 | 9 | 112 | columnar/cuboidal epithelial cell differentiation |
| GO:0003279 | 0.02047 | 2.34377 | 4 | 9 | 112 | cardiac septum development |
| GO:0042303 | 0.02047 | 2.34377 | 4 | 9 | 112 | molting cycle |
| GO:0042633 | 0.02047 | 2.34377 | 4 | 9 | 112 | hair cycle |
| GO:1901615 | 0.02051 | 1.54911 | 19 | 29 | 535 | organic hydroxy compound metabolic process |
| GO:0071774 | 0.02066 | 2.12479 | 5 | 11 | 150 | response to fibroblast growth factor |
| GO:0010463 | 0.02077 | 3.43059 | 2 | 5 | 44 | mesenchymal cell proliferation |
| GO:0032965 | 0.02077 | 3.43059 | 2 | 5 | 44 | regulation of collagen biosynthetic process |
| GO:1904407 | 0.02077 | 3.43059 | 2 | 5 | 44 | positive regulation of nitric oxide metabolic process |
| GO:0051146 | 0.02078 | 1.76260 | 11 | 18 | 293 | striated muscle cell differentiation |
| GO:0051208 | 0.02079 | 2.21788 | 5 | 10 | 131 | sequestering of calcium ion |
| GO:0048635 | 0.02107 | 2.97512 | 2 | 6 | 60 | negative regulation of muscle organ development |
| GO:0061448 | 0.02155 | 1.78743 | 10 | 17 | 273 | connective tissue development |
| GO:0055007 | 0.02180 | 2.19958 | 5 | 10 | 132 | cardiac muscle cell differentiation |
| GO:0002702 | 0.02184 | 2.46500 | 3 | 8 | 95 | positive regulation of production of molecular mediator of immune response |
| GO:0050810 | 0.02184 | 2.46500 | 3 | 8 | 95 | regulation of steroid biosynthetic process |
| GO:0006595 | 0.02200 | 5.72490 | 1 | 3 | 17 | polyamine metabolic process |
| GO:0030540 | 0.02200 | 5.72490 | 1 | 3 | 17 | female genitalia development |
| GO:0031649 | 0.02200 | 5.72490 | 1 | 3 | 17 | heat generation |
| GO:0032966 | 0.02200 | 5.72490 | 1 | 3 | 17 | negative regulation of collagen biosynthetic process |
| GO:0035313 | 0.02200 | 5.72490 | 1 | 3 | 17 | wound healing, spreading of epidermal cells |
| GO:0043373 | 0.02200 | 5.72490 | 1 | 3 | 17 | CD4-positive, alpha-beta T cell lineage commitment |
| GO:0071850 | 0.02200 | 5.72490 | 1 | 3 | 17 | mitotic cell cycle arrest |
| GO:1904996 | 0.02200 | 5.72490 | 1 | 3 | 17 | positive regulation of leukocyte adhesion to vascular endothelial cell |
| GO:2001267 | 0.02200 | 5.72490 | 1 | 3 | 17 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway |
| GO:0048511 | 0.02208 | 1.74967 | 11 | 18 | 295 | rhythmic process |
| GO:0010743 | 0.02211 | 4.11355 | 1 | 4 | 30 | regulation of macrophage derived foam cell differentiation |
| GO:0032728 | 0.02211 | 4.11355 | 1 | 4 | 30 | positive regulation of interferon-beta production |
| GO:0038111 | 0.02211 | 4.11355 | 1 | 4 | 30 | interleukin-7-mediated signaling pathway |
| GO:0045940 | 0.02211 | 4.11355 | 1 | 4 | 30 | positive regulation of steroid metabolic process |
| GO:0046596 | 0.02211 | 4.11355 | 1 | 4 | 30 | regulation of viral entry into host cell |
| GO:0061082 | 0.02211 | 4.11355 | 1 | 4 | 30 | myeloid leukocyte cytokine production |
| GO:0061157 | 0.02211 | 4.11355 | 1 | 4 | 30 | mRNA destabilization |
| GO:1904893 | 0.02211 | 4.11355 | 1 | 4 | 30 | negative regulation of STAT cascade |
| GO:1905476 | 0.02211 | 4.11355 | 1 | 4 | 30 | negative regulation of protein localization to membrane |
| GO:2000027 | 0.02225 | 1.81634 | 9 | 16 | 253 | regulation of animal organ morphogenesis |
| GO:0002688 | 0.02268 | 2.29886 | 4 | 9 | 114 | regulation of leukocyte chemotaxis |
| GO:0030218 | 0.02268 | 2.29886 | 4 | 9 | 114 | erythrocyte differentiation |
| GO:0010803 | 0.02268 | 2.92087 | 2 | 6 | 61 | regulation of tumor necrosis factor-mediated signaling pathway |
| GO:0045123 | 0.02268 | 2.92087 | 2 | 6 | 61 | cellular extravasation |
| GO:0090303 | 0.02268 | 2.92087 | 2 | 6 | 61 | positive regulation of wound healing |
| GO:1905953 | 0.02268 | 2.92087 | 2 | 6 | 61 | negative regulation of lipid localization |
| GO:0001974 | 0.02270 | 3.34463 | 2 | 5 | 45 | blood vessel remodeling |
| GO:0002820 | 0.02270 | 3.34463 | 2 | 5 | 45 | negative regulation of adaptive immune response |
| GO:0035987 | 0.02270 | 3.34463 | 2 | 5 | 45 | endodermal cell differentiation |
| GO:0042771 | 0.02270 | 3.34463 | 2 | 5 | 45 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
| GO:0031016 | 0.02274 | 2.64134 | 3 | 7 | 78 | pancreas development |
| GO:0070664 | 0.02274 | 2.64134 | 3 | 7 | 78 | negative regulation of leukocyte proliferation |
| GO:0090398 | 0.02274 | 2.64134 | 3 | 7 | 78 | cellular senescence |
| GO:1903313 | 0.02274 | 2.64134 | 3 | 7 | 78 | positive regulation of mRNA metabolic process |
| GO:0050890 | 0.02275 | 1.74328 | 11 | 18 | 296 | cognition |
| GO:0048738 | 0.02287 | 1.85041 | 8 | 15 | 233 | cardiac muscle tissue development |
| GO:0019752 | 0.02303 | 1.37108 | 39 | 52 | 1083 | carboxylic acid metabolic process |
| GO:0007267 | 0.02343 | 1.30093 | 60 | 75 | 1650 | cell-cell signaling |
| GO:1903522 | 0.02343 | 1.73693 | 11 | 18 | 297 | regulation of blood circulation |
| GO:0043603 | 0.02344 | 1.35760 | 42 | 55 | 1157 | cellular amide metabolic process |
| GO:0051271 | 0.02348 | 1.63847 | 14 | 22 | 384 | negative regulation of cellular component movement |
| GO:0016525 | 0.02376 | 2.00176 | 6 | 12 | 173 | negative regulation of angiogenesis |
| GO:0048565 | 0.02391 | 2.16386 | 5 | 10 | 134 | digestive tract development |
| GO:0050769 | 0.02393 | 1.56661 | 17 | 26 | 474 | positive regulation of neurogenesis |
| GO:0050767 | 0.02402 | 1.42304 | 30 | 41 | 822 | regulation of neurogenesis |
| GO:0007254 | 0.02420 | 1.88154 | 8 | 14 | 214 | JNK cascade |
| GO:0016051 | 0.02420 | 1.88154 | 8 | 14 | 214 | carbohydrate biosynthetic process |
| GO:0045732 | 0.02420 | 1.88154 | 8 | 14 | 214 | positive regulation of protein catabolic process |
| GO:0003151 | 0.02420 | 2.60451 | 3 | 7 | 79 | outflow tract morphogenesis |
| GO:0021675 | 0.02420 | 2.60451 | 3 | 7 | 79 | nerve development |
| GO:0006518 | 0.02427 | 1.40420 | 32 | 44 | 894 | peptide metabolic process |
| GO:0003330 | 0.02436 | 10.67596 | 0 | 2 | 7 | regulation of extracellular matrix constituent secretion |
| GO:0009445 | 0.02436 | 10.67596 | 0 | 2 | 7 | putrescine metabolic process |
| GO:0010046 | 0.02436 | 10.67596 | 0 | 2 | 7 | response to mycotoxin |
| GO:0022605 | 0.02436 | 10.67596 | 0 | 2 | 7 | mammalian oogenesis stage |
| GO:0031086 | 0.02436 | 10.67596 | 0 | 2 | 7 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay |
| GO:0031622 | 0.02436 | 10.67596 | 0 | 2 | 7 | positive regulation of fever generation |
| GO:0032344 | 0.02436 | 10.67596 | 0 | 2 | 7 | regulation of aldosterone metabolic process |
| GO:0032347 | 0.02436 | 10.67596 | 0 | 2 | 7 | regulation of aldosterone biosynthetic process |
| GO:0032489 | 0.02436 | 10.67596 | 0 | 2 | 7 | regulation of Cdc42 protein signal transduction |
| GO:0032960 | 0.02436 | 10.67596 | 0 | 2 | 7 | regulation of inositol trisphosphate biosynthetic process |
| GO:0035425 | 0.02436 | 10.67596 | 0 | 2 | 7 | autocrine signaling |
| GO:0036017 | 0.02436 | 10.67596 | 0 | 2 | 7 | response to erythropoietin |
| GO:0038089 | 0.02436 | 10.67596 | 0 | 2 | 7 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway |
| GO:0042723 | 0.02436 | 10.67596 | 0 | 2 | 7 | thiamine-containing compound metabolic process |
| GO:0043305 | 0.02436 | 10.67596 | 0 | 2 | 7 | negative regulation of mast cell degranulation |
| GO:0043615 | 0.02436 | 10.67596 | 0 | 2 | 7 | astrocyte cell migration |
| GO:0045084 | 0.02436 | 10.67596 | 0 | 2 | 7 | positive regulation of interleukin-12 biosynthetic process |
| GO:0045650 | 0.02436 | 10.67596 | 0 | 2 | 7 | negative regulation of macrophage differentiation |
| GO:0045906 | 0.02436 | 10.67596 | 0 | 2 | 7 | negative regulation of vasoconstriction |
| GO:0046643 | 0.02436 | 10.67596 | 0 | 2 | 7 | regulation of gamma-delta T cell activation |
| GO:0050942 | 0.02436 | 10.67596 | 0 | 2 | 7 | positive regulation of pigment cell differentiation |
| GO:0051005 | 0.02436 | 10.67596 | 0 | 2 | 7 | negative regulation of lipoprotein lipase activity |
| GO:0051388 | 0.02436 | 10.67596 | 0 | 2 | 7 | positive regulation of neurotrophin TRK receptor signaling pathway |
| GO:0060059 | 0.02436 | 10.67596 | 0 | 2 | 7 | embryonic retina morphogenesis in camera-type eye |
| GO:0060353 | 0.02436 | 10.67596 | 0 | 2 | 7 | regulation of cell adhesion molecule production |
| GO:0060437 | 0.02436 | 10.67596 | 0 | 2 | 7 | lung growth |
| GO:0060613 | 0.02436 | 10.67596 | 0 | 2 | 7 | fat pad development |
| GO:0072615 | 0.02436 | 10.67596 | 0 | 2 | 7 | interleukin-17 secretion |
| GO:0097577 | 0.02436 | 10.67596 | 0 | 2 | 7 | sequestering of iron ion |
| GO:1900040 | 0.02436 | 10.67596 | 0 | 2 | 7 | regulation of interleukin-2 secretion |
| GO:1903689 | 0.02436 | 10.67596 | 0 | 2 | 7 | regulation of wound healing, spreading of epidermal cells |
| GO:1903826 | 0.02436 | 10.67596 | 0 | 2 | 7 | arginine transmembrane transport |
| GO:1904747 | 0.02436 | 10.67596 | 0 | 2 | 7 | positive regulation of apoptotic process involved in development |
| GO:2000659 | 0.02436 | 10.67596 | 0 | 2 | 7 | regulation of interleukin-1-mediated signaling pathway |
| GO:2001181 | 0.02436 | 10.67596 | 0 | 2 | 7 | positive regulation of interleukin-10 secretion |
| GO:0051898 | 0.02437 | 2.86855 | 2 | 6 | 62 | negative regulation of protein kinase B signaling |
| GO:0055025 | 0.02437 | 2.86855 | 2 | 6 | 62 | positive regulation of cardiac muscle tissue development |
| GO:0044773 | 0.02441 | 2.40934 | 4 | 8 | 97 | mitotic DNA damage checkpoint |
| GO:0002724 | 0.02468 | 3.96098 | 1 | 4 | 31 | regulation of T cell cytokine production |
| GO:0033198 | 0.02468 | 3.96098 | 1 | 4 | 31 | response to ATP |
| GO:0035767 | 0.02468 | 3.96098 | 1 | 4 | 31 | endothelial cell chemotaxis |
| GO:0043304 | 0.02468 | 3.96098 | 1 | 4 | 31 | regulation of mast cell degranulation |
| GO:0044319 | 0.02468 | 3.96098 | 1 | 4 | 31 | wound healing, spreading of cells |
| GO:0048710 | 0.02468 | 3.96098 | 1 | 4 | 31 | regulation of astrocyte differentiation |
| GO:0090505 | 0.02468 | 3.96098 | 1 | 4 | 31 | epiboly involved in wound healing |
| GO:1902230 | 0.02468 | 3.96098 | 1 | 4 | 31 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage |
| GO:1902895 | 0.02468 | 3.96098 | 1 | 4 | 31 | positive regulation of pri-miRNA transcription by RNA polymerase II |
| GO:1903393 | 0.02468 | 3.96098 | 1 | 4 | 31 | positive regulation of adherens junction organization |
| GO:0001504 | 0.02473 | 3.26288 | 2 | 5 | 46 | neurotransmitter uptake |
| GO:0043300 | 0.02473 | 3.26288 | 2 | 5 | 46 | regulation of leukocyte degranulation |
| GO:0045776 | 0.02473 | 3.26288 | 2 | 5 | 46 | negative regulation of blood pressure |
| GO:1900015 | 0.02473 | 3.26288 | 2 | 5 | 46 | regulation of cytokine production involved in inflammatory response |
| GO:1904738 | 0.02473 | 3.26288 | 2 | 5 | 46 | vascular associated smooth muscle cell migration |
| GO:1904752 | 0.02473 | 3.26288 | 2 | 5 | 46 | regulation of vascular associated smooth muscle cell migration |
| GO:1903322 | 0.02502 | 2.14643 | 5 | 10 | 135 | positive regulation of protein modification by small protein conjugation or removal |
| GO:0044703 | 0.02504 | 1.37607 | 37 | 49 | 1016 | multi-organism reproductive process |
| GO:1900180 | 0.02505 | 2.25564 | 4 | 9 | 116 | regulation of protein localization to nucleus |
| GO:0032956 | 0.02532 | 1.66796 | 12 | 20 | 343 | regulation of actin cytoskeleton organization |
| GO:0034762 | 0.02548 | 1.50678 | 21 | 30 | 568 | regulation of transmembrane transport |
| GO:0060968 | 0.02558 | 2.05044 | 6 | 11 | 155 | regulation of gene silencing |
| GO:0046165 | 0.02570 | 1.97698 | 6 | 12 | 175 | alcohol biosynthetic process |
| GO:2000181 | 0.02570 | 1.97698 | 6 | 12 | 175 | negative regulation of blood vessel morphogenesis |
| GO:0010713 | 0.02571 | 5.34294 | 1 | 3 | 18 | negative regulation of collagen metabolic process |
| GO:0036166 | 0.02571 | 5.34294 | 1 | 3 | 18 | phenotypic switching |
| GO:0043011 | 0.02571 | 5.34294 | 1 | 3 | 18 | myeloid dendritic cell differentiation |
| GO:0044320 | 0.02571 | 5.34294 | 1 | 3 | 18 | cellular response to leptin stimulus |
| GO:0051023 | 0.02571 | 5.34294 | 1 | 3 | 18 | regulation of immunoglobulin secretion |
| GO:0070633 | 0.02571 | 5.34294 | 1 | 3 | 18 | transepithelial transport |
| GO:0071371 | 0.02571 | 5.34294 | 1 | 3 | 18 | cellular response to gonadotropin stimulus |
| GO:0072574 | 0.02571 | 5.34294 | 1 | 3 | 18 | hepatocyte proliferation |
| GO:0072575 | 0.02571 | 5.34294 | 1 | 3 | 18 | epithelial cell proliferation involved in liver morphogenesis |
| GO:0150078 | 0.02571 | 5.34294 | 1 | 3 | 18 | positive regulation of neuroinflammatory response |
| GO:2000047 | 0.02571 | 5.34294 | 1 | 3 | 18 | regulation of cell-cell adhesion mediated by cadherin |
| GO:2000193 | 0.02571 | 5.34294 | 1 | 3 | 18 | positive regulation of fatty acid transport |
| GO:2000319 | 0.02571 | 5.34294 | 1 | 3 | 18 | regulation of T-helper 17 cell differentiation |
| GO:0010721 | 0.02601 | 1.66271 | 12 | 20 | 344 | negative regulation of cell development |
| GO:0031398 | 0.02631 | 2.23463 | 4 | 9 | 117 | positive regulation of protein ubiquitination |
| GO:1903827 | 0.02649 | 1.52437 | 19 | 28 | 524 | regulation of cellular protein localization |
| GO:0045787 | 0.02665 | 1.61569 | 14 | 22 | 389 | positive regulation of cell cycle |
| GO:0030522 | 0.02669 | 1.73917 | 10 | 17 | 280 | intracellular receptor signaling pathway |
| GO:0043087 | 0.02680 | 1.54887 | 17 | 26 | 479 | regulation of GTPase activity |
| GO:0010799 | 0.02688 | 3.18501 | 2 | 5 | 47 | regulation of peptidyl-threonine phosphorylation |
| GO:0030574 | 0.02688 | 3.18501 | 2 | 5 | 47 | collagen catabolic process |
| GO:0031952 | 0.02688 | 3.18501 | 2 | 5 | 47 | regulation of protein autophosphorylation |
| GO:0043303 | 0.02688 | 3.18501 | 2 | 5 | 47 | mast cell degranulation |
| GO:0045058 | 0.02688 | 3.18501 | 2 | 5 | 47 | T cell selection |
| GO:0045646 | 0.02688 | 3.18501 | 2 | 5 | 47 | regulation of erythrocyte differentiation |
| GO:0061614 | 0.02688 | 3.18501 | 2 | 5 | 47 | pri-miRNA transcription by RNA polymerase II |
| GO:0120163 | 0.02688 | 3.18501 | 2 | 5 | 47 | negative regulation of cold-induced thermogenesis |
| GO:2000107 | 0.02688 | 3.18501 | 2 | 5 | 47 | negative regulation of leukocyte apoptotic process |
| GO:0006082 | 0.02727 | 1.34037 | 43 | 56 | 1192 | organic acid metabolic process |
| GO:1902930 | 0.02731 | 2.53383 | 3 | 7 | 81 | regulation of alcohol biosynthetic process |
| GO:0033006 | 0.02742 | 3.81930 | 1 | 4 | 32 | regulation of mast cell activation involved in immune response |
| GO:0042311 | 0.02742 | 3.81930 | 1 | 4 | 32 | vasodilation |
| GO:0045907 | 0.02742 | 3.81930 | 1 | 4 | 32 | positive regulation of vasoconstriction |
| GO:0055022 | 0.02742 | 3.81930 | 1 | 4 | 32 | negative regulation of cardiac muscle tissue growth |
| GO:0060325 | 0.02742 | 3.81930 | 1 | 4 | 32 | face morphogenesis |
| GO:0061117 | 0.02742 | 3.81930 | 1 | 4 | 32 | negative regulation of heart growth |
| GO:0090504 | 0.02742 | 3.81930 | 1 | 4 | 32 | epiboly |
| GO:2000778 | 0.02742 | 3.81930 | 1 | 4 | 32 | positive regulation of interleukin-6 secretion |
| GO:0019439 | 0.02771 | 1.44103 | 26 | 36 | 712 | aromatic compound catabolic process |
| GO:0061572 | 0.02777 | 2.02212 | 6 | 11 | 157 | actin filament bundle organization |
| GO:0071705 | 0.02800 | 1.24452 | 86 | 103 | 2374 | nitrogen compound transport |
| GO:0034446 | 0.02865 | 2.33038 | 4 | 8 | 100 | substrate adhesion-dependent cell spreading |
| GO:0007173 | 0.02894 | 2.19376 | 4 | 9 | 119 | epidermal growth factor receptor signaling pathway |
| GO:0051279 | 0.02897 | 2.49991 | 3 | 7 | 82 | regulation of release of sequestered calcium ion into cytosol |
| GO:0043436 | 0.02903 | 1.33818 | 42 | 55 | 1172 | oxoacid metabolic process |
| GO:0002279 | 0.02914 | 3.11077 | 2 | 5 | 48 | mast cell activation involved in immune response |
| GO:0002711 | 0.02914 | 3.11077 | 2 | 5 | 48 | positive regulation of T cell mediated immunity |
| GO:0010862 | 0.02914 | 3.11077 | 2 | 5 | 48 | positive regulation of pathway-restricted SMAD protein phosphorylation |
| GO:0032648 | 0.02914 | 3.11077 | 2 | 5 | 48 | regulation of interferon-beta production |
| GO:0042059 | 0.02914 | 3.11077 | 2 | 5 | 48 | negative regulation of epidermal growth factor receptor signaling pathway |
| GO:0051150 | 0.02914 | 3.11077 | 2 | 5 | 48 | regulation of smooth muscle cell differentiation |
| GO:0055023 | 0.02914 | 3.11077 | 2 | 5 | 48 | positive regulation of cardiac muscle tissue growth |
| GO:0046677 | 0.02965 | 1.66061 | 12 | 19 | 327 | response to antibiotic |
| GO:0002363 | 0.02972 | 5.00873 | 1 | 3 | 19 | alpha-beta T cell lineage commitment |
| GO:0002544 | 0.02972 | 5.00873 | 1 | 3 | 19 | chronic inflammatory response |
| GO:0002726 | 0.02972 | 5.00873 | 1 | 3 | 19 | positive regulation of T cell cytokine production |
| GO:0006337 | 0.02972 | 5.00873 | 1 | 3 | 19 | nucleosome disassembly |
| GO:0032026 | 0.02972 | 5.00873 | 1 | 3 | 19 | response to magnesium ion |
| GO:0036303 | 0.02972 | 5.00873 | 1 | 3 | 19 | lymph vessel morphogenesis |
| GO:0045076 | 0.02972 | 5.00873 | 1 | 3 | 19 | regulation of interleukin-2 biosynthetic process |
| GO:0046597 | 0.02972 | 5.00873 | 1 | 3 | 19 | negative regulation of viral entry into host cell |
| GO:0046641 | 0.02972 | 5.00873 | 1 | 3 | 19 | positive regulation of alpha-beta T cell proliferation |
| GO:0060149 | 0.02972 | 5.00873 | 1 | 3 | 19 | negative regulation of posttranscriptional gene silencing |
| GO:0060967 | 0.02972 | 5.00873 | 1 | 3 | 19 | negative regulation of gene silencing by RNA |
| GO:0072576 | 0.02972 | 5.00873 | 1 | 3 | 19 | liver morphogenesis |
| GO:1902074 | 0.02972 | 5.00873 | 1 | 3 | 19 | response to salt |
| GO:0033135 | 0.02983 | 2.07940 | 5 | 10 | 139 | regulation of peptidyl-serine phosphorylation |
| GO:0051099 | 0.02992 | 1.92919 | 6 | 12 | 179 | positive regulation of binding |
| GO:0006026 | 0.02993 | 2.72224 | 2 | 6 | 65 | aminoglycan catabolic process |
| GO:0072577 | 0.02993 | 2.72224 | 2 | 6 | 65 | endothelial cell apoptotic process |
| GO:0030001 | 0.02994 | 1.38724 | 32 | 43 | 883 | metal ion transport |
| GO:0050830 | 0.03016 | 2.30520 | 4 | 8 | 101 | defense response to Gram-positive bacterium |
| GO:1903426 | 0.03016 | 2.30520 | 4 | 8 | 101 | regulation of reactive oxygen species biosynthetic process |
| GO:0002698 | 0.03033 | 2.17387 | 4 | 9 | 120 | negative regulation of immune effector process |
| GO:0048011 | 0.03034 | 3.68740 | 1 | 4 | 33 | neurotrophin TRK receptor signaling pathway |
| GO:0048536 | 0.03034 | 3.68740 | 1 | 4 | 33 | spleen development |
| GO:2001024 | 0.03034 | 3.68740 | 1 | 4 | 33 | negative regulation of response to drug |
| GO:0071466 | 0.03105 | 1.91760 | 7 | 12 | 180 | cellular response to xenobiotic stimulus |
| GO:0001701 | 0.03111 | 1.60688 | 14 | 21 | 373 | in utero embryonic development |
| GO:0042737 | 0.03113 | 2.06329 | 5 | 10 | 140 | drug catabolic process |
| GO:0072073 | 0.03113 | 2.06329 | 5 | 10 | 140 | kidney epithelium development |
| GO:0097553 | 0.03113 | 2.06329 | 5 | 10 | 140 | calcium ion transmembrane import into cytosol |
| GO:0034655 | 0.03119 | 1.45028 | 23 | 33 | 648 | nucleobase-containing compound catabolic process |
| GO:0002448 | 0.03152 | 3.03990 | 2 | 5 | 49 | mast cell mediated immunity |
| GO:0002534 | 0.03152 | 3.03990 | 2 | 5 | 49 | cytokine production involved in inflammatory response |
| GO:0010712 | 0.03152 | 3.03990 | 2 | 5 | 49 | regulation of collagen metabolic process |
| GO:0001514 | 0.03171 | 8.89614 | 0 | 2 | 8 | selenocysteine incorporation |
| GO:0001547 | 0.03171 | 8.89614 | 0 | 2 | 8 | antral ovarian follicle growth |
| GO:0002246 | 0.03171 | 8.89614 | 0 | 2 | 8 | wound healing involved in inflammatory response |
| GO:0003307 | 0.03171 | 8.89614 | 0 | 2 | 8 | regulation of Wnt signaling pathway involved in heart development |
| GO:0006451 | 0.03171 | 8.89614 | 0 | 2 | 8 | translational readthrough |
| GO:0006531 | 0.03171 | 8.89614 | 0 | 2 | 8 | aspartate metabolic process |
| GO:0010519 | 0.03171 | 8.89614 | 0 | 2 | 8 | negative regulation of phospholipase activity |
| GO:0010887 | 0.03171 | 8.89614 | 0 | 2 | 8 | negative regulation of cholesterol storage |
| GO:0030854 | 0.03171 | 8.89614 | 0 | 2 | 8 | positive regulation of granulocyte differentiation |
| GO:0031620 | 0.03171 | 8.89614 | 0 | 2 | 8 | regulation of fever generation |
| GO:0036490 | 0.03171 | 8.89614 | 0 | 2 | 8 | regulation of translation in response to endoplasmic reticulum stress |
| GO:0044828 | 0.03171 | 8.89614 | 0 | 2 | 8 | negative regulation by host of viral genome replication |
| GO:0045916 | 0.03171 | 8.89614 | 0 | 2 | 8 | negative regulation of complement activation |
| GO:0050932 | 0.03171 | 8.89614 | 0 | 2 | 8 | regulation of pigment cell differentiation |
| GO:0060056 | 0.03171 | 8.89614 | 0 | 2 | 8 | mammary gland involution |
| GO:0060430 | 0.03171 | 8.89614 | 0 | 2 | 8 | lung saccule development |
| GO:0061043 | 0.03171 | 8.89614 | 0 | 2 | 8 | regulation of vascular wound healing |
| GO:0070813 | 0.03171 | 8.89614 | 0 | 2 | 8 | hydrogen sulfide metabolic process |
| GO:1901724 | 0.03171 | 8.89614 | 0 | 2 | 8 | positive regulation of cell proliferation involved in kidney development |
| GO:1902023 | 0.03171 | 8.89614 | 0 | 2 | 8 | L-arginine transport |
| GO:1902715 | 0.03171 | 8.89614 | 0 | 2 | 8 | positive regulation of interferon-gamma secretion |
| GO:2000048 | 0.03171 | 8.89614 | 0 | 2 | 8 | negative regulation of cell-cell adhesion mediated by cadherin |
| GO:2000258 | 0.03171 | 8.89614 | 0 | 2 | 8 | negative regulation of protein activation cascade |
| GO:2000347 | 0.03171 | 8.89614 | 0 | 2 | 8 | positive regulation of hepatocyte proliferation |
| GO:2000562 | 0.03171 | 8.89614 | 0 | 2 | 8 | negative regulation of CD4-positive, alpha-beta T cell proliferation |
| GO:2000586 | 0.03171 | 8.89614 | 0 | 2 | 8 | regulation of platelet-derived growth factor receptor-beta signaling pathway |
| GO:2001280 | 0.03171 | 8.89614 | 0 | 2 | 8 | positive regulation of unsaturated fatty acid biosynthetic process |
| GO:0043903 | 0.03174 | 1.80836 | 8 | 14 | 222 | regulation of symbiosis, encompassing mutualism through parasitism |
| GO:0000079 | 0.03174 | 2.28055 | 4 | 8 | 102 | regulation of cyclin-dependent protein serine/threonine kinase activity |
| GO:0098869 | 0.03174 | 2.28055 | 4 | 8 | 102 | cellular oxidant detoxification |
| GO:0046888 | 0.03195 | 2.67672 | 2 | 6 | 66 | negative regulation of hormone secretion |
| GO:1905207 | 0.03195 | 2.67672 | 2 | 6 | 66 | regulation of cardiocyte differentiation |
| GO:0043588 | 0.03202 | 1.56525 | 15 | 23 | 419 | skin development |
| GO:0043154 | 0.03247 | 2.43471 | 3 | 7 | 84 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0050852 | 0.03267 | 1.84718 | 7 | 13 | 202 | T cell receptor signaling pathway |
| GO:0019730 | 0.03323 | 2.13516 | 4 | 9 | 122 | antimicrobial humoral response |
| GO:0046883 | 0.03325 | 1.72063 | 10 | 16 | 266 | regulation of hormone secretion |
| GO:0034220 | 0.03331 | 1.32552 | 43 | 55 | 1182 | ion transmembrane transport |
| GO:0007229 | 0.03336 | 2.25641 | 4 | 8 | 103 | integrin-mediated signaling pathway |
| GO:0009164 | 0.03343 | 3.56429 | 1 | 4 | 34 | nucleoside catabolic process |
| GO:0010574 | 0.03343 | 3.56429 | 1 | 4 | 34 | regulation of vascular endothelial growth factor production |
| GO:0010765 | 0.03343 | 3.56429 | 1 | 4 | 34 | positive regulation of sodium ion transport |
| GO:0042533 | 0.03343 | 3.56429 | 1 | 4 | 34 | tumor necrosis factor biosynthetic process |
| GO:0042534 | 0.03343 | 3.56429 | 1 | 4 | 34 | regulation of tumor necrosis factor biosynthetic process |
| GO:0043368 | 0.03343 | 3.56429 | 1 | 4 | 34 | positive T cell selection |
| GO:0097009 | 0.03343 | 3.56429 | 1 | 4 | 34 | energy homeostasis |
| GO:0015718 | 0.03384 | 1.95462 | 6 | 11 | 162 | monocarboxylic acid transport |
| GO:0001706 | 0.03402 | 2.97218 | 2 | 5 | 50 | endoderm formation |
| GO:0010718 | 0.03402 | 2.97218 | 2 | 5 | 50 | positive regulation of epithelial to mesenchymal transition |
| GO:0014009 | 0.03402 | 2.97218 | 2 | 5 | 50 | glial cell proliferation |
| GO:2000725 | 0.03402 | 2.97218 | 2 | 5 | 50 | regulation of cardiac muscle cell differentiation |
| GO:0002374 | 0.03405 | 4.71384 | 1 | 3 | 20 | cytokine secretion involved in immune response |
| GO:0002577 | 0.03405 | 4.71384 | 1 | 3 | 20 | regulation of antigen processing and presentation |
| GO:0002827 | 0.03405 | 4.71384 | 1 | 3 | 20 | positive regulation of T-helper 1 type immune response |
| GO:0031936 | 0.03405 | 4.71384 | 1 | 3 | 20 | negative regulation of chromatin silencing |
| GO:0032042 | 0.03405 | 4.71384 | 1 | 3 | 20 | mitochondrial DNA metabolic process |
| GO:0033005 | 0.03405 | 4.71384 | 1 | 3 | 20 | positive regulation of mast cell activation |
| GO:0033194 | 0.03405 | 4.71384 | 1 | 3 | 20 | response to hydroperoxide |
| GO:0043369 | 0.03405 | 4.71384 | 1 | 3 | 20 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment |
| GO:0043371 | 0.03405 | 4.71384 | 1 | 3 | 20 | negative regulation of CD4-positive, alpha-beta T cell differentiation |
| GO:0043691 | 0.03405 | 4.71384 | 1 | 3 | 20 | reverse cholesterol transport |
| GO:0043931 | 0.03405 | 4.71384 | 1 | 3 | 20 | ossification involved in bone maturation |
| GO:0045019 | 0.03405 | 4.71384 | 1 | 3 | 20 | negative regulation of nitric oxide biosynthetic process |
| GO:0045655 | 0.03405 | 4.71384 | 1 | 3 | 20 | regulation of monocyte differentiation |
| GO:0048670 | 0.03405 | 4.71384 | 1 | 3 | 20 | regulation of collateral sprouting |
| GO:0050860 | 0.03405 | 4.71384 | 1 | 3 | 20 | negative regulation of T cell receptor signaling pathway |
| GO:1902236 | 0.03405 | 4.71384 | 1 | 3 | 20 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway |
| GO:1902993 | 0.03405 | 4.71384 | 1 | 3 | 20 | positive regulation of amyloid precursor protein catabolic process |
| GO:1904406 | 0.03405 | 4.71384 | 1 | 3 | 20 | negative regulation of nitric oxide metabolic process |
| GO:0030858 | 0.03407 | 2.63269 | 2 | 6 | 67 | positive regulation of epithelial cell differentiation |
| GO:0060038 | 0.03407 | 2.63269 | 2 | 6 | 67 | cardiac muscle cell proliferation |
| GO:0002028 | 0.03433 | 2.40336 | 3 | 7 | 85 | regulation of sodium ion transport |
| GO:0034308 | 0.03433 | 2.40336 | 3 | 7 | 85 | primary alcohol metabolic process |
| GO:0045682 | 0.03433 | 2.40336 | 3 | 7 | 85 | regulation of epidermis development |
| GO:0006812 | 0.03450 | 1.32564 | 42 | 54 | 1160 | cation transport |
| GO:0034764 | 0.03496 | 1.82764 | 7 | 13 | 204 | positive regulation of transmembrane transport |
| GO:0031214 | 0.03515 | 1.94165 | 6 | 11 | 163 | biomineral tissue development |
| GO:0006606 | 0.03526 | 2.01641 | 5 | 10 | 143 | protein import into nucleus |
| GO:0030879 | 0.03526 | 2.01641 | 5 | 10 | 143 | mammary gland development |
| GO:0007346 | 0.03609 | 1.43100 | 24 | 33 | 656 | regulation of mitotic cell cycle |
| GO:0000053 | 0.03621 | Inf | 0 | 1 | 1 | argininosuccinate metabolic process |
| GO:0000917 | 0.03621 | Inf | 0 | 1 | 1 | division septum assembly |
| GO:0001315 | 0.03621 | Inf | 0 | 1 | 1 | age-dependent response to reactive oxygen species |
| GO:0001576 | 0.03621 | Inf | 0 | 1 | 1 | globoside biosynthetic process |
| GO:0002194 | 0.03621 | Inf | 0 | 1 | 1 | hepatocyte cell migration |
| GO:0002332 | 0.03621 | Inf | 0 | 1 | 1 | transitional stage B cell differentiation |
| GO:0002333 | 0.03621 | Inf | 0 | 1 | 1 | transitional one stage B cell differentiation |
| GO:0002413 | 0.03621 | Inf | 0 | 1 | 1 | tolerance induction to tumor cell |
| GO:0002472 | 0.03621 | Inf | 0 | 1 | 1 | macrophage antigen processing and presentation |
| GO:0002616 | 0.03621 | Inf | 0 | 1 | 1 | regulation of macrophage antigen processing and presentation |
| GO:0002617 | 0.03621 | Inf | 0 | 1 | 1 | negative regulation of macrophage antigen processing and presentation |
| GO:0002843 | 0.03621 | Inf | 0 | 1 | 1 | regulation of tolerance induction to tumor cell |
| GO:0002845 | 0.03621 | Inf | 0 | 1 | 1 | positive regulation of tolerance induction to tumor cell |
| GO:0003068 | 0.03621 | Inf | 0 | 1 | 1 | regulation of systemic arterial blood pressure by acetylcholine |
| GO:0003069 | 0.03621 | Inf | 0 | 1 | 1 | acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure |
| GO:0003070 | 0.03621 | Inf | 0 | 1 | 1 | regulation of systemic arterial blood pressure by neurotransmitter |
| GO:0006055 | 0.03621 | Inf | 0 | 1 | 1 | CMP-N-acetylneuraminate biosynthetic process |
| GO:0006117 | 0.03621 | Inf | 0 | 1 | 1 | acetaldehyde metabolic process |
| GO:0006148 | 0.03621 | Inf | 0 | 1 | 1 | inosine catabolic process |
| GO:0006218 | 0.03621 | Inf | 0 | 1 | 1 | uridine catabolic process |
| GO:0006542 | 0.03621 | Inf | 0 | 1 | 1 | glutamine biosynthetic process |
| GO:0006738 | 0.03621 | Inf | 0 | 1 | 1 | nicotinamide riboside catabolic process |
| GO:0009444 | 0.03621 | Inf | 0 | 1 | 1 | pyruvate oxidation |
| GO:0009720 | 0.03621 | Inf | 0 | 1 | 1 | detection of hormone stimulus |
| GO:0010335 | 0.03621 | Inf | 0 | 1 | 1 | response to non-ionic osmotic stress |
| GO:0010477 | 0.03621 | Inf | 0 | 1 | 1 | response to sulfur dioxide |
| GO:0010814 | 0.03621 | Inf | 0 | 1 | 1 | substance P catabolic process |
| GO:0010816 | 0.03621 | Inf | 0 | 1 | 1 | calcitonin catabolic process |
| GO:0014810 | 0.03621 | Inf | 0 | 1 | 1 | positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion |
| GO:0014886 | 0.03621 | Inf | 0 | 1 | 1 | transition between slow and fast fiber |
| GO:0015724 | 0.03621 | Inf | 0 | 1 | 1 | formate transport |
| GO:0015797 | 0.03621 | Inf | 0 | 1 | 1 | mannitol transport |
| GO:0018272 | 0.03621 | Inf | 0 | 1 | 1 | protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine |
| GO:0021594 | 0.03621 | Inf | 0 | 1 | 1 | rhombomere formation |
| GO:0021660 | 0.03621 | Inf | 0 | 1 | 1 | rhombomere 3 formation |
| GO:0021664 | 0.03621 | Inf | 0 | 1 | 1 | rhombomere 5 morphogenesis |
| GO:0021666 | 0.03621 | Inf | 0 | 1 | 1 | rhombomere 5 formation |
| GO:0031651 | 0.03621 | Inf | 0 | 1 | 1 | negative regulation of heat generation |
| GO:0032498 | 0.03621 | Inf | 0 | 1 | 1 | detection of muramyl dipeptide |
| GO:0033214 | 0.03621 | Inf | 0 | 1 | 1 | iron assimilation by chelation and transport |
| GO:0034147 | 0.03621 | Inf | 0 | 1 | 1 | regulation of toll-like receptor 5 signaling pathway |
| GO:0034148 | 0.03621 | Inf | 0 | 1 | 1 | negative regulation of toll-like receptor 5 signaling pathway |
| GO:0034443 | 0.03621 | Inf | 0 | 1 | 1 | negative regulation of lipoprotein oxidation |
| GO:0034959 | 0.03621 | Inf | 0 | 1 | 1 | endothelin maturation |
| GO:0035041 | 0.03621 | Inf | 0 | 1 | 1 | sperm chromatin decondensation |
| GO:0035042 | 0.03621 | Inf | 0 | 1 | 1 | fertilization, exchange of chromosomal proteins |
| GO:0035504 | 0.03621 | Inf | 0 | 1 | 1 | regulation of myosin light chain kinase activity |
| GO:0035505 | 0.03621 | Inf | 0 | 1 | 1 | positive regulation of myosin light chain kinase activity |
| GO:0035935 | 0.03621 | Inf | 0 | 1 | 1 | androgen secretion |
| GO:0035998 | 0.03621 | Inf | 0 | 1 | 1 | 7,8-dihydroneopterin 3'-triphosphate biosynthetic process |
| GO:0036290 | 0.03621 | Inf | 0 | 1 | 1 | protein trans-autophosphorylation |
| GO:0036366 | 0.03621 | Inf | 0 | 1 | 1 | transforming growth factor beta3 activation |
| GO:0036497 | 0.03621 | Inf | 0 | 1 | 1 | eIF2alpha dephosphorylation in response to endoplasmic reticulum stress |
| GO:0038097 | 0.03621 | Inf | 0 | 1 | 1 | positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway |
| GO:0042628 | 0.03621 | Inf | 0 | 1 | 1 | mating plug formation |
| GO:0043049 | 0.03621 | Inf | 0 | 1 | 1 | otic placode formation |
| GO:0044524 | 0.03621 | Inf | 0 | 1 | 1 | protein sulfhydration |
| GO:0045297 | 0.03621 | Inf | 0 | 1 | 1 | post-mating behavior |
| GO:0045366 | 0.03621 | Inf | 0 | 1 | 1 | regulation of interleukin-13 biosynthetic process |
| GO:0045368 | 0.03621 | Inf | 0 | 1 | 1 | positive regulation of interleukin-13 biosynthetic process |
| GO:0045380 | 0.03621 | Inf | 0 | 1 | 1 | positive regulation of interleukin-17 biosynthetic process |
| GO:0045828 | 0.03621 | Inf | 0 | 1 | 1 | positive regulation of isoprenoid metabolic process |
| GO:0046296 | 0.03621 | Inf | 0 | 1 | 1 | glycolate catabolic process |
| GO:0046381 | 0.03621 | Inf | 0 | 1 | 1 | CMP-N-acetylneuraminate metabolic process |
| GO:0046495 | 0.03621 | Inf | 0 | 1 | 1 | nicotinamide riboside metabolic process |
| GO:0046521 | 0.03621 | Inf | 0 | 1 | 1 | sphingoid catabolic process |
| GO:0046901 | 0.03621 | Inf | 0 | 1 | 1 | tetrahydrofolylpolyglutamate biosynthetic process |
| GO:0048160 | 0.03621 | Inf | 0 | 1 | 1 | primary follicle stage |
| GO:0048673 | 0.03621 | Inf | 0 | 1 | 1 | collateral sprouting of intact axon in response to injury |
| GO:0048683 | 0.03621 | Inf | 0 | 1 | 1 | regulation of collateral sprouting of intact axon in response to injury |
| GO:0048685 | 0.03621 | Inf | 0 | 1 | 1 | negative regulation of collateral sprouting of intact axon in response to injury |
| GO:0051042 | 0.03621 | Inf | 0 | 1 | 1 | negative regulation of calcium-independent cell-cell adhesion |
| GO:0051615 | 0.03621 | Inf | 0 | 1 | 1 | histamine uptake |
| GO:0060034 | 0.03621 | Inf | 0 | 1 | 1 | notochord cell differentiation |
| GO:0060035 | 0.03621 | Inf | 0 | 1 | 1 | notochord cell development |
| GO:0060234 | 0.03621 | Inf | 0 | 1 | 1 | neuroblast delamination |
| GO:0060588 | 0.03621 | Inf | 0 | 1 | 1 | negative regulation of lipoprotein lipid oxidation |
| GO:0060611 | 0.03621 | Inf | 0 | 1 | 1 | mammary gland fat development |
| GO:0060668 | 0.03621 | Inf | 0 | 1 | 1 | regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling |
| GO:0060683 | 0.03621 | Inf | 0 | 1 | 1 | regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling |
| GO:0060690 | 0.03621 | Inf | 0 | 1 | 1 | epithelial cell differentiation involved in salivary gland development |
| GO:0060691 | 0.03621 | Inf | 0 | 1 | 1 | epithelial cell maturation involved in salivary gland development |
| GO:0060804 | 0.03621 | Inf | 0 | 1 | 1 | positive regulation of Wnt signaling pathway by BMP signaling pathway |
| GO:0060945 | 0.03621 | Inf | 0 | 1 | 1 | cardiac neuron differentiation |
| GO:0061108 | 0.03621 | Inf | 0 | 1 | 1 | seminal vesicle epithelium development |
| GO:0061114 | 0.03621 | Inf | 0 | 1 | 1 | branching involved in pancreas morphogenesis |
| GO:0061143 | 0.03621 | Inf | 0 | 1 | 1 | alveolar primary septum development |
| GO:0061772 | 0.03621 | Inf | 0 | 1 | 1 | drug transport across blood-nerve barrier |
| GO:0061868 | 0.03621 | Inf | 0 | 1 | 1 | hepatic stellate cell migration |
| GO:0061869 | 0.03621 | Inf | 0 | 1 | 1 | regulation of hepatic stellate cell migration |
| GO:0061870 | 0.03621 | Inf | 0 | 1 | 1 | positive regulation of hepatic stellate cell migration |
| GO:0070054 | 0.03621 | Inf | 0 | 1 | 1 | mRNA splicing, via endonucleolytic cleavage and ligation |
| GO:0070238 | 0.03621 | Inf | 0 | 1 | 1 | activated T cell autonomous cell death |
| GO:0070239 | 0.03621 | Inf | 0 | 1 | 1 | regulation of activated T cell autonomous cell death |
| GO:0070241 | 0.03621 | Inf | 0 | 1 | 1 | positive regulation of activated T cell autonomous cell death |
| GO:0070407 | 0.03621 | Inf | 0 | 1 | 1 | oxidation-dependent protein catabolic process |
| GO:0070429 | 0.03621 | Inf | 0 | 1 | 1 | negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway |
| GO:0070637 | 0.03621 | Inf | 0 | 1 | 1 | pyridine nucleoside metabolic process |
| GO:0070638 | 0.03621 | Inf | 0 | 1 | 1 | pyridine nucleoside catabolic process |
| GO:0071348 | 0.03621 | Inf | 0 | 1 | 1 | cellular response to interleukin-11 |
| GO:0071449 | 0.03621 | Inf | 0 | 1 | 1 | cellular response to lipid hydroperoxide |
| GO:0071471 | 0.03621 | Inf | 0 | 1 | 1 | cellular response to non-ionic osmotic stress |
| GO:0071938 | 0.03621 | Inf | 0 | 1 | 1 | vitamin A transport |
| GO:0071939 | 0.03621 | Inf | 0 | 1 | 1 | vitamin A import |
| GO:0072658 | 0.03621 | Inf | 0 | 1 | 1 | maintenance of protein location in membrane |
| GO:0072660 | 0.03621 | Inf | 0 | 1 | 1 | maintenance of protein location in plasma membrane |
| GO:0072714 | 0.03621 | Inf | 0 | 1 | 1 | response to selenite ion |
| GO:0072715 | 0.03621 | Inf | 0 | 1 | 1 | cellular response to selenite ion |
| GO:0080058 | 0.03621 | Inf | 0 | 1 | 1 | protein deglutathionylation |
| GO:0080163 | 0.03621 | Inf | 0 | 1 | 1 | regulation of protein serine/threonine phosphatase activity |
| GO:0090095 | 0.03621 | Inf | 0 | 1 | 1 | regulation of metanephric cap mesenchymal cell proliferation |
| GO:0090096 | 0.03621 | Inf | 0 | 1 | 1 | positive regulation of metanephric cap mesenchymal cell proliferation |
| GO:0090108 | 0.03621 | Inf | 0 | 1 | 1 | positive regulation of high-density lipoprotein particle assembly |
| GO:0090425 | 0.03621 | Inf | 0 | 1 | 1 | acinar cell differentiation |
| GO:0090529 | 0.03621 | Inf | 0 | 1 | 1 | cell septum assembly |
| GO:0097403 | 0.03621 | Inf | 0 | 1 | 1 | cellular response to raffinose |
| GO:0098713 | 0.03621 | Inf | 0 | 1 | 1 | leucine import across plasma membrane |
| GO:0140194 | 0.03621 | Inf | 0 | 1 | 1 | negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process |
| GO:0140214 | 0.03621 | Inf | 0 | 1 | 1 | positive regulation of long-chain fatty acid import into cell |
| GO:1900054 | 0.03621 | Inf | 0 | 1 | 1 | positive regulation of retinoic acid biosynthetic process |
| GO:1900098 | 0.03621 | Inf | 0 | 1 | 1 | regulation of plasma cell differentiation |
| GO:1900100 | 0.03621 | Inf | 0 | 1 | 1 | positive regulation of plasma cell differentiation |
| GO:1900143 | 0.03621 | Inf | 0 | 1 | 1 | positive regulation of oligodendrocyte apoptotic process |
| GO:1900159 | 0.03621 | Inf | 0 | 1 | 1 | positive regulation of bone mineralization involved in bone maturation |
| GO:1900827 | 0.03621 | Inf | 0 | 1 | 1 | positive regulation of membrane depolarization during cardiac muscle cell action potential |
| GO:1901398 | 0.03621 | Inf | 0 | 1 | 1 | regulation of transforming growth factor beta3 activation |
| GO:1901545 | 0.03621 | Inf | 0 | 1 | 1 | response to raffinose |
| GO:1901647 | 0.03621 | Inf | 0 | 1 | 1 | positive regulation of synoviocyte proliferation |
| GO:1901676 | 0.03621 | Inf | 0 | 1 | 1 | positive regulation of histone H3-K27 acetylation |
| GO:1901834 | 0.03621 | Inf | 0 | 1 | 1 | regulation of deadenylation-independent decapping of nuclear-transcribed mRNA |
| GO:1901835 | 0.03621 | Inf | 0 | 1 | 1 | positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA |
| GO:1902010 | 0.03621 | Inf | 0 | 1 | 1 | negative regulation of translation in response to endoplasmic reticulum stress |
| GO:1902045 | 0.03621 | Inf | 0 | 1 | 1 | negative regulation of Fas signaling pathway |
| GO:1902205 | 0.03621 | Inf | 0 | 1 | 1 | regulation of interleukin-2-mediated signaling pathway |
| GO:1902206 | 0.03621 | Inf | 0 | 1 | 1 | negative regulation of interleukin-2-mediated signaling pathway |
| GO:1902215 | 0.03621 | Inf | 0 | 1 | 1 | negative regulation of interleukin-4-mediated signaling pathway |
| GO:1902228 | 0.03621 | Inf | 0 | 1 | 1 | positive regulation of macrophage colony-stimulating factor signaling pathway |
| GO:1902233 | 0.03621 | Inf | 0 | 1 | 1 | negative regulation of positive thymic T cell selection |
| GO:1902238 | 0.03621 | Inf | 0 | 1 | 1 | regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator |
| GO:1902239 | 0.03621 | Inf | 0 | 1 | 1 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator |
| GO:1902748 | 0.03621 | Inf | 0 | 1 | 1 | positive regulation of lens fiber cell differentiation |
| GO:1903544 | 0.03621 | Inf | 0 | 1 | 1 | response to butyrate |
| GO:1903545 | 0.03621 | Inf | 0 | 1 | 1 | cellular response to butyrate |
| GO:1903570 | 0.03621 | Inf | 0 | 1 | 1 | regulation of protein kinase D signaling |
| GO:1903572 | 0.03621 | Inf | 0 | 1 | 1 | positive regulation of protein kinase D signaling |
| GO:1903801 | 0.03621 | Inf | 0 | 1 | 1 | L-leucine import across plasma membrane |
| GO:1903916 | 0.03621 | Inf | 0 | 1 | 1 | regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation |
| GO:1903917 | 0.03621 | Inf | 0 | 1 | 1 | positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation |
| GO:1903996 | 0.03621 | Inf | 0 | 1 | 1 | negative regulation of non-membrane spanning protein tyrosine kinase activity |
| GO:1904205 | 0.03621 | Inf | 0 | 1 | 1 | negative regulation of skeletal muscle hypertrophy |
| GO:1904246 | 0.03621 | Inf | 0 | 1 | 1 | negative regulation of polynucleotide adenylyltransferase activity |
| GO:1904531 | 0.03621 | Inf | 0 | 1 | 1 | positive regulation of actin filament binding |
| GO:1904569 | 0.03621 | Inf | 0 | 1 | 1 | regulation of selenocysteine incorporation |
| GO:1904570 | 0.03621 | Inf | 0 | 1 | 1 | negative regulation of selenocysteine incorporation |
| GO:1904572 | 0.03621 | Inf | 0 | 1 | 1 | negative regulation of mRNA binding |
| GO:1904573 | 0.03621 | Inf | 0 | 1 | 1 | regulation of selenocysteine insertion sequence binding |
| GO:1904574 | 0.03621 | Inf | 0 | 1 | 1 | negative regulation of selenocysteine insertion sequence binding |
| GO:1904618 | 0.03621 | Inf | 0 | 1 | 1 | positive regulation of actin binding |
| GO:1904716 | 0.03621 | Inf | 0 | 1 | 1 | positive regulation of chaperone-mediated autophagy |
| GO:1904935 | 0.03621 | Inf | 0 | 1 | 1 | positive regulation of cell proliferation in midbrain |
| GO:1905061 | 0.03621 | Inf | 0 | 1 | 1 | negative regulation of cardioblast proliferation |
| GO:1905062 | 0.03621 | Inf | 0 | 1 | 1 | positive regulation of cardioblast proliferation |
| GO:1905215 | 0.03621 | Inf | 0 | 1 | 1 | negative regulation of RNA binding |
| GO:1905364 | 0.03621 | Inf | 0 | 1 | 1 | regulation of endosomal vesicle fusion |
| GO:1905377 | 0.03621 | Inf | 0 | 1 | 1 | response to D-galactose |
| GO:1905404 | 0.03621 | Inf | 0 | 1 | 1 | positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process |
| GO:1905603 | 0.03621 | Inf | 0 | 1 | 1 | regulation of maintenance of permeability of blood-brain barrier |
| GO:1905834 | 0.03621 | Inf | 0 | 1 | 1 | response to pyrimidine ribonucleotide |
| GO:1905835 | 0.03621 | Inf | 0 | 1 | 1 | cellular response to pyrimidine ribonucleotide |
| GO:1990127 | 0.03621 | Inf | 0 | 1 | 1 | intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator |
| GO:1990401 | 0.03621 | Inf | 0 | 1 | 1 | embryonic lung development |
| GO:1990579 | 0.03621 | Inf | 0 | 1 | 1 | peptidyl-serine trans-autophosphorylation |
| GO:1990654 | 0.03621 | Inf | 0 | 1 | 1 | sebum secreting cell proliferation |
| GO:1990678 | 0.03621 | Inf | 0 | 1 | 1 | histone H4-K16 deacetylation |
| GO:1990790 | 0.03621 | Inf | 0 | 1 | 1 | response to glial cell derived neurotrophic factor |
| GO:1990792 | 0.03621 | Inf | 0 | 1 | 1 | cellular response to glial cell derived neurotrophic factor |
| GO:2000308 | 0.03621 | Inf | 0 | 1 | 1 | negative regulation of tumor necrosis factor (ligand) superfamily member 11 production |
| GO:2000834 | 0.03621 | Inf | 0 | 1 | 1 | regulation of androgen secretion |
| GO:2000836 | 0.03621 | Inf | 0 | 1 | 1 | positive regulation of androgen secretion |
| GO:2000979 | 0.03621 | Inf | 0 | 1 | 1 | positive regulation of forebrain neuron differentiation |
| GO:2001246 | 0.03621 | Inf | 0 | 1 | 1 | negative regulation of phosphatidylcholine biosynthetic process |
| GO:0001776 | 0.03625 | 2.37280 | 3 | 7 | 86 | leukocyte homeostasis |
| GO:0001942 | 0.03625 | 2.37280 | 3 | 7 | 86 | hair follicle development |
| GO:0035914 | 0.03627 | 2.59008 | 2 | 6 | 68 | skeletal muscle cell differentiation |
| GO:0051101 | 0.03633 | 2.09779 | 4 | 9 | 124 | regulation of DNA binding |
| GO:0051480 | 0.03633 | 1.59740 | 13 | 20 | 357 | regulation of cytosolic calcium ion concentration |
| GO:0001954 | 0.03663 | 2.90741 | 2 | 5 | 51 | positive regulation of cell-matrix adhesion |
| GO:0032007 | 0.03663 | 2.90741 | 2 | 5 | 51 | negative regulation of TOR signaling |
| GO:0045668 | 0.03663 | 2.90741 | 2 | 5 | 51 | negative regulation of osteoblast differentiation |
| GO:0072523 | 0.03663 | 2.90741 | 2 | 5 | 51 | purine-containing compound catabolic process |
| GO:0001893 | 0.03670 | 3.44912 | 1 | 4 | 35 | maternal placenta development |
| GO:0015695 | 0.03670 | 3.44912 | 1 | 4 | 35 | organic cation transport |
| GO:0033363 | 0.03670 | 3.44912 | 1 | 4 | 35 | secretory granule organization |
| GO:0060251 | 0.03670 | 3.44912 | 1 | 4 | 35 | regulation of glial cell proliferation |
| GO:0071312 | 0.03670 | 3.44912 | 1 | 4 | 35 | cellular response to alkaloid |
| GO:1902991 | 0.03670 | 3.44912 | 1 | 4 | 35 | regulation of amyloid precursor protein catabolic process |
| GO:1905332 | 0.03670 | 3.44912 | 1 | 4 | 35 | positive regulation of morphogenesis of an epithelium |
| GO:0055017 | 0.03679 | 2.20964 | 4 | 8 | 105 | cardiac muscle tissue growth |
| GO:0046328 | 0.03716 | 1.86165 | 7 | 12 | 185 | regulation of JNK cascade |
| GO:0042176 | 0.03776 | 1.57046 | 14 | 21 | 381 | regulation of protein catabolic process |
| GO:0007093 | 0.03789 | 1.91622 | 6 | 11 | 165 | mitotic cell cycle checkpoint |
| GO:2000134 | 0.03795 | 2.07959 | 5 | 9 | 125 | negative regulation of G1/S transition of mitotic cell cycle |
| GO:0006865 | 0.03822 | 1.98632 | 5 | 10 | 145 | amino acid transport |
| GO:0002690 | 0.03825 | 2.34301 | 3 | 7 | 87 | positive regulation of leukocyte chemotaxis |
| GO:0051781 | 0.03825 | 2.34301 | 3 | 7 | 87 | positive regulation of cell division |
| GO:0070227 | 0.03855 | 2.54883 | 2 | 6 | 69 | lymphocyte apoptotic process |
| GO:0003300 | 0.03859 | 2.18697 | 4 | 8 | 106 | cardiac muscle hypertrophy |
| GO:0044774 | 0.03859 | 2.18697 | 4 | 8 | 106 | mitotic DNA integrity checkpoint |
| GO:1904029 | 0.03859 | 2.18697 | 4 | 8 | 106 | regulation of cyclin-dependent protein kinase activity |
| GO:0002429 | 0.03860 | 1.50404 | 17 | 25 | 473 | immune response-activating cell surface receptor signaling pathway |
| GO:0017144 | 0.03860 | 1.36978 | 31 | 41 | 851 | drug metabolic process |
| GO:0000956 | 0.03861 | 1.79907 | 7 | 13 | 207 | nuclear-transcribed mRNA catabolic process |
| GO:0030277 | 0.03869 | 4.45171 | 1 | 3 | 21 | maintenance of gastrointestinal epithelium |
| GO:0031498 | 0.03869 | 4.45171 | 1 | 3 | 21 | chromatin disassembly |
| GO:0035743 | 0.03869 | 4.45171 | 1 | 3 | 21 | CD4-positive, alpha-beta T cell cytokine production |
| GO:0060044 | 0.03869 | 4.45171 | 1 | 3 | 21 | negative regulation of cardiac muscle cell proliferation |
| GO:0060713 | 0.03869 | 4.45171 | 1 | 3 | 21 | labyrinthine layer morphogenesis |
| GO:1900016 | 0.03869 | 4.45171 | 1 | 3 | 21 | negative regulation of cytokine production involved in inflammatory response |
| GO:2000316 | 0.03869 | 4.45171 | 1 | 3 | 21 | regulation of T-helper 17 type immune response |
| GO:1902373 | 0.03937 | 2.84539 | 2 | 5 | 52 | negative regulation of mRNA catabolic process |
| GO:2000772 | 0.03937 | 2.84539 | 2 | 5 | 52 | regulation of cellular senescence |
| GO:0002158 | 0.03980 | 7.62484 | 0 | 2 | 9 | osteoclast proliferation |
| GO:0002578 | 0.03980 | 7.62484 | 0 | 2 | 9 | negative regulation of antigen processing and presentation |
| GO:0002634 | 0.03980 | 7.62484 | 0 | 2 | 9 | regulation of germinal center formation |
| GO:0002676 | 0.03980 | 7.62484 | 0 | 2 | 9 | regulation of chronic inflammatory response |
| GO:0003263 | 0.03980 | 7.62484 | 0 | 2 | 9 | cardioblast proliferation |
| GO:0006152 | 0.03980 | 7.62484 | 0 | 2 | 9 | purine nucleoside catabolic process |
| GO:0010533 | 0.03980 | 7.62484 | 0 | 2 | 9 | regulation of activation of Janus kinase activity |
| GO:0010911 | 0.03980 | 7.62484 | 0 | 2 | 9 | regulation of isomerase activity |
| GO:0010912 | 0.03980 | 7.62484 | 0 | 2 | 9 | positive regulation of isomerase activity |
| GO:0021612 | 0.03980 | 7.62484 | 0 | 2 | 9 | facial nerve structural organization |
| GO:0021683 | 0.03980 | 7.62484 | 0 | 2 | 9 | cerebellar granular layer morphogenesis |
| GO:0030223 | 0.03980 | 7.62484 | 0 | 2 | 9 | neutrophil differentiation |
| GO:0033007 | 0.03980 | 7.62484 | 0 | 2 | 9 | negative regulation of mast cell activation involved in immune response |
| GO:0034139 | 0.03980 | 7.62484 | 0 | 2 | 9 | regulation of toll-like receptor 3 signaling pathway |
| GO:0042090 | 0.03980 | 7.62484 | 0 | 2 | 9 | interleukin-12 biosynthetic process |
| GO:0042117 | 0.03980 | 7.62484 | 0 | 2 | 9 | monocyte activation |
| GO:0042363 | 0.03980 | 7.62484 | 0 | 2 | 9 | fat-soluble vitamin catabolic process |
| GO:0043380 | 0.03980 | 7.62484 | 0 | 2 | 9 | regulation of memory T cell differentiation |
| GO:0045075 | 0.03980 | 7.62484 | 0 | 2 | 9 | regulation of interleukin-12 biosynthetic process |
| GO:0045647 | 0.03980 | 7.62484 | 0 | 2 | 9 | negative regulation of erythrocyte differentiation |
| GO:0046130 | 0.03980 | 7.62484 | 0 | 2 | 9 | purine ribonucleoside catabolic process |
| GO:0048087 | 0.03980 | 7.62484 | 0 | 2 | 9 | positive regulation of developmental pigmentation |
| GO:0048387 | 0.03980 | 7.62484 | 0 | 2 | 9 | negative regulation of retinoic acid receptor signaling pathway |
| GO:0048671 | 0.03980 | 7.62484 | 0 | 2 | 9 | negative regulation of collateral sprouting |
| GO:0060352 | 0.03980 | 7.62484 | 0 | 2 | 9 | cell adhesion molecule production |
| GO:0060539 | 0.03980 | 7.62484 | 0 | 2 | 9 | diaphragm development |
| GO:0060693 | 0.03980 | 7.62484 | 0 | 2 | 9 | regulation of branching involved in salivary gland morphogenesis |
| GO:0070424 | 0.03980 | 7.62484 | 0 | 2 | 9 | regulation of nucleotide-binding oligomerization domain containing signaling pathway |
| GO:0071225 | 0.03980 | 7.62484 | 0 | 2 | 9 | cellular response to muramyl dipeptide |
| GO:0097084 | 0.03980 | 7.62484 | 0 | 2 | 9 | vascular smooth muscle cell development |
| GO:1902415 | 0.03980 | 7.62484 | 0 | 2 | 9 | regulation of mRNA binding |
| GO:1904685 | 0.03980 | 7.62484 | 0 | 2 | 9 | positive regulation of metalloendopeptidase activity |
| GO:2000096 | 0.03980 | 7.62484 | 0 | 2 | 9 | positive regulation of Wnt signaling pathway, planar cell polarity pathway |
| GO:2000321 | 0.03980 | 7.62484 | 0 | 2 | 9 | positive regulation of T-helper 17 cell differentiation |
| GO:2001179 | 0.03980 | 7.62484 | 0 | 2 | 9 | regulation of interleukin-10 secretion |
| GO:1901343 | 0.03982 | 1.84017 | 7 | 12 | 187 | negative regulation of vasculature development |
| GO:1901215 | 0.03989 | 1.78974 | 8 | 13 | 208 | negative regulation of neuron death |
| GO:0010742 | 0.04015 | 3.34115 | 1 | 4 | 36 | macrophage derived foam cell differentiation |
| GO:0071634 | 0.04015 | 3.34115 | 1 | 4 | 36 | regulation of transforming growth factor beta production |
| GO:0090077 | 0.04015 | 3.34115 | 1 | 4 | 36 | foam cell differentiation |
| GO:0006508 | 0.04026 | 1.24812 | 68 | 82 | 1874 | proteolysis |
| GO:0051259 | 0.04031 | 1.45153 | 21 | 29 | 568 | protein complex oligomerization |
| GO:0006767 | 0.04031 | 2.31396 | 3 | 7 | 88 | water-soluble vitamin metabolic process |
| GO:0022404 | 0.04031 | 2.31396 | 3 | 7 | 88 | molting cycle process |
| GO:0022405 | 0.04031 | 2.31396 | 3 | 7 | 88 | hair cycle process |
| GO:0098773 | 0.04031 | 2.31396 | 3 | 7 | 88 | skin epidermis development |
| GO:1902476 | 0.04031 | 2.31396 | 3 | 7 | 88 | chloride transmembrane transport |
| GO:0035051 | 0.04078 | 1.89144 | 6 | 11 | 167 | cardiocyte differentiation |
| GO:0009743 | 0.04085 | 1.74060 | 8 | 14 | 230 | response to carbohydrate |
| GO:0060395 | 0.04093 | 2.50886 | 3 | 6 | 70 | SMAD protein signal transduction |
| GO:0030029 | 0.04126 | 1.38518 | 27 | 37 | 759 | actin filament-based process |
| GO:0035270 | 0.04133 | 2.04411 | 5 | 9 | 127 | endocrine system development |
| GO:0010212 | 0.04134 | 1.95710 | 5 | 10 | 147 | response to ionizing radiation |
| GO:0043524 | 0.04134 | 1.95710 | 5 | 10 | 147 | negative regulation of neuron apoptotic process |
| GO:0071236 | 0.04134 | 1.95710 | 5 | 10 | 147 | cellular response to antibiotic |
| GO:1903320 | 0.04211 | 1.73248 | 8 | 14 | 231 | regulation of protein modification by small protein conjugation or removal |
| GO:0000186 | 0.04223 | 2.78595 | 2 | 5 | 53 | activation of MAPKK activity |
| GO:0032964 | 0.04223 | 2.78595 | 2 | 5 | 53 | collagen biosynthetic process |
| GO:0045744 | 0.04223 | 2.78595 | 2 | 5 | 53 | negative regulation of G protein-coupled receptor signaling pathway |
| GO:0070228 | 0.04223 | 2.78595 | 2 | 5 | 53 | regulation of lymphocyte apoptotic process |
| GO:1905517 | 0.04223 | 2.78595 | 2 | 5 | 53 | macrophage migration |
| GO:0007610 | 0.04225 | 1.43518 | 22 | 30 | 594 | behavior |
| GO:0006094 | 0.04245 | 2.28561 | 3 | 7 | 89 | gluconeogenesis |
| GO:0060341 | 0.04262 | 1.34846 | 33 | 43 | 906 | regulation of cellular localization |
| GO:0002792 | 0.04297 | 1.94281 | 5 | 10 | 148 | negative regulation of peptide secretion |
| GO:0035148 | 0.04297 | 1.94281 | 5 | 10 | 148 | tube formation |
| GO:0002089 | 0.04363 | 4.21717 | 1 | 3 | 22 | lens morphogenesis in camera-type eye |
| GO:0007289 | 0.04363 | 4.21717 | 1 | 3 | 22 | spermatid nucleus differentiation |
| GO:0035929 | 0.04363 | 4.21717 | 1 | 3 | 22 | steroid hormone secretion |
| GO:0042094 | 0.04363 | 4.21717 | 1 | 3 | 22 | interleukin-2 biosynthetic process |
| GO:0044321 | 0.04363 | 4.21717 | 1 | 3 | 22 | response to leptin |
| GO:0045624 | 0.04363 | 4.21717 | 1 | 3 | 22 | positive regulation of T-helper cell differentiation |
| GO:0060065 | 0.04363 | 4.21717 | 1 | 3 | 22 | uterus development |
| GO:0060487 | 0.04363 | 4.21717 | 1 | 3 | 22 | lung epithelial cell differentiation |
| GO:0071404 | 0.04363 | 4.21717 | 1 | 3 | 22 | cellular response to low-density lipoprotein particle stimulus |
| GO:0072643 | 0.04363 | 4.21717 | 1 | 3 | 22 | interferon-gamma secretion |
| GO:0000289 | 0.04377 | 3.23972 | 1 | 4 | 37 | nuclear-transcribed mRNA poly(A) tail shortening |
| GO:0033280 | 0.04377 | 3.23972 | 1 | 4 | 37 | response to vitamin D |
| GO:0060323 | 0.04377 | 3.23972 | 1 | 4 | 37 | head morphogenesis |
| GO:0015698 | 0.04381 | 1.86729 | 6 | 11 | 169 | inorganic anion transport |
| GO:0043043 | 0.04401 | 1.38353 | 27 | 36 | 739 | peptide biosynthetic process |
| GO:0072009 | 0.04433 | 2.12166 | 4 | 8 | 109 | nephron epithelium development |
| GO:0003008 | 0.04438 | 1.22367 | 80 | 95 | 2216 | system process |
| GO:0032970 | 0.04439 | 1.53989 | 14 | 21 | 388 | regulation of actin filament-based process |
| GO:0010717 | 0.04466 | 2.25795 | 3 | 7 | 90 | regulation of epithelial to mesenchymal transition |
| GO:0045778 | 0.04466 | 2.25795 | 3 | 7 | 90 | positive regulation of ossification |
| GO:0006470 | 0.04498 | 1.59719 | 12 | 18 | 321 | protein dephosphorylation |
| GO:0002763 | 0.04521 | 2.72895 | 2 | 5 | 54 | positive regulation of myeloid leukocyte differentiation |
| GO:0010524 | 0.04521 | 2.72895 | 2 | 5 | 54 | positive regulation of calcium ion transport into cytosol |
| GO:0051353 | 0.04521 | 2.72895 | 2 | 5 | 54 | positive regulation of oxidoreductase activity |
| GO:1904645 | 0.04521 | 2.72895 | 2 | 5 | 54 | response to amyloid-beta |
| GO:0051129 | 0.04546 | 1.37944 | 27 | 36 | 741 | negative regulation of cellular component organization |
| GO:0038034 | 0.04596 | 2.43256 | 3 | 6 | 72 | signal transduction in absence of ligand |
| GO:0051155 | 0.04596 | 2.43256 | 3 | 6 | 72 | positive regulation of striated muscle cell differentiation |
| GO:0097192 | 0.04596 | 2.43256 | 3 | 6 | 72 | extrinsic apoptotic signaling pathway in absence of ligand |
| GO:0048588 | 0.04604 | 1.70857 | 8 | 14 | 234 | developmental cell growth |
| GO:0008360 | 0.04635 | 1.91484 | 5 | 10 | 150 | regulation of cell shape |
| GO:0042157 | 0.04678 | 1.99310 | 5 | 9 | 130 | lipoprotein metabolic process |
| GO:0046700 | 0.04692 | 1.38872 | 25 | 34 | 695 | heterocycle catabolic process |
| GO:0003205 | 0.04700 | 1.84374 | 6 | 11 | 171 | cardiac chamber development |
| GO:0002768 | 0.04708 | 1.45950 | 18 | 26 | 506 | immune response-regulating cell surface receptor signaling pathway |
| GO:0060560 | 0.04741 | 1.70074 | 9 | 14 | 235 | developmental growth involved in morphogenesis |
| GO:0002707 | 0.04757 | 3.14426 | 1 | 4 | 38 | negative regulation of lymphocyte mediated immunity |
| GO:0010667 | 0.04757 | 3.14426 | 1 | 4 | 38 | negative regulation of cardiac muscle cell apoptotic process |
| GO:0048246 | 0.04757 | 3.14426 | 1 | 4 | 38 | macrophage chemotaxis |
| GO:0060045 | 0.04757 | 3.14426 | 1 | 4 | 38 | positive regulation of cardiac muscle cell proliferation |
| GO:0060416 | 0.04757 | 3.14426 | 1 | 4 | 38 | response to growth hormone |
| GO:0071604 | 0.04757 | 3.14426 | 1 | 4 | 38 | transforming growth factor beta production |
| GO:0044270 | 0.04770 | 1.38655 | 25 | 34 | 696 | cellular nitrogen compound catabolic process |
| GO:0055088 | 0.04811 | 1.90116 | 5 | 10 | 151 | lipid homeostasis |
| GO:0015893 | 0.04816 | 1.73573 | 8 | 13 | 214 | drug transport |
| GO:2001020 | 0.04816 | 1.73573 | 8 | 13 | 214 | regulation of response to DNA damage stimulus |
| GO:0002011 | 0.04831 | 2.67422 | 2 | 5 | 55 | morphogenesis of an epithelial sheet |
| GO:0002090 | 0.04831 | 2.67422 | 2 | 5 | 55 | regulation of receptor internalization |
| GO:0002886 | 0.04831 | 2.67422 | 2 | 5 | 55 | regulation of myeloid leukocyte mediated immunity |
| GO:0006576 | 0.04831 | 2.67422 | 2 | 5 | 55 | cellular biogenic amine metabolic process |
| GO:0070830 | 0.04831 | 2.67422 | 2 | 5 | 55 | bicellular tight junction assembly |
| GO:2000242 | 0.04831 | 2.67422 | 2 | 5 | 55 | negative regulation of reproductive process |
| GO:0098661 | 0.04845 | 2.08023 | 4 | 8 | 111 | inorganic anion transmembrane transport |
| GO:0000290 | 0.04858 | 6.67136 | 0 | 2 | 10 | deadenylation-dependent decapping of nuclear-transcribed mRNA |
| GO:0001660 | 0.04858 | 6.67136 | 0 | 2 | 10 | fever generation |
| GO:0002713 | 0.04858 | 6.67136 | 0 | 2 | 10 | negative regulation of B cell mediated immunity |
| GO:0002890 | 0.04858 | 6.67136 | 0 | 2 | 10 | negative regulation of immunoglobulin mediated immune response |
| GO:0007028 | 0.04858 | 6.67136 | 0 | 2 | 10 | cytoplasm organization |
| GO:0009396 | 0.04858 | 6.67136 | 0 | 2 | 10 | folic acid-containing compound biosynthetic process |
| GO:0015809 | 0.04858 | 6.67136 | 0 | 2 | 10 | arginine transport |
| GO:0032341 | 0.04858 | 6.67136 | 0 | 2 | 10 | aldosterone metabolic process |
| GO:0032342 | 0.04858 | 6.67136 | 0 | 2 | 10 | aldosterone biosynthetic process |
| GO:0034350 | 0.04858 | 6.67136 | 0 | 2 | 10 | regulation of glial cell apoptotic process |
| GO:0036500 | 0.04858 | 6.67136 | 0 | 2 | 10 | ATF6-mediated unfolded protein response |
| GO:0042536 | 0.04858 | 6.67136 | 0 | 2 | 10 | negative regulation of tumor necrosis factor biosynthetic process |
| GO:0043379 | 0.04858 | 6.67136 | 0 | 2 | 10 | memory T cell differentiation |
| GO:0045657 | 0.04858 | 6.67136 | 0 | 2 | 10 | positive regulation of monocyte differentiation |
| GO:0046642 | 0.04858 | 6.67136 | 0 | 2 | 10 | negative regulation of alpha-beta T cell proliferation |
| GO:0048570 | 0.04858 | 6.67136 | 0 | 2 | 10 | notochord morphogenesis |
| GO:0050861 | 0.04858 | 6.67136 | 0 | 2 | 10 | positive regulation of B cell receptor signaling pathway |
| GO:0051409 | 0.04858 | 6.67136 | 0 | 2 | 10 | response to nitrosative stress |
| GO:0051901 | 0.04858 | 6.67136 | 0 | 2 | 10 | positive regulation of mitochondrial depolarization |
| GO:0071233 | 0.04858 | 6.67136 | 0 | 2 | 10 | cellular response to leucine |
| GO:0071281 | 0.04858 | 6.67136 | 0 | 2 | 10 | cellular response to iron ion |
| GO:0072015 | 0.04858 | 6.67136 | 0 | 2 | 10 | glomerular visceral epithelial cell development |
| GO:0072203 | 0.04858 | 6.67136 | 0 | 2 | 10 | cell proliferation involved in metanephros development |
| GO:0090030 | 0.04858 | 6.67136 | 0 | 2 | 10 | regulation of steroid hormone biosynthetic process |
| GO:0090336 | 0.04858 | 6.67136 | 0 | 2 | 10 | positive regulation of brown fat cell differentiation |
| GO:0090715 | 0.04858 | 6.67136 | 0 | 2 | 10 | immunological memory formation process |
| GO:0140052 | 0.04858 | 6.67136 | 0 | 2 | 10 | cellular response to oxidised low-density lipoprotein particle stimulus |
| GO:1902033 | 0.04858 | 6.67136 | 0 | 2 | 10 | regulation of hematopoietic stem cell proliferation |
| GO:1902237 | 0.04858 | 6.67136 | 0 | 2 | 10 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway |
| GO:1903897 | 0.04858 | 6.67136 | 0 | 2 | 10 | regulation of PERK-mediated unfolded protein response |
| GO:1990253 | 0.04858 | 6.67136 | 0 | 2 | 10 | cellular response to leucine starvation |
| GO:1990822 | 0.04858 | 6.67136 | 0 | 2 | 10 | basic amino acid transmembrane transport |
| GO:2000628 | 0.04858 | 6.67136 | 0 | 2 | 10 | regulation of miRNA metabolic process |
| GO:2000833 | 0.04858 | 6.67136 | 0 | 2 | 10 | positive regulation of steroid hormone secretion |
| GO:2001214 | 0.04858 | 6.67136 | 0 | 2 | 10 | positive regulation of vasculogenesis |
| GO:0032945 | 0.04862 | 2.39612 | 3 | 6 | 73 | negative regulation of mononuclear cell proliferation |
| GO:0050672 | 0.04862 | 2.39612 | 3 | 6 | 73 | negative regulation of lymphocyte proliferation |
| GO:0061844 | 0.04862 | 2.39612 | 3 | 6 | 73 | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GO:1902807 | 0.04869 | 1.97665 | 5 | 9 | 131 | negative regulation of cell cycle G1/S phase transition |
| GO:0032753 | 0.04886 | 4.00609 | 1 | 3 | 23 | positive regulation of interleukin-4 production |
| GO:0042401 | 0.04886 | 4.00609 | 1 | 3 | 23 | cellular biogenic amine biosynthetic process |
| GO:0042454 | 0.04886 | 4.00609 | 1 | 3 | 23 | ribonucleoside catabolic process |
| GO:0051043 | 0.04886 | 4.00609 | 1 | 3 | 23 | regulation of membrane protein ectodomain proteolysis |
| GO:0051152 | 0.04886 | 4.00609 | 1 | 3 | 23 | positive regulation of smooth muscle cell differentiation |
| GO:0051882 | 0.04886 | 4.00609 | 1 | 3 | 23 | mitochondrial depolarization |
| GO:0060055 | 0.04886 | 4.00609 | 1 | 3 | 23 | angiogenesis involved in wound healing |
| GO:0060479 | 0.04886 | 4.00609 | 1 | 3 | 23 | lung cell differentiation |
| GO:0070977 | 0.04886 | 4.00609 | 1 | 3 | 23 | bone maturation |
| GO:0071425 | 0.04886 | 4.00609 | 1 | 3 | 23 | hematopoietic stem cell proliferation |
| GO:0072215 | 0.04886 | 4.00609 | 1 | 3 | 23 | regulation of metanephros development |
| GO:0089718 | 0.04886 | 4.00609 | 1 | 3 | 23 | amino acid import across plasma membrane |
| GO:1901032 | 0.04886 | 4.00609 | 1 | 3 | 23 | negative regulation of response to reactive oxygen species |
| GO:1902254 | 0.04886 | 4.00609 | 1 | 3 | 23 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator |
| GO:1903206 | 0.04886 | 4.00609 | 1 | 3 | 23 | negative regulation of hydrogen peroxide-induced cell death |
| GO:2001039 | 0.04886 | 4.00609 | 1 | 3 | 23 | negative regulation of cellular response to drug |
| GO:0019319 | 0.04929 | 2.20457 | 3 | 7 | 92 | hexose biosynthetic process |
| GO:0060627 | 0.04947 | 1.44076 | 19 | 27 | 532 | regulation of vesicle-mediated transport |